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Abstract 
 
The aim of this Ph.D project was to synthesize and characterise nanoparticle-based 
MRI contrast agents. In the first instance, the DTPA (diethylenetriaminepentaacetic 
acid) based ligand was designed, synthesized and characterised. This ligand was 
utilised for stabilisation of gold nanoparticles. The gold nanoparticles protected by 
DTPA based ligand were characterised using UV-Vis, NMR spectroscopies, TGA 
and TEM. The nanoparticles were then loaded with gadolinium. The relaxivity of 
gadolinium loaded gold nanoparticles were studied using inversion recovery method 
and compared with commercially available MRI contrast agents (i.e. Gd-DTPA). 
The Gd-loaded AuNPs showed only a moderate increase in their relaxivity as 
compared to the Gd-DTPA complex. 
 
The factors limiting the relaxivity of Gd-loaded AuNPs were explored using EPR 
spectroscopy. For EPR measurements, Gd3+ was replaced with vanadyl (VO2+) 
which gives EPR spectra sensitive to the rate of molecular tumbling on nanosecond 
time scale. The EPR measurements of VO2+-loaded AuNPs showed that the 
nanoparticle attached metal ion retains high molecular mobility. This is likely 
responsible for only a moderate increase in relaxivity. We next explored different 
strategies for increasing the relaxivity of gold nanoparticles based MRI contrast 
agents. In the first strategy, in order to enhance ligand packing at AuNPs surface, the 
size of the AuNPs was increased from ~2.0 nm to ~6.0 nm. The relaxivity was found 
to increase with the increased size of the AuNPs. Secondly, polyelectrolyte coating 
of charged Gd-loaded AuNPs surface also resulted in increase of relaxivity due to 
better immobilisation of the Gd3+ ions. 
 
Gold nanoparticles were also used as templates for nitroxide based redox sensitive 
MRI contrast agents. The reducing behaviour and relaxivity of nitroxide protected 
AuNPs was measured and found slightly better than that of free nitroxide. 
 
Finally other useful applications of nanoparticles protected by DTPA based ligand 
were explored. For example, the DTPA ligand can also chelate strongly with other 
   
ii 
 
lanthanides such as Eu3+, Tb3+etc. The luminescence measurements of lanthanides 
(Eu3+ and Tb3+) loaded onto AuNPs were explored. Lanthanide-loaded AuNPs were 
also used as model compounds to test an important EPR methodology after labelling 
with a nitroxide based spin label. 
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Abbreviations 
aq   Aqueous 
AuNPs   Gold nanoparticles 
Ar   Aromatic 
BTT   Biotin terminated thiol 
Calcd   Calculated 
CAs   Contrast agents 
Da   Dalton 
d   Doublet 
DTPA   Diethylenetriamine pentaacetic acid 
DCC   Dicyclohexyl carbodimide 
DMAP   4-N,N-Dimethylaminopyridine 
DMF   Dimethylformamide 
DMSO   Dimethylsulfoxide 
DCM   Dichloromethane 
EPR   Electron paramagnetic resonance 
ESI   Electron spray ionization 
Eq   Equation 
g   Gram 
GPC   Gel permeation chromatography 
h   Hour 
ICP   Inductively Coupled Plasma (Spectrometry) 
HR-MS  High Resolution Mass Spectrometry 
Ln   Lanthanide 
kDa   Kilo Dalton 
MRI   Magnetic resonance imaging 
Mn   Number average molecular mass 
MW   Molecular weight 
MWCO  Molecular weight cut off 
MS   Mass spectrometry 
m/z   Charge to mass ratio 
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mL   Millilitre 
mg   Milligram 
min   Minute 
NMR   Nuclear magnetic resonance 
NMV   Net magnetization vector 
NBS   N-bromosuccinimide 
nm   Nanometre 
o/n   Overnight 
Obsd   Observed 
ppm   Parts per million 
R1   Spin lattice relaxivity 
RF   Radio frequency 
RMM   Relative molecular mass 
s   singlet , seconds 
SPB   Surface Plasmon Band 
T1   Spin lattice relaxation time 
T2   Spin spin relaxation time 
TEM   Transmission electron microscopy 
TEMPO  2,2,6,6-tetramethyl-1-piperidinyloxyl 
TFA   Trifluroacetic acid 
TGA   Thermogravimetric analysis 
THF   Tetrahydrofuran 
TR   Time of repetition 
TE   Echo time 
t   triplet 
UV-Vis.  Ultraviolet visible 
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Chapter 1: Introduction 
 
1.1 Magnetic resonance imaging (MRI) 
 
Magnetic resonance imaging (MRI) is a powerful modern diagnostic technique. It is 
primarily used to produce anatomical images, but physico-chemical state, flow 
diffusion and other tissue parameters can also be determined using MRI images. 
MRI can provide excellent soft tissue contrast up to submillimeter resolution, 
penetrating deep into the tissues. It is frequently used in modern biomedical 
research.1-2 The first MRI image was published in 1973 and the first MRI scan of a 
human body was done on July 3, 1977. 3-4 Paul Lauterbur and Peter Mansfield were 
awarded a Noble Prize (in 2003) for their major contributions to the invention of 
MRI. MRI has many advantages over other diagnostic techniques such as X-ray and 
computed tomography (CT) scanning. The X-ray and CT scan both involve the use 
of ionizing radiation. MRI, on the other hand, uses a harmless magnetic field and 
electromagnetic radiation and is therefore referred to as a non-invasive technique.5 
 
1.1.1 Principles of MRI 
 
MRI relies on the nuclear magnetic resonance (NMR) phenomenon and was 
originally termed NMR imaging. The 1H nucleus is magnetic resonance (MR) 
active as it contains only one proton and has spin (I) = ½. Most MRI experiments 
use the 1H nucleus due to the following reasons: 
• It is abundant (>60%) in human body (in the form of water and fat). 
• Its solitary proton gives it a large magnetic moment.6 
 
MRI gives the spatial distribution of the intensity of water protons in the specific 
volume of the body, while NMR gives information about chemical shifts and 
coupling constants.  
 
  Chapter 1  
3 
 
The signal intensity depends upon the amount of (water) protons and their 
relaxation times. The basic NMR theory and the relaxation phenomenon are 
therefore discussed in detail in the following sections.  
 
1.1.2 Basic theory of NMR (creating magnetic resonance signal)  
 
According to the quantum mechanical approach, nuclei with spin “I” possess 
(quantised) angular momentum P which is further associated with their magnetic 
moment (µ) (Eq 1.1 and 1.2). 
 
h)I(IP 1+=  , where ħ=h/2π     Eq. 1.1 
 γPµ =        Eq. 1.2 
 
In equation (1.2), γ is a proportionality constant (i.e. magnetogyric ratio) for the 
given isotope. In the presence of an applied magnetic field (B0), the angular 
momentum component parallel (along z-axis) to the B0 is given as: 
 
 hmzP =        Eq. 1.3 
 
In equation (1.3), “m” is the magnetic quantum number that has values from I, I–
1,…… to “–I”. The number of possible orientations of nuclear angular momentum in 
the presence of B0 can be determined from the value of I by the simple formula 2I+1. 
For example, in the case of 1H nuclei (I = ½), the nuclear angular momentum will 
have two orientations i.e. either parallel (m= +1/2) or antiparallel (m= –1/2) to the 
magnetic field. This classical approach which is used to simplify the NMR picture 
assumes the magnetic moments of nuclei behave as tiny magnetic bars. In the 
absence of B0 tiny magnetic bars are randomly oriented and thus their spins are 
averaged out. In the presence of B0, the nuclear spins with relatively higher energy 
align antiparallel while those with lower energy align parallel to B0 and the energy 
difference (∆E) between these two states is given as:  
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0
BE hγ=∆        Eq. 1.4 
 
The energy difference is usually very small and therefore the population difference 
of nuclei between these two states is also very small. For example the number of 
excess nuclei in the lower energy level is 1 in 100000 at 3.0 T and 1 in 30000 at 9.4 
T. These extra nuclei in the low energy state add together to give a net bulk 
magnetisation along the direction (z-axis) of the applied magnetic field (B0) (Figure 
1.1). This net magnetisation is usually represented by a vector called the net 
magnetisation vector (NMV).  
 
x y
z
Bo
Precessional motion
 
Figure 1.1: Schematic representation of bulk magnetisation (i.e. NMV) in the presence 
of a magnetic field. 
 
The applied magnetic field imposes a torque on the magnetic moments of nuclei and 
therefore they are forced to remain at certain angle to the B0. As a result the 
magnetic moments of the nuclei wobble around the axis of B0 with a certain 
frequency. This motion (wobbling) is called precessional motion and the frequency 
of this motion is called the Larmor frequency (ω) which is given as:  
 
  γω
0
B=       Eq. 1.5 
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In above equation, ω is the angular frequency. Equation 1.5 can be modified to give 
Larmor frequency “ν” (in hertz) as follows: 
 
 
π
γ
π
ω
ν
2
0
2
B
alprecession
==      Eq 1.6 
 
When radiofrequency (RF) pulses are applied, the transition of nuclei between low 
and high energy levels occurs as the frequency of the magnetic field component of 
RF pulses matches the Larmor frequency. The magnetic field (B1) associated with 
the RF pulses is in transverse (x-y) plane i.e. B1 is perpendicular to B0.  
 
The visualisation of the processes occurring during an NMR experiment can be aided 
by a simplified formalism known as “rotating frame of reference” which is opposite 
to the “laboratory (fixed) frame of reference” (which has been used so far) (Figure 
1.2). A rotating frame of reference is a non-inertial frame of reference which is 
rotating relative to an inertial frame of reference. For simplification B1 is supposed to 
be composed of two counter rotating magnetic vectors in x-y plane with the 
frequency equal to Larmor frequency (νL). In the rotating frame of reference things 
can be simplified further. Out of two parts of B1, one part can be frozen (as in 
rotating frame of reference both NMV and B1 are moving) while the other part 
(moving opposite to NMV) can be ignored as it is moving with frequency far away 
from the Larmor frequency.  
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Figure 1.2: Schematic representation of the laboratory frame of reference and the 
rotating frame of reference.  
 
As the electromagnetic field B1 imposes a torque on the NMV (i.e. Mz as NMV is 
parallel to the z-axis) perpendicular to the direction of B1, the NMV moves from z-
axis to the x-y plane (Mxy) (depending upon the amplitude and duration of the pulse 
which will be discussed later). When the RF pulses are turned off, two things occur: 
(a) the NMV moves back to align along B0 (this phenomenon is called relaxation), 
and (b) if a receiver coil is placed in the area of rotating magnetic moments, a 
voltage (i.e. magnetic resonance signal) is produced; this voltage is responsible for 
the NMR signal. The NMR signal thus depends upon the amplitude and duration of 
the pulse. The 90o and 270o RF pulses yield the maximum signals while in case of 
180o pulse, NMV will move into the –z-axis and no signal will be detected. 7-9 
 
The relaxation phenomenon plays an important role in the image formation during 
MRI. The relaxation phenomenon in NMR is of two types i.e. spin lattice relaxation 
and spin-spin relaxation, and is discussed in the next section.10 
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1.1.3 Spin-lattice relaxation  
The recovery of NMV along the z-axis (i.e. longitudinal axis) after the removal of 
the RF pulse is called spin lattice or longitudinal relaxation (Figure 1.3) while the 
loss of Mxy is termed transverse or spin-spin relaxation. In the spin lattice relaxation, 
the absorbed energy is dissipated to the lattice. The lattice may be surrounding 
molecules or walls of the vessel. Nuclei in the lattice are in rotational and vibrational 
motion that creates complex magnetic fields. Some of the components of this 
magnetic field may have a frequency equal to the Larmor frequency. This makes the 
nuclei relax. The interaction of the lattice nuclei/molecules with the excited nuclei 
also depends upon the mobility of the lattice; i.e. if mobility is high, there will be 
more interaction of lattice nuclei with the excited nuclei and vice versa. According to 
time dependent perturbation theory the relaxation rates depend upon the spectral 
density functions. The spectral density function is the intensity / concentration of 
fluctuating magnetic field at the given frequency of motion. In more precise way it 
indicates the amount of molecular motion which is at correct frequency to cause the 
relaxation. 
 
Figure 1.3: Schematic illustration of spin-lattice (longitudinal) relaxation. 
The time constant which describes how NMV returns to its equilibrium value Mz(0) 
is called the spin lattice relaxation time (T1). Spin lattice relaxation is a first order 
process and T1 is the time required to recover ~63% of net magnetization vector of 
its original value Mz(0) (Figure 1.4). 
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Figure 1.4: Spin-lattice relaxation time (T1). 
 
 Mathematically the recovery of magnetization is given by eq. (1.7)    
 
 
1
)0()()(
T
zMtzM
dt
tzdM −=    Eq. 1.7 
In equation 1.7,  
Mz(t) = Recovered magnetization vector after the removal of RF pulse at time t.
9-10 
 
1.1.4 Spin-spin relaxation 
 
Spin-spin relaxation results in the loss of transverse magnetization (Mxy) and hence 
is also called transverse relaxation. In spin-spin relaxation, energy is transferred from 
one nucleus to another via fluctuating nuclear dipoles. As a result, the energy of one 
nucleus is increased while for the other is decreased. The net energy remains the 
same, only the Mxy(t) returns to Mxy(0). The Mxy is the sum of magnetic moments of 
several nuclei, and all these nuclear magnetic moments are supposed to possess 
phase coherence in the x-y plane after the application of RF pulse. All these nuclear 
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spins (i.e. magnetic moments) will remain static in the rotating frame if all the 
nuclear spins in the sample are experiencing exactly the same magnetic field. 
However, in fact this is not possible; therefore some of the nuclei precess with the 
frequency slightly higher than Larmor frequency while some exhibit precessional 
motion with the frequency slightly smaller than the Larmor frequency. Two main 
factors are responsible for inhomogeneous fields experienced by the sample: (a) 
static magnetic field inhomogenity which is purely instrumental imperfection and (b) 
local magnetic field arising from intermolecular and intramolecular interactions in 
the sample. The second factor is responsible for the genuine or natural transverse 
relaxation. When RF pulse is switched off, spin-spin interactions between low and 
high energy nuclei lead to the fanning-out of the individual magnetisation vectors 
(Figure 1.5). 
 
 
Figure 1.5: Schematic illustration of spin-spin (or transverse) relaxation. 
 
Both longitudinal and transverse relaxation phenomena take place simultaneously. 
Spin-spin relaxation is characterized by the spin-spin relaxation time constant, 
denoted by T2. Spin-spin relaxation time (T2) is the time required for ~37% of 
transverse magnetization (Mxy(t)) to decay from its original value (Mxy(0)) (Figure 
1.6). 
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Figure 1.6: Spin-spin relaxation time. 
 
Mathematically the spin-spin relaxation time T2 is given as: 
2/)0()( Ttxyxy eMtM
−=     Eq. 1.8 
As this thesis mainly deals with T1 measurements, the next section briefly describes 
experimental methods for the determination of T1. 
1.1.5 Experimental determination of spin-lattice relaxation time 
(T1)  
The following three pulse techniques are frequently used for determination of T1. 
1. Inversion Recovery (IR) 
2. Saturation Recovery (SR) 
3. Null Method 
 
 Inversion recovery method was used for measuring T1 relaxation time in this work, 
it is discussed in detail in the following section.11 
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1.1.5.1 Inversion-recovery sequence for determination of T1  
The inversion-recovery is the most frequently used method for determination of 
longitudinal relaxation time T1. The inversion recovery experiment is a simple two 
pulse experiment. In the first instance, the Mz(0) is inverted (to –z axis) by applying 
a 180o pulse. The –Mz(t) relaxes back to +Mz(0) with the time constant T1. As the 
+Mz needs to be observed, it is again moved to the transverse (x-y) plane (Mxy) by a 
90o pulse after a suitable delay time τ (Figure 1.7).  
 
 
Figure 1.7: Schematic representation of inversion recovery process. 
 
When τ is zero, the Mz = –Mz. This experiment is repeated with increasing values of 
τ and the signal after every 90o pulse is recorded. Mathematically, magnetisation 
detected at various values of τ is given as: 
 
  )21)(0()( 1/Tzz eMtM
τ−−=     Eq. 1.9 
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In equation (1.9), Mz(0) is the equilibrium magnetisation which is recorded at τ∞. 
The relaxation time T1 is determined by fitting the signal intensities (i.e. recovered 
magnetisation at various time intervals τ) to equation (1.9). The fitting can be done 
using algorithms which are available in many NMR software packages. 
Alternatively, T1 can also be determined from the slope of the plot of ln(Mz(0) – 
Mz(t)) vs τ.                                             
 
1.1.6 Obtaining spatial information (for image  formation in 
MRI)
12-14 
 
In the above section, the basic principles of NMR were discussed i.e. interaction 
between NMR active nuclei and the RF pulses in the presence of an applied 
magnetic field. In MRI, magnetic field gradients are applied in addition to the main 
magnetic field (B0), which are small perturbations superimposed on B0. 
Mathematically, the magnetic field (Bi) at position “ri” is given as: 
 
  iTi rGBB += 0      Eq. 1.10 
 
In equation (1.10), GT is the total gradient amplitude. Gradients are generated by 
coils which are placed within the bore of the magnet and they produce linear 
variations in one direction only, therefore for 3D imaging three gradient coils located 
in three different orientations (i.e. along x, y and z-directions) are required. Gradients 
are usually applied for a short period of time during a scan and hence are called 
gradient pulses. Gradient pulses, RF-pulses, the data sampling period and the time 
interval between each of them are collectively referred to as a pulse sequence 
(discussed in section 1.1.7). 
 
In the presence of magnetic field gradients, the Larmor frequency equation (1.5) will 
be modified as: 
   
  )( 0 ii GrB += γω    Eq. 1.11 
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In equation (1.11), ωi is the Larmor frequency of protons at position i while G 
represents the total gradient amplitude (expressed in mT/m or G/cm). According to 
equation 1.11, every proton has a unique Larmor frequency which depends on its 
location / position within the gradient field.  
 
Gradients perform the following three main tasks in encoding the spatial 
information. 
 
(a) Slice selection 
(b) Frequency encoding 
(c) Phase encoding  
 
1.1.6.1 Slice selection 
 
Field gradients change the frequency (νL) of body protons in a linear fashion along 
the direction of the gradients. Therefore, protons in selected slice along the direction 
of the gradients have a specific range of Larmor frequencies (slice selection gradient 
GSS). A frequency selective RF pulse having a central frequency and a narrow band 
of frequencies which coincides with the proton frequencies in the selected slice is 
applied. As a result, only the protons in the selected slice are excited. The central 
frequency determines the particular position of the slice. The thickness of the slice 
can be determined from the slice selected gradient amplitude (GSS) and the 
bandwidth of frequencies (∆ωss) in the RF pulse as given by following equation 
(1.12). 
 
 )Thickness Slice( ×∆=∆ ssGγω      Eq 1.12 
 
∆ω is usually fixed and the amplitude of GSS is changed to get a slice of the desired 
thickness. 
 
MRI requires multislice imaging, which is achieved by using the same GSS and a 
unique RF pulse for each slice.  
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After selecting the slice of desired thickness, the spatial location of MR signal in the 
slice is determined by the frequency encoding (which tells us the position of the 
nuclei giving rise to the signal along x-axis on the MR image) and phase encoding 
(which tells us the position of signal along y-axis on the MR image) which are 
discussed in the following sections. 
 
1.1.6.2 Frequency encoding or readout process 
 
During signal detection (i.e. read out process) in MRI measurements, frequency 
encoding is performed which gives us spatial information about MR signal along the 
x-axis. In an MRI pulse sequence, the signal is always detected in the presence of a 
gradient known as a readout gradient GRO. The readout gradient GRO is responsible 
for producing one of the two visual dimensions of the image. Typically, MRI pulse 
sequences use a slice selective RF pulse (such as 90o) which excites the protons in 
the selected slice and make the NMV flip away from the z-direction to the transverse 
plane. After the RF pulse is applied, the transverse relaxation dephases the NMV. 
The dephasing can be partially reversed by a 180o RF pulse which will form an echo. 
During the formation of the echo, GRO is applied perpendicular to the direction of the 
slice. Now in the presence of this new gradient field protons will start precessing 
with different frequencies depending on their positions. Each of these frequencies is 
superimposed onto the echo and the echo signal is measured at the desired time by 
the receiver coil. Thus positions of the protons are determined from the GRO 
magnitude and the corresponding frequency (Figure 1.8). 
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Figure 1.8: Schematic illustration of frequency encoding (or readout process). 
 
In Figure (1.8), x1, x2 and x3 are three different positions of the protons in the 
selected slice, while ω1, ω2, and ω3 are the corresponding detected frequencies. 
 
1.1.6.3 Phase encoding  
 
Phase encoding is applied before the readout process and it tells us about the MR 
signal location along y-axis. The phase encoding gradient (GPE) is applied 
perpendicular to both GSS and GRO which alters the magnetic field strength and the 
precessional frequencies of the protons. GPE is usually applied just before the 180
o 
rephasing pulse as mentioned in the previous section. Prior to application of GPE, 
protons have frequency ω0 (or Ф2 as indicated in Figure 1.9) called base frequency. 
The GPE will increase or decrease this frequency. When the GPE is switched off, 
protons will resume their base precessional frequency, but the relative phases will be 
either slightly larger or smaller than Ф2 as illustrated in Figure 1.9. This change is 
called induced shift and its magnitude depends on the magnitude and duration of 
GPE. The induced shift is different for protons located at different positions in the 
phase encoding direction for the same magnitude of GPE. For example in the Figure 
1.9  y1, y2 and y3 are three different locations in the phase encoding direction and 
they experience three different induced shifts indicated as Ф1, Ф2 and Ф3, 
respectively. 
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Figure 1.9: Schematic illustration of phase encoding phenomenon. 
 
1.1.6.4 k-Space 
 
Traditionally in MRI the letter “k” is used to represent the coordinate in the Fourier 
domain, and hence the Fourier domain in MRI is represented as “k-space”. This term 
was introduced by Ljunggren and Twieg in 1983. k-space has two axes i.e. kx which 
represents the frequency information and ky which represents the phase information. 
This information is then translated into an image using software with the help of 
computers. Briefly, k-space is a two dimensional matrix of digitized MR data which 
upon Fourier transformation yields the MR image. 
 
1.1.7 Pulse sequences 
 
A pulse sequence consists of RF pulses, gradient pulses and timings which are 
applied in a specific order to generate an MR image. Several types of pulse sequence 
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are used in MRI, of which spin echo and gradient echo sequences are the two main 
methods while echo planar imaging sequence is an example of specialist sequences. 
Here we will discuss only Spin Echo Sequences, which are commonly used in MRI. 
 
1.1.7.1 Spin echo sequences 
 
Spin echo sequences consist of a 90o excitation pulse and one or more 180o 
refocusing pulses. The 90o excitation pulse makes the NMV (or Mz(0)) flip away 
from z-axis to the x-y plane(Mxy). After the 90
o pulse, the NMV moves back by the 
T2 dephasing mechanism. A 180
o pulse is then applied which refocuses the NMV in 
the x-axis. This produces a spin echo also known as Hartman-Hahn echo. Spin echo 
sequences are characterised by the timing parameters TR (repetition time) and TE 
(echo time). TR is the time interval between successive excitation pulses while TE is 
the time interval from excitation pulse to the echo maximum for a given slice (Figure 
1.10). In Figure 1.10, τ is the time taken to rephase the NMV after the application of 
180o (which is equal to time for dephasing NMV by 90o pulse). 
 
Figure 1.10: Schematic illustration of spin echo pulse sequences. 
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1.2 Image contrast in MRI 
 
To trace abnormal tissue, the MRI image must produce the contrast between normal 
(healthy) tissue and abnormal (diseased) tissue. Intensity based image contrast     
C(A, B) between two tissues A and B may be defined as: 
 
 
ref
I
BIAI
BAC
|)()(|
),(
−
=      Eq. 1.13  
 
In eq. 1.13, IA and IB are the intensities of tissues A and B, respectively and Iref  is the 
arbitrary reference intensity. In such a simple MRI image there is no external or 
internal reference, image contrast is simply the difference between intensities of two 
tissues. An MRI image has contrast if there are areas of high signal intensity (white 
on the image) and areas of low signal intensity (dark on the MRI image). The images 
having intermediate signal intensity have grey shades in between white and black.  
 
1.2.1 Contrast mechanism in MRI 
 
Generally three different types of intensity contrast in MR images can be created 
which are briefly discussed in the following section. 
 
1.2.1.1 T1 Weighted contrast 
 
The repetition time TR (i.e. time interval between two successive excitation pulses) 
is the key parameter responsible for T1 contrast during a pulse sequence. For T1 
contrast a short TR is selected. When a pulse sequence with short TR is applied, the 
tissues with relatively short T1 relax quickly (after the application of 90
o pulse) and 
thus exhibit large signal intensity after the application of next (180o) pulse. On the 
other hand, tissues with a long T1 undergo only little relaxation between two RF 
pulses and thus yield low signal intensity. For example fat has a shorter T1 (because 
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it has a relatively slow tumbling rate which is similar to that of the Larmor 
frequency) and thus will appear with strong signal intensity while water has a 
relatively longer T1 (due to relatively high tumbling rate which does not match the 
Larmor frequency) and will appear with low signal intensity on a T1 weighted MR 
image (Figure 1.11). 
 
 
 
Figure 1.11: T1 weighted image of brain showing contrast between fat and water.
15  
  
On the other hand, in case of a long TR, both water and fat recover their NMV along 
the z-axis before the application of the next RF excitation pulse. This results in a 
very small difference in T1 contrast which cannot be demonstrated on MR images 
(Figure 1.12). 
 
 
(Water appears dark on T1 image)
(Fat appears bright on T1 image)
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Figure 1.12:T1 contrast between fat and water in a tissue due to different T1 values. 
15
 
 
1.2.1.2 T2  Weighted contrast 
 
The effect of T2 on the image contrast is based on the echo time (TE is the time 
interval between (90o) excitation pulse and maximum echo). To create T2 contrast in 
MR images, long TE (which must be in the range of T2 of tissues) is used in spin 
echo pulse sequences. The tissues with relatively shorter T2 will lose magnetisation 
(i.e. NMV) quickly which will yield low signal intensity, while tissues with 
relatively larger T2 exhibit high signal intensity. For example fat appears with low 
signal intensity (as it has short T2) and water appears with high signal intensity (as it 
has larger T2) on T2-weighted images (Figure 1.13).    
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(fat appear dark on T2 image)
(water appear bright on T2 image)
 
Figure 1.13: T2 weighted image of the brain showing contrast between fat and water.
15
  
 
On the other hand, if a short TE is used, no contrast will be created because neither 
the fat nor water transverse magnetization vectors will decay significantly. There 
will not be much difference in T2 signals between fat and water as demonstrated in 
Figure 1.14. 
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Figure 1.14: T2 contrast between fat and water in the tissue.
15
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1.2.1.3 Proton density images 
 
Apart from differences in relaxation times in different tissues, the difference in the 
number of protons per unit volume in different tissues can also create contrast in the 
MRI images. In proton density images, the extrinsic parameters are selected in the 
range (TE << T2 and TR >> T1) so that they do not significantly affect the image 
contrast and thus image contrast primarily depends upon the proton density. In 
proton density images, tissues with higher proton density appear bright (e.g. brain 
tissues) and the tissues with lower proton density appear dark (e.g. cortical bone) 
(Figure 1.15). 
 
Brain tissues
Cortical bone  
Figure 1.15: Proton density image of the brain. 
15
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1.2.1.4 Chemical shift imaging 
 
In conventional MRI, various hydrogen atoms in the body are not differentiated 
depending upon their chemical environment. However the protons bonded with 
water have different Larmor frequency than those bonded with aliphatic carbon 
chains (such as methylene protons in lipids or tissues). The spatial determination of 
these different protons leads to the chemical shift imaging. Proton chemical shifting 
imaging may give better results than MRI in diagnostic studies in some situations. 
For example, chemical shift imaging is reported to diagnose fatty liver disease more 
efficiently.16 
 
1.3 Contrast agents (CAs) in MRI 
 
 In the previous sections, it has been discussed that contrast in image can be created / 
enhanced by altering TR or TE which gives T1 and T2 weighted images. The image 
contrast also depends upon the proton density. However, abnormal tissues under 
examination may not have significant differences in T1 and / or T2 from the 
surrounding normal tissues which results in very little inherent contrast. The signal 
difference between normal and diseased tissues can be enhanced through 
administration of paramagnetic substances called contrast agents. For example in 
Figure 1.16, the T1-weighted image without contrast agent lacks some information 
which is clearly present (i.e. two additional lesions) in the image obtained after the 
administration of a contrast agent.   
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Figure 1.16: T1 weighted images of transverse orientation of central nervous system 
(CNS) with (right) and without (left) contrast agent.
13
 
 
In the early years (1948) of NMR, it was found that relaxation of the water protons 
can be enhanced by paramagnetic substances like FeCl3 etc.
17 30 years later, 
Lauterbur et al.18 successfully distinguished different tissues on the basis of different 
relaxation rate using a Mn(II) salt and thus published the first MRI image. 
Nowadays, Gd-complexes are widely used as MRI contrast agents and will be 
discussed in the section 1.5. 
 
1.4 Relaxivity of contrast agents (i.e. Metal Complexes) 
 
The main purpose of the use of contrast agent is to get better contrast so that one can 
easily distinguish the diseased tissues from the normal ones. The body protons (in 
the form of water or proteins) are the basis of MRI. The tumbling rate of body water 
molecules is much higher than the Larmor frequency. As a result, relaxation rate of 
water protons is very low which results in long relaxation (T1) times and thus poor / 
weak MRI signals. By using contrast agents, the relaxation rate is increased resulting 
in better contrast of the MRI image.1, 5 The fluctuating magnetic field around the 
paramagnetic centre due to unpaired electrons is responsible for increasing the 
relaxation of nearby water protons. There are several mechanisms for affecting the 
relaxation of surrounding protons by paramagnetic metal complexes; the most 
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dominant is the dipole-dipole interactions between paramagnetic centre and the 
surrounding water molecules. The dipolar mechanism is orientation dependent i.e. 
highly dependent on the rate of tumbling of coupled species. The dipolar mechanism 
of relaxation is discussed in more detail in chapter 3 (section 3.1).  
 
The general theory of solvent nuclear relaxation was developed by the groups of 
Bloembergen, Solomon and others.19-21 According to this theory the metal 
complexes affect both spin lattice relaxation rate (1/T1) and spin-spin relaxation rate 
(1/T2). The observed relaxation rate of surrounding water protons (1/T1,obs) in the 
presence of paramagnetic substance is generally given by the following 
mathematical equation. 
 
 
1 1 1
,, ,
T T T
i pi obs i d
= +   where i = 1, 2   Eq. 1.14 
  
In equation 1.14, 1/Ti,d is the relaxation in the absence of any paramagnetic 
substance, while 1/Ti,p is the relaxation enhancement by the paramagnetic 
substance. The relaxation enhancement is directly proportional to the 
concentration of the paramagnetic species 22, equation 1.14 can be modified as: 
 
1 1
[ ]
, ,
r M
i
T T
i obs i d
= +      Eq. 1.15 
 
The concentration of paramagnetic species [M] is usually expressed in mmol/L 
and relaxation time is in seconds. A straight line is obtained from the plot of 
various concentrations of paramagnetic species vs relaxation rate; the slope of this 
plot gives us relaxivity (ri). Relaxivity is the tendency of contrast agent to increase 
the relaxation rate of surrounding protons and is usually expressed as mM-1s-1. 
 
There are also several other factors which control / limit the relaxivity of contrast 
agents and are discussed in the section 1.7.  
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1.5 Gadolinium based contrast agents  
 
Due to the toxicity of many uncomplexed paramagnetic ions at the doses required for 
imaging, they must be chelated to form thermodynamically and kinetically stable 
chelates, hence, MRI contrast agents consist of two main parts, i.e. (a) a 
paramagnetic centre and (b) a chelating ligand. Various paramagnetic ions were 
considered as paramagnetic centres for MRI CAs as shown in table 1.1. 
 
Table 1.1: Various paramagnetic metal ions with their magnetic moment values.
23
 
 
Atomic No. Ions 3d 4f Magnetic moment / BM 
24 Cr3+ 
 
- 3.8 
25 Mn2+ 
 
- 5.9 
26 Fe3+ 
 
- 5.9 
29 Cu2+ 
 
- 1.7-2.2 
63 Eu3+ - 
 
6.9 
64 Gd3+ - 
 
7.9 
66 Dy3+ - 
 
10.42 
67 Ho3+ - 
 
10.46 
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 Gd3+ has received the most attention as a paramagnetic centre for the MRI contrast 
agent due to its following unique features: 
 
• It has a very high value of magnetic moment due to the seven unpaired 
electrons present in the “3+” oxidation state. 
• The electronic relaxation time for Gd3+ is much longer (~10-9 s) than for the 
other lanthanides such as Dy3+, Eu3+ and Ho3+ (~10-13 s). 
 
Lanthanides such as Dy3+ and Ho3+ have higher magnetic moments than Gd due to a 
greater orbital angular momentum contribution, but due to their relatively short 
electronic relaxation time, they are rarely used as paramagnetic centres for MRI 
contrast agents. The relatively high electronic relaxation time of Gd3+ is responsible 
for changing the relaxation time of the surrounding protons. Another important 
paramagnetic centre is the Fe3+ and iron oxide based MRI contrast agents will be 
discussed briefly in section 1.6.  
 
The second component of the contrast agent is the ligand which must possess some 
unique characteristics to form the MRI contrast agents. For example, ligands must be 
water soluble, form stable complexes with Gd and finally after chelating with Gd3+ 
they must have some exchangeable water molecules. The exchangeable water 
molecules play a crucial role in increasing the relaxation rate of surrounding water 
protons by transferring the effect of magnetic moment of the paramagnetic centre to 
the surrounding protons. 
 
Initially Ethylenediaminetetraacetic acid,(EDTA, a hexadentate ligand) was used for 
complexation with gadolinium but due to poor in vivo stability, it is unsuitable for 
clinical use, although Gd-EDTA complex includes three exchangeable water 
molecules which could significantly contribute to increase the relaxation rate of the 
surrounding protons (Figure 1.17). 
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Figure 1.17: [Gd-EDTA]
1-
 chelate. 
  
On the other hand, DTPA and DTPA-like ligands have attracted much attention due 
to their good in vivo stability (Figure 1.18).24 
   
Figure 1.18: [Gd-DTPA]
2-
 chelate. 
 
Macrocyclic ligands can also form stable complexes with lanthanides. For example,  
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) (Figure 1.19) and 
similar ligands form complexes which are very stable due to their macrocyclic 
structure and inert behaviour at physiological pH in blood serum. The main 
drawback associated with macrocyclic ligands is their synthesis as the synthetic 
procedure involves several steps. This problem can be solved by synthesizing 
smaller, cyclen-based ligands such as DOTA (Figure 1.19).  
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Figure 1.19: Chemical structure of DOTA. 
 
Currently all MRI contrast agents approved for clinical applications are based on Gd-
chelates with either DTPA (and DTPA based ligands) or DOTA (and DOTA based 
ligands) (Figure 1.20).25 
 
 
Figure 1.20: Commercially available MRI contrast agents approved for clinical 
applications.
25
 
 
The main drawback associated with these small molecule based contrast agents is 
their diffusion to the extravenous area immediately after the intravenous injection 
because of their low molecular weights. In order to slow down their diffusion, high 
molecular weight based contrast agents were developed and these will be discussed 
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in section 1.8. Other drawbacks associated with small molecule based contrast agents 
are that they are non-specific, and have relatively small circulation times due to their 
fast renal excretion.26 
 
1.6 Iron oxide based contrast agents 
 
Iron oxide particles present a major advantage compared to other paramagnetic ions 
such as Gd3+ and Mn2+ etc as each iron oxide particle bears a huge magnetic moment 
as compared to a single paramagnetic ion (Gd3+ and Mn2+). Iron oxide particles are 
superparamagnetic. On the other hand, the main drawback associated with iron oxide 
based CAs is that they can only be used for T2-weighted images i.e. negative contrast 
agents. 
 
As naked iron oxide particles readily aggregate, a range of different ligands is used 
to stabilise the particles. There are several functional groups, which can be 
covalently bonded to the surface of iron oxide particles. For example, the presence of 
the hydroxyl group (Fe-OH) at the surface of iron oxide particles provides the 
opportunity to attach a wide range of other functionalities which will stabilise the 
nanoparticles. A range of chemical reactions can be carried out at the Fe-OH surface, 
via electrostatic or covalent interactions.  
 
Depending upon the size, there are two main classes of iron oxides particles used for 
MRI applications27 (a) Superparamagnetic iron oxide nanoparticles (SPIO) and (b) 
Ultra-small superparamagnetic iron oxide (USPIO). Both SPIO and USPIO have 
been extensively studied for MRI applications because both types of nanoparticles 
can be synthesized easily and are bio-compatible. 
 
SPIO are larger particles and have size range 60-350nm. SPIO suspension can be 
used for oral applications for MRI studies of abdomen. These particles are usually 
protected by a non-biodegradable and soluble matrix which reduces the aggregation 
of SPIO particles. A typical example of SPIO is iron oxide crystals coated with 
dextran having diameter 80-150 nm commercially known as Endorem.25 USPIO 
have size smaller than 50 nm.28 They have prolonged blood half life, therefore they 
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can pass through the capillary walls and can be taken up by lymph nodes and bone 
marrow. Combidex i.e. iron oxide particles coated with dextran having size 20-40 
nm is a typical example of USPIO and it has human blood pool half life more than 
24 h. 
 
1.7 Factors affecting the relaxivity of Gd-based contrast agents 
 
Several factors limiting relaxivity of MRI contrast agents are summarised in the 
Figure 1.21 and are discussed below. There are several mechanisms of relaxivity, 
however the most dominant is the dipolar relaxation, this mechanism is assumed as 
the main source of relaxivity for the following discussion. Mathematically inner 
sphere proton relaxivity is given as; 
 
 
1
1
.................................Eq.1.16
55.5 1
cq
R
T m mτ
 
= +  
 + 
     
 
In the above eq.1.16, c = molar concentration, q = number of bound water nuclei per 
Gd, R1 = Longitudinal relaxation rate, T1m = Longitudinal relaxation rate for bound 
water protons and τm = Lifetime of water molecule in the inner sphere of the 
complex 
 
1.7.1 Number of coordinated water molecules (q) 
 
In Figure 1.21, three types of water molecules are associated  with the one 
paramagnetic centre (i.e. Gd3+): (a) inner sphere water molecules which are directly 
coordinated with the paramagnetic centre; (b) second-sphere water molecules, which 
are indirectly coordinated with the paramagnetic centre, these water molecules are 
bonded to the ligand via weak interaction forces; (c) the third type of water 
molecules are outer sphere molecules which come in contact with the paramagnetic 
chelate as a result of translational motion of the complex and water molecules. These 
exchangeable water molecules are responsible for transferring the effect of the 
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magnetic moment from the Gd3+ centre to the surrounding water protons. Thus, the 
observed relaxivity in the presence of paramagnetic centre is the sum of inner sphere 
relaxivity and outer sphere relaxivity. But it is the inner sphere relaxivity which can 
be modified and thus for the new generation of contrast agents inner sphere 
relaxivity plays a crucial role in the overall relaxivity. This mechanism is depicted in 
the Figure 1.21. The inner-sphere relaxivity is directly proportional to the number of 
water molecules directly bonded to the paramagnetic centre. Generally, aquated Gd3+ 
can coordinate eight water molecules in its first coordination sphere, but due to 
toxicity gadolinium has to be chelated with some stable ligand. Several 
poly(aminocarboxylate) ligands have been approved for medicinal use; they occupy 
eight coordination sites of gadolinium leaving one free to bind a water molecule. 
Increasing the hydration number (q) of Gd-chelates is very difficult, as an increased 
number of inner-sphere water molecules results in a decreased stability of the 
gadolinium chelate. So far all approved gadolinium chelates for MRI applications 
have just one water molecule in their first coordination sphere4 (Figure 1.21). 
 
1.7.2 Metal-H distance (r) 
 
Relaxivity (due to dipolar interactions) is proportional to 1/r6, which indicates that an 
increase in distance between the Gd and the bound water molecule will decrease the 
relaxivity and vice versa. The average Gd to OH2 distance (now referred as the Gd-H 
distance for simplicity) has been found in the range of 2.5-3.3 Å.29 Theoretically a 
decrease of 0.1 Å in Gd-H distance will enhance relaxivity by 20 %, and a 0.2 Å 
decrease results in 50 % increased relaxivity. The Gd-H distance can be decreased by 
increasing the tilt angle between the plane of bound water molecule with respect to 
the Gd-O vector.30 The tilt angle can be increased by H-bonding between H2O 
molecule and any suitable side group of the chelate.   
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Figure 1.21: Schematic illustration showing various factors which limit the relaxivity.
1
 
 
1.7.3 Rotational correlation time (τR) 
 
The time which a species takes to move by one radian is termed its rotational 
correlation time.31 This is a very important parameter which controls the relaxivity 
by controlling dipole-dipole interactions between electronic (Gd3+) and nuclear spins 
(surrounding protons) as shown below mathematically: 
 
 
1 1 1 1
..................................Eq1.17
1c R m
T
e
τ τ τ
= + +
                                            
 
In above equation 1.17, τc is the reorientational correlational time, τR is the rotational 
correlational tome and T1e is the longitudinal electron spin relaxation time. 
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The dipolar relaxivity can be enhanced by increasing the τR.
1, 4
 The increased τR will 
increase the electronic-nuclear dipolar interactions leading to increased relaxivity.  
 
For example, Figure 1.22 shows a typical effect of τR on relaxivity for Gd(III) 
chelates. It is clear from the Figure (1.22) that as the τR is increased the relaxivity 
also increased.  
 
 
Figure 1.22: Calculated relaxivities vs Larmor frequency for different values of τR for 
Gd(III) complexes. 
4
 
 
According to Debye-Stokes theory, τR is directly proportional to the viscosity of the 
medium as given by eq. 1.18. 
 
 
kT
a
R 3
3
4 ηπτ =       Eq. 1.18 
 
In eq. 1.16 “a” is the radius of a spherical molecule, k is Boltzman constant, and T is 
the temperature. Three basic strategies for increasing the τR are found in literature.
4 
 
I. The distribution of the contrast agent into the tissue or compartment of a 
tissue with high local viscosity. 
II. By attaching contrast agents to large molecules, such as proteins etc before 
injection. 
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III. By non-covalent binding of the contrast agent molecule to a macromolecule 
in the tissue.  
 
For example, Meijer et al.32 described the effect of molecular weight on relaxivity by 
attaching Gd-chelates to various generations of poly(propylene imine). They found 
that an increase in molecular weight of the contrast agent molecule increases the 
relaxivity (table 1.2).  
 
Table 1.2: Effect of Molecular Weight on Relaxivity.
32
 
 
Gd-DTPA species *r1 /mM
-1s-1 **r2 / mM
-1s-1 MW / Da 
Gd-DTPA 4.2 ± 0.1 4.7 ± 0.1 592 
Gd-DTPA-Dendrimer (Go) 8.2 ± 0.2 9.6 ± 0.2 748 
Gd-DTPA-Dendrimer (G1) 11.7 ± 0.2 13.0 ± 0.2 3071 
Gd-DTPA-Dendrimer (G3) 16.0 ± 0.2 19.7 ± 0.2 12705 
Gd-DTPA-Dendrimer (G5) 19.7 ± 0.3 27.8 ± 0.3 51242 
*r1 stands for longitudinal relaxivity and 
**r2 for transverse relaxivity 
 
1.7.4 Water exchange (or residence life time of water molecule τM) 
 
Water (protons) exchange is a key factor for relaxivity because through the water 
exchange between paramagnetic centre and the surrounding bulk water molecules, 
the relaxation effect is transferred to the surrounding water protons. Relaxivity can 
be limited either by fast water exchange or too slow water exchange. The fast water 
exchange will result in a very small residence life time (τM) of the water molecule in 
the paramagnetic centre. As a result of small τM values, the water molecule is not 
coordinated to the paramagnetic centre (e.g. Gd3+) long enough to be relaxed. Too 
slow water exchange (i.e. higher τM) will also result in poor relaxivity due to poor 
transmission of the relaxation effect from the paramagnetic centre to the bulk water 
molecules.  
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1.8 Recent advances / developments in MRI contrast agents 
 
In the previous sections, several factors have been discussed which limit / control of 
the relaxivity of CAs. Among these factors, the tuning of τR is the most frequently 
reported factor in the recent literature. The τR can be tuned easily by bio-conjugation 
of a small paramagnetic molecule i.e. Gd-DTPA chelate with macromolecules or/and 
macromolecular species (either) covalently (or non-covalently). There are many 
reports in the literature of Gd complexes (i.e. Gd-chelates) covalently attached to 
macromolecules or macromolecular species such as dendrimers, micelles, liposomes, 
nano-emuslion, carbon nanotubes etc (Figure 1.23)33-35, in order to enhance the 
efficiency of MRI CAs. In this section the discussion will focus recent advances in 
the field of liposomes, micelles, dendrimers and zeolites and silica based contrast 
agents.  
 
 
Figure 1.23: Schematic illustration of Gd-loaded species (i.e. dendrimers, micelles, 
liposomes etc).
33
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1.8.1 Liposome based MRI contrast agents 
 
Liposomes (discovered in early 1960s by Bangham et al.36) are microscopic 
spherical vesicles composed of two phospholipids layers with a hydrophilic core and 
a hydrophobic tail which are often used as drug delivery vehicles.37-38 Usually they 
have a size in the range of ~20-400 nm. Recently, they attracted attention for MRI 
contrast agents’ applications due to several favourable features. For example, they 
can be readily prepared from simple reagents, their size can be easily manipulated 
and they are biocompatible.25, 33 Liposome based contrast agents can be further 
subdivided into the following sections. 
 
1.8.2 Ensomes 
 
The main advantage of selecting liposomes as paramagnetic chelates carriers for the 
purpose of MRI contrast agents is attributed to their extended circulation time in 
blood. A short circulation time is the main drawback associated with small molecule 
based contrast agents. Initially the paramagnetic species were loaded into the interior 
(hydrophilic) core of the liposome giving rise to the structures called “Ensomes” 
(Figure 1.24). Various types of paramagnetic species such as Mn-chelates, Gd-
chelates etc can be loaded into the liposomes core. A significant decrease in the 
relaxivity of Gd-chelates was observed after the encapsulation into the liposomes.  
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Figure 1.24:  Schematic illustration of liposomes containing paramagnetic species.
25
 
 
For efficient relaxivity, the Gd-chelates must have effective contact with bulk water 
for the efficient transferring of their relaxation effect via water exchange. The water 
exchange rate is hampered in case of Gd-chelates that are encapsulated into the 
liposomes. This leads to poor relaxivity (efficiency). The poor water exchange 
between encapsulated Gd-chelates and bulk water protons was further confirmed by 
relaxivity measurements at elevated temperatures. At relatively high (~35 oC) 
temperature, higher relaxivities values are obtained which are directly attributed to 
the increased water exchange rate across the liposomes membrane. Different 
strategies were developed to overcome this problem (i.e. slow water exchange rate) 
and these are discussed in the following sections.39 
 
1.8.3 Memsomes 
 
The rate of water exchange across the liposome layer can be enhanced by 
incorporating the paramagnetic species into the membrane. In this approach, the 
metal binding chelates can be attached at hydrophilic heads of the lipids (Figure 
1.25). The resulting structure in which metal chelates are incorporated into the 
liposome leaflets, are called “Memsomes”. These memsomes give better relaxivity 
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than the Ensomes due to direct contact with the surrounding water. For example the 
relaxivity of Gd-DTPA-stearylamide and Gd-DTPA-stearylester incorporated in the 
lipid membrane was found to be two to five folds higher as compared to relaxivity of 
paramagnetic chelates (Gd-DTPA-stearylamide etc) in a bulk aqueous solution. This 
significant increase in relaxivity is due to fast water exchange and restricted motion 
(which increased τR) of the paramagnetic species in the liposome membrane. The 
increased τR of the Gd-chelates that are incorporated into the lipid membrane might 
be due to increased effective molecular size.  
 
Figure 1.25: DTPA derivatives: (A) stearylamide, (B) stearylester and (C) 
phosphatidylethanolamine.
25
 
However, increasing the size of the memsome did not result in any further increase 
in relaxivity. This behaviour of memsomes may be due to diffusion of the 
paramagnetic chelates within the membrane. 
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1.8.4 Micellar MRI contrast agents 
 
Amphiphilic Gd-chelates with carbon chains that are more than 10 carbons long can 
self assemble to form colloidal aggregates called micelles. These micelles are much 
smaller (~5-30 nm) than liposomes (~20-400 nm). Micelles are often used as carriers 
of poorly soluble pharmaceutical agents.40-41 As the micelles have hydrophilic heads 
(i.e. Gd-chelates in our case) that point outwards and hydrophobic tails that point 
inwards, the water exchange between the paramagnetic centre and the surrounding 
bulk is not affected. The water exchange rates between the paramagnetic centre and 
the surrounding bulk as determined for free Gd-chelates and micellar Gd-chelates 
did not show any difference. Furthermore the supramolecular assembly formed as a 
result of the micellar phenomenon has a relatively rigid structure. This increased 
rigidity of supramolecular assembly increases the rotational correlational time τR, 
which increases the relaxivity. Further increases in relaxivity could be achieved by 
further increases in rigidity e.g. rigidity of micelles can be increased by incorporating 
cholesterol molecules into the hydrophobic interior.25 Various ligands can be 
coupled to the surface of such micelles in order to allow them to target specific sites. 
Alternatively, mixed micelles can be used to get target specific contrast agents. For 
example Accardo et al.42 described the micellar contrast agent formed from two 
different surfactants. Both these surfactants have a C18 carbon chain; however one 
surfactant has Gd-DTPA chelates at its hydrophilic end while the other surfactant has 
no Gd-DTPA chelates (Figure 1.26). The surfactant without Gd-chelates has a strong 
affinity for specific receptors (which are over expressed in many tumours). 
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Figure 1.26: Schematic representation of mixed micellar aggregates (C18CCK8 stands for C18 
hydrophobic moiety bound to C-terminal of cholecystokinin octapeptied amide) .
42
 
The relaxivity of self assembled micelle based contrast agents was found to be four 
fold higher than the simple complex C18DTPAGlu(Gd). This was attributed to a 
much longer τR (650 ps) for C18DTPAGlu(Gd) than for the corresponding free Gd-
chelate (100 ps).  
 
Another big advantage of micellar contrast agents is that they can be designed for the 
purpose of pH responsive contrast agents because of their pH dependent aggregation 
behaviour in certain conditions. For example, it has been reported that Gd-DOTA 
based amphiphilic structures (having tertiary amino group at side chain) (Figure 
1.27) exhibit pH dependent relaxivity. 
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Figure 1.27: Chemical structure of Gd-DOTA based chelate. 
 
At lower pH (3-6) the relaxivity was relatively small (7.9 mM-1s-1), at higher pH (8-
10) an approximate three fold increase in relaxivity was observed. This increase is 
attributed to the formation of colloidal aggregates of the deprotonated complex, 
while no aggregation is suggested at lower pH (i.e. for the protonated or positively 
charged complex). The presence of the tertiary amino group makes the overall 
complex pH responsive. Consequently, by modifying the structures of the 
amphiphilic Gd-chelates they can be made either pH-sensitive or pH-insensitive 
contrast agents. The pH sensitive contrast agents have potential applications because 
tumors usually have lower extracellular pH as compared to the normal tissues.  
 
Unfortunately due to poor renal elimination problems associated with the liposomal 
and micellar contrast agents they could not be approved for clinical use and so 
researchers turned to dendrimers which are discussed in the next section. So far only 
small molecule based CAs have been approved for clinical purpose.26 
 
1.8.5 Dendritic MRI contrast agents 
 
Dendrimers (discovered in 1980s by Donald Tomalia et al.43) are repeatedly 
branched polymeric materials which possess three main parts, (a) core, (b) branches 
and (c) end groups and usually they have a size in the range 1-10 nm (Figure 1.28).44 
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Figure 1.28: Schematic representation of PAMAM (poly(amidoamine)) dendrimer.
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Dendrimers are actively used as drug delivery vehicles, in diagnostic studies and 
tissue engineering etc.45-46 Due the feasibility of attaching multiple functionalities 
(for instance, recognition vectors as well as Gd-chelates) to the same dendrimer 
molecule, dendrimers are promising templates for MRI CAs. As dendritic CAs have 
paramagnetic chelates at their termini, the water exchange rate will again not be 
affected. Dendrimers have better efficiency / relaxivity than the liposomes and 
micelles. Dendrimer relaxivity can be increased by increasing their size, on the other 
hand the relaxivity of liposomes as well as micelles could not be increased by 
increasing their size after a certain limit. The first report describing the feasibility of 
using dendrimers as MRI CAs was published in 1994 by Wiener et al.47 They 
prepared various generations of dendrimers containing Gd-chelates and described the 
effect of generation on relaxivity (Figure 1.29). 
  Chapter 1  
45 
 
 
Figure 1.29: PAMAM based MRI contrast agent. 
The Gd-DTPA chelates attached to the 6th generation of PAMAM dendrimer (MW: 
139 kDa) exhibited about a six fold higher relaxivity than the free Gd-DTPA chelate 
(0.55 kDa), which is due to restricted tumbling of GD-DTPA chelates at the termini 
of the dendrimer molecule.48 The relaxivity measurements of Gd-DTPA chelates 
attached to flexible polymers with similar MW did not show any increase in 
relaxivity. There are several other literature reports related to dendrimer based MRI 
contrast agents.49-55  
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Dendrimer based contrast agents are excellent blood pool agents but their efficiency 
can be further enhanced by attaching target specific vectors which will enable the 
contrast agent to accumulate at the target site. Various groups such as 
polysaccharides56, oligopeptides57, proteins58, antibodies59 and folic acid60 can be 
attached at the periphery of the dendrimers as the recognition units.  
There are some future challenges associated with dendrimer based contrast agents 
and research in this regard is still in progress. For example, the optimal ratio between 
targeting units and the Gd-chelates at the same dendrimer molecules is very 
important for efficient output. 
Another important class of chemical substances which attracted attention as potential 
MRI CAs is zeolite and silica based nanomaterials which are discussed in the next 
section.  
 
1.8.6 Zeolite based contrast agents 
Zeolites are microporous aluminosilicates with well defined pores (cavities) and 
channels which can accommodate a wide variety of cations (such as Na+, K+, Mg2+, 
Ca2+ etc). The ability of these materials to easily exchange with other cations61 led to 
their applications as ion exchange beds for water purification. Zeolites are also used 
as food additives as well as in personal care, thus their non-toxicity is already proven 
and hence they can be used as MRI CA templates.61-69 Zeolites being microporous in 
nature, have exceptionally high internal surface area which leads to their high 
adsorption capacities. The main purpose of selecting zeolites and silica is to increase 
immobilization of paramagnetic ions by attaching / adsorbing them to the inner side 
of their cavities / pores. This increase in immobilization will lead to enhanced 
relaxivity, which might be better than for dendrimer and micelle based contrast 
agents.70 For example, Platas-Iglesias and co-workers64 described the Gd3+-doped 
zeolite NaY nanoparticles with 80-100 nm diameter as high relaxivity MRI contrast 
agents. Zeolite NaY is composed of eight sodalite cages which are linked with a 
large central cavity called a supercage with diameter 0.74 nm (Figure 1.30).  
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Figure 1.30: Schematic illustration of water exchange between Gd-loaded Zeolites and 
bulk solvent: “A” represents water coordinated to the Gd, “B” represents an intra-
framework water molecule and “C” are bulk water molecules.
64
 
Different amounts of Gd3+ were incorporated into the central cavity of zeolite NaY 
and the effect of [Gd3+] on the relaxivity was explored and very interesting 
observations found. It was reported that relaxivity was decreased with increased 
Gd3+ content. The maximum relaxivity by Gd-doped zeolites was found to be 37.7 
mM-1s-1 (per Gd ion) for a 1.3 Gd3+ Wt% loading which is about nine fold higher 
than that for the Gd-DTPA (at the same field strength). The increased relaxivity with 
low Gd3+ content was supported by a ca. 25 times longer τR for the Gd
3+ ions which 
were immobilized in the interior cavity of the zeolite as compared to free Gd3+ ions 
in aqueous. Another important parameter which played a role in the increased 
relaxivity is the number of Gd3+ coordinated water molecules (q). As in the zeolites, 
the Gd3+ ions are immobilized (rather than Gd-chelates), therefore about eight water 
molecules are expected to coordinate per Gd3+ ion. This high number of q, and of 
course τR, are responsible for the higher relaxivity of zeolites based contrast agents. 
But the decrease in relaxivity with the increased Gd content might be due to several 
factors. For example, the high Gd content might hinder the water exchange between 
zeolite central cavity and the surrounding bulk solution. To increase the water 
exchange rate between the paramagnetic centre and the bulk solution, lanthanides 
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were incorporated into the framework of zeolites rather than into cavities (pores).67 
But still the relaxivity of zeolite based contrast agents was limited by the slow water 
exchange rate between the paramagnetic centre and the bulk solution. This 
unexpected behaviour is attributed to the long distance between lanthanide ions in 
the framework and the water molecules present in the central cavities. Due to this 
large gap, the magnetic moment propagation between paramagnetic lanthanide ions 
and the surrounding water protons via water molecules present in the pores of the 
zeolites was hindered which decreased the relaxivity. 
A unique feature of zeolite based contrast agents is the hydration number q. In the 
zeolites, lanthanide ions (such as Gd3+ etc) are incorporated which can have upto 
eight water molecules, on the other hand in liposomes and micelles Gd-chelates are 
immobilized which have only one water molecule coordinated to the Gd-chelates. 
In general, lanthanide ions (rather than lanthanides chelates) could be immobilized 
on the interior cavities of the zeolites, but the water exchange rate between the 
paramagnetic centre and the surrounding bulk water protons via zeolite channels 
were greatly reduced due to the narrow size of the channels. The reduction in water 
exchange rate directly affected the relaxivity of lanthanide loaded zeolites. However, 
this problem can be solved using mesoporous materials (e.g. mesoporous silica) 
which have relatively wider channel diameters of as discussed in the next section. 
 
1.8.7 Mesoporous silica based contrast agents 
Mesoporous silica has pores in the range of 2-50 nm and was first prepared by 
researchers in Japan in 1990. Due to the relatively large pore size, as compared to 
zeolites, and several other characteristics like non-toxicity, biocompatibility, surface 
modification etc, mesoporous silica can be used as MRI contrast agents.71-74 The 
relatively large pore size might solve the problem of slow water exchange which was 
exhibited by zeolite based contrast agents and the immobilization of Gd-chelates on 
their surface may exhibit better relaxivity than the liposome and dendrimer based 
contrast agents. Recently, Taylor et al.73 described relaxivity measurements of 
mesoporous silica based contrast agents. The mesoporous nanospheres (MSNs) 
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particles with diameter ~ 75 nm were prepared and then several Gd-chelates were 
grafted onto the interior walls (Figure 1.31) of the mesoporous silica nanospheres. 
The relaxivity (R1) was found to be 28.8 mM
-1s-1 which is about seven fold larger 
than for a commercially available MRI contrast agent (Gd-DTPA). This high value 
of R1 can be explained by considering several parameters which optimize the 
relaxivity of MRI contrast agents. The foremost is the relatively fast water exchange 
between paramagnetic centre and the surrounding bulk water due to large channels 
of the mesoporous silica. The second factor is the high τR which is due to 
immobilization of Gd-chelates at the MSNs interior walls. The third factor which 
also played role in increasing relaxivity of silica based contrast agents is the number 
of coordinated water molecules q, which was 2 in this Gd-chelate (Figure 1.31). 
 
 
Figure 1.31: Schematic representation of the Gd-chelates grafted onto the interior 
walls of the mesoporous silica nanoparticles.
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These recent observations of zeolite and silica based contrast agents showed that 
relaxivity / efficiency of contrast agent molecules can be enhanced by immobilizing 
the Gd3+-chelates on the nanomaterials surface. Metal nanoparticles can also be used 
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as templates for MRI contrast agents because of their several unique features e.g. 
metal nanoparticles are non-toxic, Gd-chelates can be adsorbed on the surface of the 
nanoparticles rather than on the interior walls as in zeolites and silica based contrast 
agents. In addition, various recognition vectors can be attached to Gd-chelates on the 
surface of metal nanoparticles etc. 
 
1.8.8 Metal nanoparticles based contrast agents in MRI 
Metal nanoparticles (or metal colloids) attract much attention due to their unique 
electronic and optical properties which are highly size dependent. The nanoparticles 
have large surface to volume ratios and hence the behaviour of surface atoms is 
different from the atoms inside the nanoparticle. This different behaviour of surface 
atoms (and hence electrons) is responsible for several unique properties of 
nanoparticles.75-76 For example, the optical properties of gold nanoparticles are size 
dependent. They exhibit a wide range of colours from bright red (smallest particles) 
to purple and blue (largest particles) depending upon the size of particle. Due to the 
change in size, the frequency of the oscillating surface electrons is changed which 
affects the colour of nanoparticle. Interestingly, the colour of the particles not only 
depends on their size, but also on the shape of the particles and refractive index of 
the medium. As metal nanoparticles exhibit intense colours, they can be used as 
pigments for glasses and ceramics.77-78 They have also many other applications in 
catalysis, nanoelectronics, medical diagnosis and therapy etc. However, we will limit 
our discussion to the gold nanoparticle applications in medical diagnosis and 
therapy, especially as MRI contrast agents.  
 
1.8.9 Gold nanoparticle based MRI contrast agents 
Gold nanoparticles (or colloidal gold) have been used in medicine for revitalization 
and longevity since prehistoric times (i.e. ancient China and India). In Europe they 
were used as a nerve tonic and as a drug for epilepsy and syphilis.79-80 In the modern 
period, gold nanoparticles have a wide range of applications in medical science and 
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in catalysis because of their non-toxic behaviour and good resistance to oxidation. 
They are easy to synthesize, their size can be tuned easily and a wide range of 
stabilizing agents can be attached at the gold nanoparticles surface. Gold 
nanoparticles are the most stable metal nanoparticles.81 For example, gold 
nanoparticles modified by gum arabic (GA) were reported82 as contrast agents for 
computed tomography (Figure 1.32) after evaluation of their toxicity and stability 
behaviour.  
 
Figure 1.32: Synthesis of gold nanoparticles stabilised by GA.
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The contrast enhancement studies showed that gold due to high atomic number (Z) 
and greater absorption coefficient than iodine can be used as contrast agent in CT 
imaging. Gold nanoparticles are also reported in cellular imaging studies using light 
scattering phenomenon,83 photothermal cellular damage,84 as DNA carrier for gene 
therapy85 etc but we will focus our discussion on the recent reports of gold 
nanoparticle based MRI contrast agents. 
1.8.9.1 Gold nanoparticles protected by multilayered Gd-chelates 
In 2006, a group in France (Prof. Roux et al.)86-87 pioneered the design of gold 
nanoparticles for the purpose of MRI contrast agents. They synthesized dithiolated-
DTPA multilayered gold nanoparticles with diameter 2-2.5 nm. These multilayered 
nanoparticles could accommodate ca. 150 gadolinium ions per nanoparticle (Figure 
1.33). The T1-weighted images and relaxation measurements showed that these gold 
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nanoparticles have better efficiency than the commercially available MRI contrast 
agent i.e. Gd-DTPA but the enhancement in relaxation was moderate (~30 %). This 
was attributed to the relatively mobile Gd-chelates at gold nanoparticles surface. 
Furthermore, the multilayered nanoparticles were not sufficiently stable (i.e. 
decomposed after one day) at room temperature. Roux et al. in their second report87 
regarding Gd-loaded AuNPs explained that the stability of these nanoparticles can be 
enhanced by decreasing the number of gadolinium ions per particle from 150 to 50.  
 
Figure 1.33: Multilayered Gd-loaded AuNPs.
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They also used these nanoparticles as contrast agents for X-ray computed 
tomography studies which showed that very small amount of gold nanoparticles (10 
mg / mL) can give contrast equal to relatively large amount of iodine (35 mg / mL). 
Park et al.88 reported a similar strategy for gold nanoparticle based MRI contrast 
agents. They synthesized DTPA conjugated with glutathione protected gold 
nanoparticles of 5-7 nm in diameter. This report showed quite high number of 
gadolinium ions (104) per nanoparticle, which may be due to formation of 
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multilayers around relatively large nanoparticles as compared to the previous reports 
of Roux et al86-87. The relaxivity of these nanoparticles was found to be (17.9 mM-1s-
1) five fold higher than for the commercially available MRI contrast agent i.e. 
Omniscan® (3.30 mM-1s-1). In their recent report89, they reported bigger (~ 14 nm) 
gold nanoparticles coated by Gd-DTPA conjugates of cysteine as multimodal (i.e. 
for X-ray computed and MRI imaging) contrast agents. The cytotoxic studies 
showed that these nanoparticles are non-toxic and hence are suitable for practical 
applications. In both reports, multilayers of Gd-chelates (Figure 1.34) were formed at 
the nanoparticles surface and the stability of these multilayered nanoparticles was 
not described. In general, the efficiency of these gold nanoparticle based contrast 
agents can be enhanced by accumulation of the contrast agent at the specific site, 
which can be achieved by attaching recognition vectors at the surface of gold 
nanoparticles. 
 
Figure 1.34: Gd-DTPA coated AuNPs.
89
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1.8.9.2 Multifunctional (or target specific) gold nanoparticle based MRI contrast 
agents 
Lim et al.90 reported paramagnetic gold nanostructures as targeted contrast agents for 
MRI as well as for optical imaging. The cancer targeting antibody (anti-HER2) was 
reacted with a DTPA based ligand, gadolinium was chelated with DTPA units and 
finally Gd-chelates modified with the antibody were attached at the gold 
nanoparticles surface (Figure 1.35). These nanoparticles with Gd and cancer cell 
targeting units were evaluated for both MRI and optical imaging purpose. The 
relaxation measurement and the optical imaging studies exhibited better results than 
commercially available Gd-DTPA chelates. Furthermore, gold nanostructures with 
cancer targeting antibodies bound to breast cancer cells and due to their absorption in 
the NIR (near infrared region) by the cancer cells could be destroyed by irradiation. 
The energy absorbed by gold nanoparticles in the NIR is converted into thermal 
energy which damaged the cancer cells. These gold nanostructures had diameter of  
~60 nm, which might lead to their instability / decomposition. With the increased 
diameter of the gold nanoparticles, the surface coverage may be incomplete and thus 
they may have some vacant sites which may lead to aggregation due to interactions 
with the solvent or/and with other particles.  
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Figure 1.35: Schematic illustration of synthesis of targeted paramagnetic gold 
nanostructures.
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Glyconanoparticles are particles which are protected by carbohydrates. 
Multifunctional gold nanoparticles (with diameter 2-4 nm)  protected by sugar 
conjugates of β-glucose (glycC2S and glycC5S), β-galactcose (galC5S), and β-lactose 
(lacC5S) have recently been studied as MRI CAs.
91 Some sugar conjugates have Gd-
chelates at their ends while the sugar conjugates without Gd-chelates may serve as 
recognition vectors. The in vivo imaging studies confirmed that glycC5SAuNPs 
enhanced the contrast in tumoral zone while the other AuNPs (such as lacC5SAuNPs 
etc) did not show any affinity for the tumors. The relaxivities of most of these 
paramagnetic glyconanoparticles was higher than for the corresponding small 
molecule Gd-chelate. The interesting observation is that the relaxivity of these 
glyconanoparticles can be tuned by changing the nature of sugar moiety and length 
of the linker (Figure 1.36). 
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Figure 1.36: Thiol-ending sugar conjugates and the corresponding paramagnetic 
glyconanoparticles.
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It has been found that the gold core of gold nanoparticles can exhibit paramagnetism 
under certain conditions.92 This paramagnetism of the gold core may contribute to 
the overall relaxivity of Gd-chelates attached to the gold nanoparticles surface. In all 
previous reports on gold nanoparticle based MRI contrast agents86-88, 90-91, the 
contribution of this paramagnetism from the gold core to the magnetic moment of 
Gd3+ (and thus to the relaxivity) was not explored. Recently, Moriggi and co-
workers93 reported that gold nanoparticles do not contribute significantly to the 
magnetic moment of Gd3+ ions at the gold nanoparticles surface. They prepared Gd-
coated and Ytterbium(Y)-coated gold nanoparticles with diameter ~ 5.0 nm, the 
magnetic moment (µeff) of Gd in these Gd-chelated AuNPs was found 7.94BM 
(which is exactly equal to the magnetic moment of free Gd3+), while no magnetic 
moment was detected in Y-coated AuNPs. Thus it was proved that in Gd-loaded 
AuNPs, there is no contribution of gold core paramagnetism to the overall relaxivity 
of surrounding water protons.   
In all reports of gold nanoparticle based contrast agents, it has been found that 
several gadolinium ions can be loaded per particles and these contrast agents gave 
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better relaxivity (presumably due to relatively slow tumbling of Gd-chelates at 
nanoparticles surface) and T1 contrast in MRI images. In many reports
86-89 
multilayers of Gd-chelates were formed at nanoparticles surface, which might not 
favour the stability issues of these nanostructures. Few reports87, 89 showed the 
applicability of these gold nanoparticle based contrast agents for X-ray CT imaging 
because nanoparticles have longer circulation time than iodine, they are non-toxic 
and various targeting vectors can be attached at the gold nanoparticles surface.  
 
1.9 Aim of the project 
Gold nanoparticles as templates for MRI contrast agents were selected due to their 
highest stability among metal nanoparticles, low toxicity and strong resistance 
against oxidation. When the projected was started, there were no published reports in 
the literature regarding gold nanoparticle based contrast agents, hence our main aim 
was to synthesize and characterize new DTPA ligands which can chelate with 
gadolinium ions on one end and then can bind to the gold surface on the other end to 
give us gold nanoparticle based MRI contrast agents. In the very beginning of the 
project (i.e. in 2006), the first report regarding gold nanoparticles based MRI CAs 
appeared in the literature.86 That report dealt with multilayered gold nanoparticles 
which were highly unstable. We then decided to continue with our aim to synthesize 
and characterise more stable monolayer protected gold nanoparticles as MRI CAs. 
Furthermore targeted specific gold nanoparticles based MRI CAs had also not been 
explored at that time, therefore one direction of our project was to attach some 
recognition vectors to the Gd-loaded AuNPs and to test their recognition studies. The 
synthesis of monolayer protected AuNPs with and without recognition vectors and 
their relaxivity measurements and imaging studies will be discussed in chapter 2. 
 As the project proceeded, a few more reports88, 90-91, 93 on gold nanoparticle based 
MRI CAs were published. The relaxivity measurements of our monolayer Gd-loaded 
AuNPs were found similar to the recent reports. The relaxivity values of Gd-loaded 
AuNPs were not found much higher than for small molecule CAs. This relatively 
low relaxivity of gold nanoparticle based MRI CAs warranted a mechanistic 
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investigation which was lacking in the literature. Therefore, it was decided to explore 
the main factor responsible for relatively poor relaxivity exhibited by gold 
nanoparticle based contrast agents which is discussed in chapter 3 of this thesis. 
Another important aim of the project was to synthesize and characterise redox 
sensitive contrast agents for MRI applications. To achieve this goal, nitroxide radical 
based ligand was used to form monolayer at the surface of gold nanoparticles and 
then they were characterised and studied for the purpose of redox sensitive MRI CAs 
and will be discussed in chapter 4.  
Apart from applications as MRI contrast agents, the gold nanoparticles were also 
studied as optical imaging contrast agents after replacing Gd3+ with other lanthanides 
such as Tb3+ and Eu3+. The study was finally extended to apply gold nanoparticles as 
model compounds for heterogeneous systems for distance measurements between 
paramagnetic radical and metal ions which were attached at the gold nanoparticles 
surface. The luminescence studies (for the purpose of optical imaging) and some 
other useful application of lanthanide-loaded nitroxide labelled AuNPs are discussed 
in chapter 5. 
Chapter 6 contains overall conclusions of the project and some possible future 
directions of the project and chapter 7 describes experimental procedures.  
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M. F. Warsi, R. W. Adams, S.B. Duckett and V. Chechik, Chem. Comm., 2010, 46 , 
451-453.
  Chapter 2  
67 
 
Chapter 2:  Synthesis and relaxivity measurements of     
Gd-loaded gold nanoparticles 
 
2.1 Introduction 
 
Gadolinium (Gd3+), a highly paramagnetic hard acid needs to be reacted with hard 
ligands to yield a stable chelate, to be utilised as an MRI contrast agent. Lanthanides 
form strong complexes with carboxylate ligands due to the hard nature of the 
carboxylic acid groups.1 Polyaminopolycarboxylic acids are thus an important class 
of chelating ligands which are often used to bind lanthanides (such as Gd3+, Eu3+ etc) 
as well as cations of radionuclides e.g. 90Y (III), 212Bi(III) etc. For example, 
diethylenetriaminepentaacetic acid (DTPA) is an octadentate chelating ligand 
(Figure 2.1) which forms very stable complexes with metals. The X-ray 
crystallography of DTPA complexes with metals e.g. Gd-DTPA, show that eight out 
of the nine coordination sites of Gd3+ are occupied by DTPA i.e. three by N atoms 
and five by COO- groups. The remaining ninth site is occupied by a water molecule 
which plays a crucial role in ensuring high relaxivity of Gd-DTPA complexes.2 
  
   O
N
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HO
N
N
O
OH
O
OH
O OH
 
Figure 2.1: Chemical structure of diethylenetriaminepentaacetic acid (H5DTPA). 
 
Other polyaminopolycarboxylates (as mentioned in chapter 1, section 1.5) can also 
be used to chelate Gd3+. For instance, ethylenediaminetetraacetic acid (EDTA) is a 
commercially available hexadentate chelate; in its Gd-EDTA complex, three water 
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molecules are directly bonded to the Gd3+ to make it an excellent MRI contrast 
agent. Due to poor in vivo stability (log K = 17.35) as compared to Gd-DTPA (log K 
= 22.55), Gd-EDTA have not been subject to significant investigation.3 Some 
decadentate polyaminopolycarboxylic acid based chelates are also found in the 
literature.4 Despite very strong affinity for metals, however, these lanthanide chelates 
have no water molecule in the first coordination sphere which makes them unsuitable 
for applications as MRI contrast agents.  
 
From all the different types of the polyaminopolycarboxylic acid based chelates, 
DTPA thus attracted the most attention in the field of MRI contrast agents. Therefore 
in this study we selected DTPA as a primary unit for the preparation of Gd-loaded 
gold nanoparticles. In order to make the DTPA based ligand attach / adsorb onto a 
gold nanoparticle surfaces it needs to be functionalised with a disulfide group. The 
functionalisation of a DTPA based ligand with a thiol or disulfide group can be 
achieved by selecting a commercially available amino acid i.e. N-ε-CBZ-L-Lysine t-
butyl.HCl and dithiobutyric acid as primary building blocks  to make a ligand having 
DTPA units and a disulfide group (Figure 2.2). 
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Figure 2.2: Chemical structure of DTPA based ligand 6. 
 
 The chain length of the DTPA ligand was relatively long which can give extra 
stability to the gold nanoparticles as compared to those protected by relatively short 
chain ligands. The synthesis of ligand 6 is discussed in the following sections. 
  Chapter 2  
69 
 
 
2.2 Synthesis of DTPA based ligand 6 
 
The synthetic strategy for DTPA ligand 6 is depicted in Scheme 1. In the first step, 
dialkylation of ethanolamine with an ester protected bromoacetate yielded 
compound 1. The hydroxyl group was then converted into bromide to give 
compound 2. The second dialkylation of commercially available N-ε-Cbz-L-
Lysine t-butyl ester with bromide 2 produced pentaester protected DTPA 
analogue. The Cbz (benzoylcarboxy) protection was selected as it is orthogonal to 
the t-Butyl protection therefore it can be removed easily by catalytic 
hydrogenolysis to give pentaester protected DTPA analogue 4. The amino group 
of the DTPA analogue 4 was then coupled with dithiobutyric acid to give the t-
butyl ester protected DTPA ligand 5. Dithiobutyric acid was selected to avoid 
extra steps of protection and deprotection of thiol groups. In the last step, the 
deprotection of t-butyl ester groups gave the target DTPA ligand 6. 
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Scheme 1: Synthesis of DTPA based ligand 6 
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2.2.1 Synthesis of t-butyl ester protected DTPA analogue 3 
 
Compounds 1 and 2 were prepared and purified by following the literature 
procedure5 without any significant difference in yield. 
 
Compound 3 was synthesized following the literature6 procedure. However, the 
amphiphilic nature of compound 3 created some difficulties in its purification. 
When the literature procedure was followed and the crude reaction product was 
dissolved in DCM, washed with water and dried by anhydrous sodium sulphate, 
~78 % material was lost. Silica gel flash chromatography led to 92 % loss of 
product. To trace the lost material, the workup process was analyzed carefully. 
Compound 3 could be lost during extraction from the aqueous phase. TLC and MS 
data showed that extracting the crude material from aqueous phase with DCM did 
not give any target material. NMR and TLC helped to trace the product losses to 
the drying agent. The product was found to adsorb strongly to anhydrous sodium 
sulphate. The second problem was traced to silica gel flash chromatography as 
even after elution with very polar solvents (ethyl acetate and MeOH) no product 
was collected from the column. But when the same purification was repeated using 
silica gel of better quality (BDH), NMR, MS and TLC confirmed the successful 
purification of compound 3 with good yield. The particle size in both grades of 
silica gel was the same but the differences in the specific pore volume / surface 
area and defect density might be responsible for irreversible adsorption of ligand 
by a poorer grade silica gel.7 
 
2.2.2 Deprotection of DTPA analogue 3 
 
Hydrogenolysis of the t-butyl ester protected DTPA analogue 3 was carried out by 
following the literature procedure6 to get compound 4. In the literature6, the flash 
chromatographic purification of compound 4 was described using pure MeOH as 
eluent. Compound 4, i.e. DTPA based primary amine, is basic and therefore could 
adsorb on acidic sites of silica gel during flash chromatography. Indeed, a TLC of 
crude product 4 in pure MeOH showed a long tail. However, well separated spots of 
starting material and product were observed with slightly basic MeOH (i.e. with a 
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few drops of Et3N). Therefore, compound 4 was purified using slightly basic MeOH. 
The yield (72%) was higher than in the literature (60%).   
 
2.2.3 Coupling of t-butyl ester protected DTPA analogue 4 with 
dithiobutyric acid  
 
Compound 5 (t-butyl ester protected DTPA based ligand) was synthesized using a 
standard coupling procedure.8 The conversion of the carboxylic acid group into a 
reactive acylating agent was achieved by using a coupling agent, 
dicyclohexylcarbodiimide (DCC).9 
 
The intermediate O-acyl urea that is formed during peptide coupling can undergo 
rearrangement to form an N-acyl urea which is not reactive. The solution to this 
problem is to use a nucleophilic catalyst alongside DCC. The commonly used 
additives are 1-hydroxybenzotriazole (HOBt) and dimethylaminopyridine 
(DMAP)10. We used DMAP due to its strong nucleophilicity. Compound 5 is a new 
compound and it was characterized by MS and NMR. NMR peak assignments were 
facilitated by using “SpecSurf” NMR prediction software that is available via the 
chemistry database service at www.cds.dl.ac.uk. 
 
2.2.4 Deprotection of t-butyl ester groups of DTPA based ligand 5 
 
The t-butyl ester groups of compound 5 need to be removed in order to make the 
ligand to chelate with Gd3+ ions. The deprotection also made the ligand water 
soluble.  
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Figure 2.3: DTPA based ligand 6. 
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The standard11,12 procedure for the deprotection of the t-butyl ester group includes  
treatment of the desired reactant with a mixture of trifluoroacetic acid and 
dichloromethane. We used a 1 / 1 ratio of TFA / DCM for the deprotection of the     
t-butyl ester groups of DTPA based ligand 5. The main factor that we had to 
optimise for the complete deprotection was the reaction time. The reaction was 
monitored by taking 1H NMR spectra at regular time intervals; the 24-30 h period 
was optimised for complete deprotection that gave us more than 70 % yield. After 
the deprotection reaction, the crude product was quite soluble in water, which 
confirmed the successful deprotection. 
 
 Compound 6 was purified by dialysing against deionised water using 500 MWCO 
dialysis tubing. Purified compound 6 was characterized by MS and NMR 
spectroscopy. 
 
The 1H NMR spectra of compound 6 showed broadened peaks. This may be due to 
the restricted tumbling of the large molecule (RMM 1130). The assigned 1H NMR 
spectrum of compound 6 is shown in Figure 2.4. The complete deprotection is 
indicated by complete absence of a t-butyl ester peak at 1.40 ppm. The 1H NMR 
spectrum of compound 6 (Figure 2.4) will be referred to in the next section (2.3.2). 
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Figure 2.4:  
1
H NMR spectrum of DTPA ligand 6.  
 
2.3 Synthesis of water soluble AuNPs protected by DTPA based 
ligand 6 
 
Water soluble gold nanoparticles (AuNPs) protected by DTPA based ligand 6 were 
prepared by modification of the Brust et al. protocol13 which involves the reduction 
of metals in the presence of a stabilising agent. Brust’s protocol is a biphasic method 
in which gold ions are transferred from the aqueous phase to the organic phase with 
tetraoctylammonium bromide, a phase transfer agent. This is followed by reduction 
of Au3+ in the presence of the stabilising / protecting agent in the organic phase. This 
biphasic method is necessary if the protecting agents are soluble in the organic 
medium. If the protecting agents are soluble in the aqueous medium, then gold 
nanoparticles can be prepared by using a single phase method. As the DTPA ligand 6 
was water soluble, therefore a single phase method was used.  
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The gold nanoparticles were thus synthesized by reduction of Au (III) to Au (0) in 
water in the presence of ligand 6 to ensure the immediate stabilization as shown in 
the Figure 2.5. Sodium borohydride (NaBH4) was used as a reducing agent.  
 
  
Au
N OO
HO HO
N
S
NH
O
O
OH
N
OH
O
O
HO
N
O
O
OH
OH
N
S
NH
O
O
HO
NHO
O OHO
N
O
OHO
HO
N
S
HN O
O
OH
N OH
OO
OH
NO O
OHOH
N
S
HN
O
O
HO
N
HO
O
O
OH
 
Figure 2.5: Gold Nanoparticles (AuNPs) protected by ligand 6. 
The concentration of reducing agent plays a very important role in the stability of 
gold nanoparticles. Usually the reducing agent is used in a large excess. However, it 
was found that very high concentration (~ 30 fold excess) of sodium borohydride led 
to poor stability of the gold nanoparticles. The optimal ratio between gold and 
reducing agent for the synthesis of gold nanoparticles was found 1:10. After 
synthesis, the aq AuNPs were dialysed against deionised water to remove water 
soluble impurities / by-products and also the unbound ligand. Unfortunately the 
dialysis could not remove the unbound ligand completely (as shown by 1H NMR). 
The AuNPs were then purified by size exclusion chromatography using Sephadex 
gel (G 100) as a stationary phase and 0.1M aq NaCl as an eluent to prevent 
electrostatic binding of the AuNPs to the column. The purified aq AuNPs were again 
dialysed against deionised water to remove NaCl. The purified AuNPs were 
characterised by 1H NMR, UV/Vis spectroscopy, TEM and TGA.  
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2.3.1 UV-Vis spectrum of AuNPs protected by DTPA ligand 6 
 
Surface plasmon band (SPB) is the most distinct feature in the UV-Vis spectra of 
noble metal (Cu, Ag & Au) nanoparticles. This peak is exhibited by particles having 
d << λ (where d is the diameter of the nanoparticles and λ is the wavelength of 
light).14 When light interacts with nanoparticles, the electric component of the light 
induces the coherent oscillation of the surface electrons having frequency in the 
range of visible region. The coherent oscillation of the surface electrons of the 
nanoparticles is termed the Surface Plasmon Band (SPB). The interaction of the light 
with the surface electrons of the nanoparticles is represented in Figure 2.6.  
 
      
Figure 2.6:  Origin of Surface Plasmon Band.
15 
 
In their UV-Vis spectra, AuNPs usually show a surface plasmon band (SPB) at 520-
525 nm.14-16 The SPB is strongly size dependent: with increase in AuNPs size, the 
SPB is found to shift towards the longer wavelength. In nanoparticles with size less 
than 1 nm, SPB is damped; SPB is also absent in bulk gold metal. The UV-Vis 
spectrum of the AuNPs protected by ligand 6 showed a SPB at 520-525 nm (Figure 
2.7) that confirmed the formation of gold nanoparticles. This intensity and position 
of SPB (Figure 2.7) is typical for  small alkanethiol protected AuNPs (~ 2.0 nm).17 
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Figure 2.7: UV-Vis Spectrum of Gold Nanoparticles Stabilised by DTPA ligand 6. 
 
2.3.2 1H NMR spectrum of AuNPs 
 
NMR is a very important technique for the characterization of thiol based gold 
nanoparticles. The major difference between the 1H NMR spectra of the free thiol 
based ligand and that adsorbed at the gold nanoparticle surface is the lack of a peak 
corresponding to the CH2 group adjacent to the S atom. This is due to the restricted 
tumbling of ligands adsorbed at AuNPs surface. The peaks of the groups which are 
further away from the AuNPs surface18-19 are also broadened. Restricted tumbling 
leads to incomplete averaging of the anisotropic interactions and hence broadening 
of peaks of thiol based ligands at AuNPs surface. 
 
 In the 1H NMR spectrum of gold nanoparticles protected by DTPA ligand 6, two 
major changes were observed as compared with the 1H NMR spectrum of the free 
ligand (Figure 2.8). The first change is the complete disappearance of the 1H peak of 
the CH2S group. Secondly, all peaks became broader. These observations confirmed 
the successful adsorption of ligand on the AuNPs surface. The peaks of ligand 
  Chapter 2  
78 
 
adsorbed on the AuNPs surface appeared at the same chemical shift as the free 
ligand.  
 
  
Figure 2.8: 
1
H NMR Spectra of free ligand 6 (a) and ligand 6 adsorbed on gold 
nanoparticles surface (b). 
 
2.3.3 TEM analysis of AuNPs 
 
Transmission electron microscopy (TEM) is a standard tool for assessing the core 
dimensions of metal nanoparticles.  Morphology, size, and size distribution of 
AuNPs can be obtained from the TEM image; therefore this technique is essential 
for the characterisation of AuNPs. TEM produces a visual image of the gold core 
of AuNPs. The sample for TEM analysis must be prepared in the form of a thin 
film which allows the transmission of electrons.14 The samples of AuNPs 
protected by ligand 6 were prepared by placing a drop of the AuNP solution in 
deionised water on a carbon-coated copper grid. The drop was allowed to dry 
slowly at room temperature and this resulted in the formation of a very thin film. 
At least six images were taken for each sample. Figure 2.9 shows uniform AuNPs 
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distribution was achieved with reasonable application of dispersity. Nanoparticle 
diameters were calculated from the particle areas by the mathematical formula 
 Diameter = [Area / π] ½× 2 
 
The average diameter of the gold nanoparticles was found to be 1.75 nm ± 0.42, 
which is comparable with those reported the literature20 for thiol protected AuNPs 
prepared by a similar method.  
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Figure 2.9: TEM image and histogram of AuNPs protected by ligand 6. 
 
2.3.4 Thermogravimetric analysis (TGA) of AuNPs 
 
Thermogravimetric analysis (TGA) determines the rate of change in the weight of 
a material as a function of temperature in a controlled atmosphere (usually an inert 
atmosphere). TGA measurements are used primarily to determine the composition 
of materials and to predict their thermal stability at high temperature. The 
technique can characterize materials that exhibit weight loss or gain due to 
decomposition, oxidation, or dehydration. When gold nanoparticles protected by 
organic ligands are heated, the organic ligands desorb from the AuNPs surface 
leaving the gold core. The change in weight of AuNPs upon heating gives the 
amount of organic ligand present on the AuNP surface. The AuNPs protected by 
ligand 6 were accurately weighed (5.58 mg) and dried under vacuum for ca. 3-4 
hours and submitted for TGA analysis. The TGA graph of AuNPs protected by 
compound 6 is reported in Figure 2.10.  The weight loss starts at ca. 200 oC.  This 
value is quite similar to values (200 oC) that are reported in the literature21 for 
similar thiol protected AuNPs. Total weight loss calculated from the TGA graph 
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corresponds to the loss of organic ligands from the nanoparticle surface. From 
TGA analysis, the ratio between the gold and protecting ligand (compound 6) was 
determined as 3.98:1 (Au: Ligand). This ratio allowed us to estimate the amount of 
ligand present at AuNP surface which is needed for calculating gadolinium 
loading. This composition of gold nanoparticles is similar to the simple 
alkanethiol-protected gold nanoparticles having similar diameters. 22-23  
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Figure 2.10: TGA graph of gold nanoparticles protected by DTPA ligand 6. 
 
2.4 Complexation of gadolinium (Gd3+) with DTPA ligand 6 at 
AuNP surface  
 
The characterised AuNPs protected by DTPA ligand 6 were loaded with gadolinium 
to act as MRI contrast agents. The loaded gadolinium was complexed with DTPA 
units of the ligand at AuNPs surface as shown in Figure 2.11. 
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Figure 2.11: Gd-loaded AuNPs. 
 
The amount of gadolinium for loading on AuNPs was calculated using the 
composition of AuNPs as described in the previous (TGA) section. The protocol was 
similar to that developed for Gd-complexation with similar AuNPs.24  To the 
aqueous AuNPs protected by ligand 6, aqueous GdCl3 was added portion wise. The 
excess amount of gadolinium was removed by dialysing the Gd-loaded AuNPs 
against deionised water. The exact amount of gadolinium in Gd-loaded AuNPs was 
then determined by ICP and UV-Vis spectroscopy independently and is discussed in 
the following sections. 
 
2.4.1 Determination of [Gd3+] using xylenol orange titration 
 
A calibration curve for determination of [Gd3+] in Gd-loaded AuNPs was 
determined by following the literature procedure.25 Xylenol orange is a weak 
lanthanide chelating agent that can chelate with free gadolinium ions. Xylenol 
orange exhibits two absorption peaks at 434 nm and 576 nm in the absence of any 
lanthanide. In the presence of lanthanides, the intensity of the first peak at 434 nm 
decreases while that at 575 nm increases. The ratio between the intensities of the 
two peaks can be used for the quantitative determination of lanthanides (Gd3+ in 
our case). The UV/Vis spectra of xylenol orange in the presence of various 
concentrations of Gd-atomic standard solutions and the calibration curve built 
using these spectra are shown in Figures 2.12 and 2.13, respectively.   
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Figure 2.12: UV/Vis spectra of xylenol orange in the presence of Gd atomic standard 
solution. 
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Figure 2.13: Calibration curve for the determination of [Gd
3+
]. 
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The calibration curve shown in Figure 2.13 was used for the determination of [Gd3+] 
in Gd-loaded AuNPs. The Gd-loaded-AuNPs were decomposed by treatment with 
aqua regia at ca. 80 oC for at least 24 h. Under these conditions, the AuNPs and 
organic ligands are destroyed and Gd3+ ions become free. The decomposed Gd-
loaded-AuNPs were filtered using syringe filter, pH adjusted (~6) and diluted by the 
acetate buffer (pH 5.8) to make a solution for analysis (with [Gd3+] in the range 10-
50 µM). The unknown concentration of Gd in this solution was determined by 
adding a 30 µL aliquot to 0.4 mL of xylenol orange and recording UV-Vis spectrum. 
From the ratio of absorbance at 434 nm and 576 nm, the [Gd3+] could be determined 
using the calibration curve. For example, in 5.0 mg of Gd-loaded AuNPs, 0.51 mg of 
Gd content was determined by this method. Using this method, Gd-loaded AuNPs 
were found to contain ca. 10.13 wt % Gd 
.  
2.4.2 In situ monitoring of Gd3+ loading on AuNPs by UV-Vis 
titration using xylenol orange as indicator 
 
The gadolinium concentration in Gd-loaded AuNPs was also independently 
determined by another method which allowed in situ monitoring of Gd-loading. 
The need for in situ monitoring was realised due to the following reasons. 
 
• Gd determination needs confirmation by an independent method (e.g. to 
confirm complete decomposition of Gd-loaded AuNPs with aqua regia). 
• The in situ monitoring allowed us to determine the exact saturation point 
of Gd3+, so that the exact amount of gadolinium can be loaded rather than 
an excess of gadolinium requiring removal by dialysis. 
 
 The UV/Vis spectra of xylenol orange in aq AuNPs were recorded after each 20-
30 µL addition of aqueous GdCl3. No change in UV-Vis spectra of xylenol orange 
was observed until all the ligand at AuNPs surface was complexed with 
gadolinium. As soon as the gadolinium is coordinated by xylenol orange, the 
sudden changes in peak intensities of xylenol orange were observed as shown in 
Figure 2.14. Figure 2.14 shows titration results for two different batches of aq 
AuNPs (2.0 mg dissolved in ca. 5.0 mL of H2O) that gave saturation point of 
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gadolinium at the AuNPs surface at 235 µL concentration of GdCl3. According to 
this data, 9.98 %  the gadolinium content in AuNPs was determined by this 
method which is in a very close agreement with that determined by the calibration 
curve method (10.13 %) as described in the previous section.  
 
 
Figure 2.14: Titration of AuNPs with [GdCl3] in the presence of xylenol orange. 
 
2.4.3 Characterisation of Gd-loaded AuNPs by Inductively Coupled 
Plasma Spectrometry (ICP) 
 
Gd-loaded AuNPs were characterised by ICP to determine the amount of gold and 
gadolinium. The ICP, TGA and UV/Vis data are summarised in Table 2.1. 
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Table 2.1: ICP, TGA and UV/Vis data for Gd-loaded AuNPs. 
Technique Element Composition / % 
ICP 
Au 45.64 
Gd 10.95 
TGA Ligand 42.0 
 
UV/Vis 
 
Gd 
10.13* 
9.98** 
 
 *Determined by Calibration Curve Method, **By In situ monitoring method 
 
The amount of gadolinium in Gd-loaded AuNPs determined by ICP analysis was 
compatible with the amount of DTPA ligand 6 at the AuNP surface determined by 
thermogravimetric analysis (42 %). Similarly, the amount of gadolinium determined 
by UV/Vis method and ICP are in close agreement with each other. These data were 
used to derive the composition of Gd-loaded AuNPs which is described in the next 
section. 
 
2.4.4 Composition of Gd-loaded AuNPs  
 
On the basis of TEM, TGA, ICP and UV-Vis data, the composition of the Gd-loaded 
AuNPs was determined. The average number of gold atoms per particle (166) were 
determined from TEM data (i.e. 1.75 nm average diameter of AuNPs) by assuming 
the same packing density of AuNPs as in bulk gold (eq. 2.1).17 
 
 fcc
AuAu nDN
3
6
π
=       Eq. 2.1 
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Here NAu is the number of gold atoms in particle, D is the diameter of the AuNPs and 
fcc
Aun  is the packing density of gold (59.2 g / cm
3). The ratio between gold and ligand 
was estimated by TGA and then confirmed by ICP analysis and UV/Vis 
spectroscopy. The ratio between Au, Gd and ligand was found as Au3.3 Ligand1.07 
Gd1.0. As each nanoparticle contains 166 atoms, the composition of Gd-loaded 
AuNPs was determined as  Au166 Ligand54 Gd50. 
 
2.4.5 Spin lattice relaxivity (r1) of Gd-loaded AuNPs, Gd-DTPA and 
GdCl3  
 
The longitudinal relaxation constant for the water 1H signal, T1, was measured in the 
presence of Gd-DTPAligand@AuNPs, Gd-DTPA and GdCl3 using an inversion 
recovery method (which has been discussed in detail in chapter 1 (section 1.5)).26 
The T1 (spin lattice relaxation time) can be calculated using equation 2.2. 
 
 ))/exp(21( 10 TMM z τ−−=        Eq. 2.2 
 
Here Mz is the longitudinal magnetisation, M0 is the equilibrium magnetisation and τ 
is the variable time delay. All the relaxation measurements were carried out at 
magnetic field 7.0 T with variable time delay “τ” ranging from 0.0001-6.0 s. The 
inversion recovery curves for Gd-loaded AuNPs are shown in Figure 2.15.  
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Figure 2.15: Inversion recovery curves for Gd-loaded-AuNPs. 
 
Spin-lattice relaxivity (r1) was calculated from the slope of the plot 1/T1 vs [Gd
3+] 
using equation 2.3. 
 
 ][
1
1
1
GdR
T
=       Eq. 2.3  
 
The r1 curves for Gd-loaded AuNPs, Gd-DTPA and GdCl3 are shown in Figure 2.16. 
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Figure2.16: Spin lattice relaxivity (r1) curves for Gd-DTPA (blue), Gd-DTPA@AuNPs 
(green), and GdCl3 (black) at 300 MHz and 298 K 
 
The R1 of GdCl3 was found to be (12.10 mM
-1 s-1) much higher than for Gd-DTPA 
and Gd-loaded AuNPs, but unfortunately due to high toxicity of free Gd3+, it cannot 
be utilised as an MRI contrast agent. In free Gd3+, eight water molecules are directly 
coordinated with Gd3+ [i.e. Gd(H2O)8]
3+. This water can exchange with surrounding 
water molecules and thus transfer more magnetic moment from Gd3+ centre to the 
surrounding medium, resulting in high R1. 
 
The r1 (at 300 MHz and at 298 K) value for Gd-loaded AuNPs (4.77 mM
-1 s-1) was 
found somewhat higher than that of a commercially available MRI contrast agent i.e. 
[Gd-DTPA]-2  (3.83 mM-1 s-1) at the same field strength and same temperature. This 
increase, however (~25.0%) is not very large. The only moderate increase in R1 by 
Gd-loaded AuNPs may be due to several reasons. One possibility is the slow water 
exchange rate between Gd-DTPA ligand at the AuNPs surface and the surrounding 
medium. But as the AuNPs are protected by a monolayer of the DTPA ligand, 
therefore all Gd-DTPA ligand chelates are located at the surface of AuNPs and their 
water molecules are expected to exchange with surrounding medium easily without 
any hindrance as shown in Figure 2.17. 
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Figure 2.17: Gd-loaded AuNPs. 
 
The second argument for only moderate increase in R1 is the fairly fast tumbling of 
the DTPA ligand at AuNPs surface. Fast tumbling will result in averaging of dipole-
dipole interactions between the electron spin of Gd3+ and the nuclear spin of protons, 
thus reducing the efficiency of relaxation. We noted that some other reports 27-28 on 
gold nanoparticle based contrast agents showed similar r1 values. For example, Roux 
et al.27 prepared dithiolated DTPA multilayered AuNPs having diameter 2.0-2.5 nm, 
which also exhibited only moderate increase in r1 as compared to Gd-DTPA. 
Furthermore, multilayered Gd-loaded AuNPs were found to decompose within 24 
hours.27 We improved the stability of Gd-loaded AuNPs significantly. Our Gd-
loaded AuNPs were stable at room temperature for several months. The relatively 
long carbon chain (C10) of the DTPA ligand 6 as compared to the dithiolated 
DTPA27 ligand may be the major factor improving the stability of Gd-loaded AuNPs. 
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2.4.6 T1-weighted images of Gd-loaded AuNPs and Gd-DTPA 
 
The suitability of Gd-loaded AuNPs for MRI applications was evaluated by taking 
T1 weighted images of solutions of commercially available MRI contrast agent i.e. 
Gd-DTPA and Gd-loaded AuNPs. The concentration of gadolinium in both 
samples for taking T1-weighted images was kept at 0.25 mM. Figure 2.18 clearly 
shows the contrast enhancement with increased nanoparticle concentration. Gd-
loaded AuNPs have somewhat higher relaxivity than the Gd-DTPA complex as 
discussed in previous section, which leads to a slightly better contrast in T1-
weighted images (Figure 2.18). 
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Figure 2.18: T1-weighted images of Gd-DTPA and Gd-DTPA@AuNPs. 
 
The positive contrast thus confirmed the feasibility of using Gd-loaded AuNPs as 
MRI contrast agents. The positive contrast in T1 weighted images by other gold 
nanoparticles based contrast agent was also reported in the literature.29 
 
2.4.7 Attaching a recognition vector to Gd-loaded AuNPs 
 
For applications in medical diagnosis and therapy, the surface modification of gold 
nanoparticles is important.30 For example to transport the nanoparticles to a 
specific tissue / organ, a recognition vector with ability to recognise the specific 
target is required. Target-specific MRI contrast agents modified with a recognition 
vector yield better contrast as compared to the non-specific contrast agents due to 
in situ accumulation at the target place. For example, Dirksen et al.31 recently 
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reported the multivalent target-specific MRI contrast agents for MRI imaging 
angiogenesis process. They prepared a cyclic peptide (asparagine-glycine-arginine 
sequence) based MRI contrast agent having Gd-DTPA chelate at one end. The 
asparagine-glycine-arginine sequence (cyclic peptide) has strong affinity for 
aminopeptidase (a protein over-expressed by angiogenic endothelial cells). 
 
Biotin (vitamin H) forms an exceptionally strong complex with avidin (association 
constant Ka = 10
15 M-1)  based on non-covalent interactions. This complex is often 
used for selective functionalisation or targeting of nanostructures. Figure 2.19 shows 
how a biotin-avidin complex at a nanoparticle surface can be used for targeting 
biotinylated ligands via biotin-avidin-biotin complex.  
 
Figure 2.19: Surface functionalisation via biotin-avidin-biotin.
30
 
 
As a proof of principle, we also selected biotin-avidin system for recognition studies 
of Gd-loaded AuNPs, as described in the following sections.  
 
2.4.7.1 Synthesis of biotin-terminated thiol (BTT) 
 
A recognition vector for the attachment to Gd-loaded AuNPs must have a functional 
group with strong affinity for AuNPs, and should also be water soluble. Therefore 
we chose a commercially available hydrophilic biotin derivative NHS-(PEO)4-biotin 
(Figure 2.20), which can be readily modified with a thiol group (thiols show very 
strong affinity for gold). A further advantage of this molecule is that the PEO (poly 
(ethylene oxide)) spacer arm reduces the steric hindrance thus facilitating binding 
with avidin. In order to introduce the thiol group, NHS-(PEO)4-biotin was treated 
with cysteamine32. Biotin-terminated thiol (BTT) thus prepared (Figure 2.20) has 
three main functional moieties: (a) thiol for binding to the gold surface, (b) biotin for 
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molecular recognition studies, (c) poly (ethylene oxide) spacer arm for solubility in 
aqueous medium, and is hence suitable for recognition studies of Gd-loaded AuNPs. 
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Figure 2.20: Synthesis of biotin-terminated thiol (BTT). 
 
2.4.7.2 Attachment of BTT to Gd-loaded AuNPs 
 
Ligand exchange reaction at AuNPs surface is an efficient way of preparing poly-
functionalised nanoparticles. Ligand exchange can be carried out using ligands 
higher affinity for gold than the ligands already present on the surface. The ligands 
having similar affinity can also be exchanged.33 DTPA ligands 6 at Gd-loaded 
AuNPs surface were exchanged with biotin-terminated thiol (that has similar affinity 
for gold as the DTPA ligand) by stirring in aqueous medium at room temperature. 
Biotin terminated thiol (BTT) replaced some of the DTPA ligand molecules on gold 
nanoparticles (Figure 2.21).  
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Figure 2.21: BTT-labelled Gd-loaded AuNPs. 
 
The excess of BTT molecules was removed by overnight dialysis against deionised 
water. The Gd-loaded AuNPs having BTT recognition vectors at their surface were 
found quite stable and then their recognition studies were carried out (as described in 
the next section). The gold nanoparticle based targeted MRI contrast agents were 
thus prepared which contain Gd-DTPA chelates (to act as an MRI contrast agent) 
and biotin-terminated thiol (a recognition vector) at their surface (Figure 2.21). 
 
2.4.7.3 Molecular recognition of BTT-labelled-Gd-loaded AuNPs  
 
Recognition studies of BTT-labelled-Gd-loaded-AuNPs were carried out by MRI 
imaging experiments. The avidin-functionalized gel was taken as a target, to which 
BTT-labelled Gd-loaded AuNPs were expected to bind. Two columns filled with the 
target gel of identical length and diameters were taken. BTT-labelled-Gd-loaded-
AuNPs and Gd-loaded-AuNPs without BTT labelling were passed through the two 
columns. The BTT labelled Gd-loaded-AuNPs were found to adsorb to the avidin 
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column, while the nanoparticles without BTT labelling do not show any affinity for 
the avidin column. Although the binding of BTT-labelled Gd-loaded AuNPs with the 
avidin functionalized gel could be observed easily with a naked eye, it was further 
confirmed by acquiring T1-weighted images of the columns and the filtrates (i.e. 
BTT labelled and unlabelled AuNPs). T1 weighted MRI images are shown in Figure 
2.22. The image “I” (i.e. for avidin column with nanoparticles) is brighter than the 
image “III” (i.e. for avidin column without nanoparticles). 
 
 
Figure 2.22: T1-weighted images of BTT labelled and unlabelled Gd-loaded AuNPs, 
and avidin-functionalized gel columns. 
 
2.5 Conclusions 
 
A DTPA based ligand was synthesized and characterised successfully. The Au 
nanoparticles protected by the new ligand were synthesized and characterised by 
UV-Vis spectroscopy, TEM and TGA. The gold nanoparticles were then 
characterised by ICP after loading with gadolinium. Two different methods based on 
UV/Vis titrations were established for determination / monitoring of Gd3+ loading on 
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AuNPs. The average composition of Gd-loaded AuNPs was determined as “Au166 
Lig54Gd50”. The efficiency of Gd-loaded AuNPs to act as MRI contrast agents was 
assessed in terms of relaxivity. The gold nanoparticles based contrast agent showed a 
25 % increase in relaxivity as compared to the commercially available MRI contrast 
agent Gd-DTPA. The increase in R1 for Gd-loaded AuNPs was not very large, 
possibly due to relatively fast tumbling of nanoparticle-attached Gd-DTPA units. 
 
 A recognition vector (biotin terminated thiol) was synthesized and then attached to 
Gd-loaded-AuNPs. The gold nanoparticles with recognition vector were found to 
successfully recognize their target (i.e. avidin modified gel). This illustrates that gold 
nanoparticle based MRI contrast agents can be used as target specific contrast 
agents. 
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Chapter 3: Strategies for increasing relaxivity of Gd-loaded 
gold nanoparticles 
 
3.1 Introduction 
 
Spin lattice relaxivity (r1) measurements of Gd-loaded-AuNPs were carried out and 
discussed in chapter 2 in detail. The r1 of Gd-loaded-AuNPs (Gd-DTPA@AuNPs) 
was compared with commercially available MRI contrast agents i.e. Gd-DTPA and 
only a moderate increase was observed. Although this increase is comparable with 
some recent literature values1,2, we decided to explore the strategies for improving 
the relaxivity. The increase in r1 may be limited by weaker coupling between Gd-
DTPA chelates at the AuNP surface and surrounding water protons (as discussed in 
chapter 2). In particular, dipole-dipole3 (dipolar) coupling is the most important 
mechanism of relaxation. The coupling depends upon the inverse sixth power of the 
distance between the two nuclei and the direction of the vector joining the two spins 
(Figure 3.1) e.g. it is proportional to 
6
2 1cos3
ABr
−θ
. 
 
   
Figure 3.1: Two spins (one is nuclear spin, but the other one is an electron spin) A and 
B are interacting with each other via dipolar mechanism.                                                                                                                                           
 
B
r
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A
Ө 
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The frequency of rotational motion of tumbling species is also important for 
effective dipolar coupling and this frequency is usually expressed in terms of so-
called correlation time (τc). The τc is related with spin-lattice relaxation time (T1) as: 
 
   
2
1 )2(1
1
co
c
T τπν
τ
+
∝      Eq. 3.1  
 
Here νo is the precessional frequency of the target nucleus (e.g A in Figure 3.1). 
According to this equation, for rapidly tumbling species with 1/τc>>2πνo, relaxation 
rate (1/T1) will be proportional to τc, while in case of slowly tumbling species 
(1/τc<< 2πνo) 1/T1 will be inversely proportional to τc. In rapidly tumbling species  
(τc <10
-11 s ), the dipolar interaction averages out, while in slowly tumbling species 
(τc >10
-11 s ) the dipolar coupling is significant which can lead to higher relaxivity.4 
 
Table 3.13 illustrates this effect of τc  on r1. For instance, if τc is decreased 1000 fold, 
the r1 will increase four-fold. 
 
  Table 3.1 Effect of  τc on r1. 
Rotational Correlational 
Time (τc) / ps 
Relaxivity (r1 / mM
-1s-1) 
58  8.0 
58,000 32.0 
 
In this chapter, EPR spectroscopy was used to determine the tumbling rate (τc) of 
nanoparticle-attached ligand in order to unravel the main factors responsible for the 
limited increase in R1 of Gd-loaded AuNPs as compared to commercially available 
Gd-DTPA MRI contrast agent.  
 
3.1.1 An introduction to EPR5-7 
 
Electron Paramagnetic Resonance phenomenon was discovered by Prof. E. K. 
Zavoisky in 1944 at Kazan University (Russia) and is abbreviated as EPR and also 
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as ESR (i.e. electron spin resonance). The EPR spectroscopy is used to study 
materials with unpaired electron(s). EPR is similar to NMR, but EPR is based on the 
interaction of magnetic field with electron spin, while NMR relies on the nuclear 
spin. 
 
3.1.1.1 Principles of EPR 
 
Electrons have intrinsic angular momentum called spin (S). Electron has two spin 
states represented as α and β in the presence of static magnetic field (Bo) (this 
phenomenon is called Zeeman Effect). These two spin states have different 
orientations but the same magnitude of spin angular momentum. Electronic angular 
momentum (S) gives rise to magnetic moment (µe). Both µe and
 S are equal in 
magnitude and opposite in direction (proportionality constant µB in negative) and 
related by following equation. 
 
Sg Be µµ =       Eq. 3.1 
 
In eq 3.1 “g” is a constant called g-factor and µB (Bohr magneton) is also a constant. 
The α and β states of a free electron in the presence of a static magnetic field are 
shown schematically in Figure 3.2. 
        
Bo ≠ 0
Bo = 0
β
α
oB
BgE µ=∆E = 0
 
 
Figure 3.2: Spin states of an electron in the absence and presence of the applied 
magnetic field Bo. 
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As electron spin energy is a scalar product of magnetic moment (µe) and applied 
magnetic filed (B), the energy difference between α and β states of a free electron is 
given by equation 3.2. 
 
  oBBgE µ=∆        Eq 3.2 
 
In EPR, magnetic field is swept keeping the frequency of electromagnetic radiation 
constant. As the magnetic field strength matches the energy difference between 
electron spin states (i.e. α and β), the inversion of the spin state occurs. The energy 
absorbed for inversion / transition of electron from one state to the other is recorded. 
EPR spectra are usually recorded as first derivative of the absorbed energy against 
applied magnetic field. The first derivative is used to improve the resolution and to 
decrease the background noise. An example of a first derivative of absorbed energy 
vs magnetic field is shown in Figure 3.3. 
 
   
Figure 3.3: EPR absorption curve and its first derivative. 
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3.1.1.2 The anisotropic g-tensor 
 
“g” factor is a constant and a free electron has “g” (i.e. ge) value 2.002319.  
Equation 3.2 implies that the position of EPR signal depends on the “g” factor for a 
given field Bo. For example, in the case of organic free radical (especially when they 
contain only light atoms), the “g” values are very close to “ge” (i.e. g∆  ~ 0) and 
hence provide relatively little structural information. On the other hand, g∆  may be 
significant for heavy atoms. The “g” factor becomes more important for structure 
determination when hyperfine splitting (described in the next section) is not 
observed.  
 
The value of “g” factor may depend on the direction of magnetic field with respect to 
molecular axes. In general the “g” factor is a rank 2 tensor defined by the principal 
values which often correspond to molecular axes. This anisotropic behaviour of “g” 
factor can be illustrated by TEMPO (2,2,6,6-tetramethyl pyrrolidine-N-oxyl) free 
radical as shown in Figure 3.4.  
   
N
O  
2.0090
2.0060
2.0027  
 
Figure 3.4: Chemical structure of TEMPO radical with anisotropic principal values of 
the "g" tensor. 
 
3.1.1.3 Hyperfine interactions 
 
The presence of magnetic nuclei with I ≠ 0 affects the transition of electrons. As a 
result of this coupling between electron and nuclear spins, EPR signal of unpaired 
  Chapter 3  
105 
 
electron is split into more than one line. This splitting is called “Nuclear Hyperfine 
Splitting” and the strength of the hyperfine interaction is given by a hyperfine 
constant “A”. The spacing between the split lines determines the extent of hyperfine 
coupling. 
 
The number of lines in a splitting pattern depends upon the nuclear spin and the 
number of magnetically equivalent nuclei and is determined by eq. 3.5. 
 
   No of lines = 2nI + 1      Eq 3.5 
 
Here n is the number of equivalent nuclei and I is the nuclear spin. 
 
The hyperfine splitting is very helpful for structure elucidation. An example of 
nuclear hyperfine splitting found in nitroxide radical is shown in the Figure 3.5. The 
nitroxide EPR spectrum consists of three lines due to hyperfine coupling of unpaired 
electron with one N atom (I = 1). 
 
N O
  
(Nitroxide radical)
Bo
(A)
 
 
Figure 3.5: EPR spectrum of a free nitroxide in a fluid solution showing isotropic 
hyperfine coupling ("A" is the hyperfine splitting, Bo is applied magnetic field). 
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3.1.1.4 Mechanism of the hyperfine interactions 
 
There are two mechanisms of hyperfine interaction. 
 
1. Fermi Contact (isotropic) 
2. Dipole-dipole (anisotropic) 
 
The Fermi contact usually dominates in dilute solutions of rapidly tumbling systems. 
In rapidly tumbling systems, the anisotropic contributions average out to zero and 
spectra like in Figure 3.5 are observed. The Fermi contact interaction mathematically 
is given as: 
 
  )().(
3
8 2 oU en ψµµπ−=      Eq 3.6 
 
In eq 3.6, U is the energy of interaction, µn is the nuclear magnetic moment, µe is the 
electron magnetic moment, and Ψ2(0) is spin density at the nucleus. Fermi contact 
interaction can occur only for electrons with s-character. Isotropic interactions are 
also encountered in systems with unpaired electrons in p, d and f-orbitals. In such 
systems, the isotropic hyperfine is explained by mechanisms like configuration 
interactions or spin polarization.  
 
Dipole-dipole interactions are classical interactions between electron spin magnetic 
dipole and nuclear spin dipole moment. The magnetic field generated by nuclear 
moments is experienced by electron spins. The dipole-dipole hyperfine interactions 
are usually important for paramagnetic systems in solid, crystal and other cases 
where molecules are not tumbling very fast. In such systems all orientations are 
present and anisotropic interaction dominates the spectrum. For example, nitroxide 
radical is anisotropic i.e. its EPR spectrum depends on its orientation with respect to 
the direction of the external magnetic field. EPR spectra of an individual nitroxide 
molecule in different orientations are shown in Figure 3.6. 
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Figure 3.6: Single crystal spectra of nitroxide in three directions of nitroxide frame.
8
 
 
Figure 3.6 shows that when the direction of external magnetic field is changed, the 
distance between hyperfine extrema and central line (hyperfine splitting) changed 
uniformly. In the spectra of frozen solutions, spins are orientated randomly with 
respect to the magnetic field and the resulting spectrum is the sum of the contribution 
of all the orientations as explained in Figure 3.7. The hyperfine splitting tensor 〈A〉 
can be obtained by simulation of such powder / frozen spectra. 
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Figure 3.7: Frozen solution spectrum of a nitroxide in toluene. In sets: the overlapping 
of  1st derivative features yields the positive and negative signals at low and high 
field  respectively.
8
 
 
 “g” is also anisotropic but at X-band region of the microwave frequency “A” 
anisotropy dominates.  
 
Consequently the tumbling rate of species on a ns (nanosecond) time scale has a 
direct effect on hyperfine interactions, which defines the line shape (and line width) 
of the EPR spectra. By analysing / simulating line shape of EPR spectra, tumbling 
rate of species under question can be determined. The tumbling rate of nanoparticle-
attached DTPA ligand was determined using EPR spectroscopy and is discussed in 
the next section.  
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3.2 Vanadyl complexation with DTPA and DTPA based 
ligand@AuNPs 
 
To assess the tumbling rate (i.e. rotational correlational time) of nanoparticle-
attached DTPA ligand using EPR spectroscopy, Gd3+ needed to be replaced with 
some other paramagnetic ion due to the following reasons: 
 
• Gd3+ is paramagnetic (due to seven unpaired electrons), but its EPR 
spectrum consists of only one broad line due to spin-spin interactions 
between unpaired electrons (Figure 3.8).  
• As no hyperfine splitting is observed in Gd3+ EPR spectrum, hence it is 
isotropic and is not affected by changing the motion of the Gd3+.  
 
 
Figure 3.8: EPR spectrum of Gd
3+
 (i.e. aq solution of GdCl3). 
 
The alternative paramagnetic ion must be able to bind with DTPA and DTPA based 
ligands and its EPR spectrum should be motionally sensitive.9 
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In this work, vanadyl cation (VO2+) was used for this purpose. Vanadium (51V) is a 
transition metal that exhibits +2 to +5 oxidation state. Vanadyl has coordination 
number six, one is already occupied by oxygen, the remaining five can chelate with 
octadentate DTPA and DTPA based ligands9. Vanadyl (VO+2) is one of the most 
stable diatomic cations with a  3d1 configuration that makes it EPR active.10 
 
Chen at al.10 reported that vanadyl can be used to determine the tumbling rate of 
MRI contrast agents by replacing Gd3+ with vanadyl. As vanadyl possesses very 
anisotropic hyperfine (A) and Zeeman (g) tensors as well as large nuclear spin (I = 
7/2, 100 % natural abundance), it is very sensitive to small changes in the motion.  
 
VO2+-DTPA@AuNPs (Figure 3.9) were prepared using a modified literature11 
procedure and then characterized by EPR spectroscopy to determine the tumbling 
rate of nanoparticle-attached ligand. The ratio between vanadyl and DTPA based 
ligand at AuNPs surface was kept 1 : 3, to avoid any spin-spin interactions among 
vanadyl ions. High concentration of AuNPs was used as VO2+ binding to DTPA is 
weak. 
 
N
H
O
O
N
N
N
O
O
O
O
O
O
S
O
O
O
Au 
VO2+  
Figure 3.9: Vanadyl complexed with DTPA ligand@AuNPs. 
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3.2.1 Determination of principal values of “g” and “A” tensors for 
free VO
2+
 and VO
2+
-DTPA@AuNPs 
 
Principal values of “g” and “A” tensors need to be accurately known to determine τR 
of nanoparticle-attached ligand by simulating room temperature EPR spectra 
(discussed in the next section). As described in sections 3.1.1.2-3.1.1.3, the 
anisotropic “g” and “A” tensors can be obtained by fitting the EPR spectra of frozen 
solutions (e.g. immobilised). We prepared VOSO4 (free VO
2+) and VO2+-
DTPA@AuNPs solutions in 10 % glycerol (in deionised water) and recorded their 
EPR spectra. The 10% glycerol was used as a solvent as it forms good glassy state at 
low temperature. 
 
 The EPR spectra were recorded at 130 K and the magnetic field was calibrated 
using DPPH (2,2-diphenyl-1-picrylhydrazyl). The EPR spectra of free vanadyl 
(VOSO4) along with DPPH at 130 K (i.e. in frozen form) are shown in the Figure 
3.10. 
 
DPPH
  
Figure 3.10: EPR spectrum of free vanadyl with (red) and without (blue) DPPH at    
130 K. 
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As discussed earlier (section 3.1.1.4), the EPR spectra depend on molecular 
orientation with respect to applied magnetic field and the spectra of frozen solutions 
thus include a sum of spectra in different orientations.  
 
The simulated EPR spectra of vanadyl molecule in different orientations with respect 
to applied magnetic field and of frozen vanadyl solution are shown in Figure 3.11. 
For simulation, axial symmetry of the vanadyl molecule was assumed. 
 
 
Figure 3.11: Simulated EPR spectra (red for powder, blue for parallel and green for 
perpendicular orientation of vanadyl to applied magnetic field). 
 
The EPR spectrum of vanadyl exhibits eight lines due to one unpaired electron (and I 
= 7/2) (Figure 3.11). Due to large value of hyperfine coupling, the hyperfine 
components are not equally spaced (first order approximation thus cannot be used). 
The EPR spectrum in frozen form is quite complex (Figure 3.11 red). However 
certain features in this spectrum correspond to EPR spectra of vanadyl in parallel and 
perpendicular orientations (Figure 3.11 green and blue). These characteristic features 
are very important as they allow us to estimate the magnetic parameters (g and A 
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tensors) in parallel and perpendicular orientations of applied magnetic field. These 
estimates are then used as a starting point for simulations to get accurate values of 
“g” and “A” tensors. 
 
The experimental EPR spectrum of frozen vanadyl (Figure 3.10) is similar to that of 
the simulated spectrum (Figure 3.11 red). The fitting of experimental EPR spectra of 
free vanadyl and VO-DTPA@AuNPs was done using easyspin12 and the values of g 
and A-tensors are given in Table 3.2. The experimental and simulated EPR spectra 
for free vanadyl and VO-DTPA@AuNPs are shown in Figures 3.12. 
 
(A)
(B)
 
Figure 3.12: Experimental (thick lines) and simulated (thin lines) EPR spectra of free 
vanadyl (A) and VO-DTPA@AuNPs (B) at 130 K. 
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Table 3.2 Magnetic parameters of free VO
2+
 and VO-DTPA@AuNPs. 
S. 
No. 
Paramagnetic 
species 
A / MHz g 
Axx Axy Azz gxx gxy gzz 
1 VOSO4 207.3 210.4 543.9 1.9772 1.9708 1.9338 
2  
VO-DTPA@AuNPs 
175.1 187.0 511.7 1.9755 1.9783 1.9412 
3 * VO-DTPA 186.1 172.0 508.2 1.980 1.978 1.944 
*Literature values 
  
3.2.2 Determination of rotational time from room temperature EPR 
measurements 
 
Rotational time (τR) is defined as the time required for a species to rotate by one 
radian.13 The incomplete averaging of “A” and “g” tensors for structures that do not 
tumble rapidly, affects the line shape. Therefore, simulation of EPR spectra makes it 
possible to determine τR. The τR for free vanadyl and VO-DTPA at AuNP surface 
were thus determined by simulating their room temperature EPR spectra using 
accurately determined “g” and “A” tensor values from the frozen solution spectra. 
The tumbling of VO2+ species was assumed to be isotropic. The room temperature 
EPR spectra (Figure 3.13) show a linehape characteristic of fast motion e.g. faster 
than the Redfield limit τR
-1 >> ∆ω. The τR
-1 is the tumbling rate and ∆ω is the 
anisotropy of the hyperfine and Zeeman interactions. Fast motion approximation 
significantly simplifies simulations. 
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(A)
(B)
 
Figure 3.13: Experimental (thick lines) and simulated (thin lines) EPR spectra of free 
vanadyl (A) and VO-DTPA@AuNPs (B) at 298 K. 
 
The τR values for free VO
2+ and of VO-DTPA@AuNPs are shown in table 3.3. The 
τR of VO-DTPA@AuNPs was found to be only twice as long as for free VO
2+. This 
increase is not very large. The relatively high tumbling rate suggests that ligand 
molecules are not well packed at AuNP surface (ligand packing at nanoparticles 
surface is discussed in detail in section 3.4). The branching of DTPA units at the end 
of ligand molecule might be responsible for preventing tight packing of ligands at 
the AuNP surface. 
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 Table 3.3 Rotational correlational time of free vanadyl and vanadyl-
DTPA@AuNPs. 
 
 
 
 
 
 
 
 
 
3.3 Conclusions of EPR results 
 
 The EPR results showed that the DTPA based ligand molecules at the AuNP 
surface tumble relatively fast; attachment of ligands to nanoparticle surface only 
resulted in slowing down molecular tumbling by a factor of ca. 2. This fast tumbling 
is probably responsible for the only moderate increase in relaxivity of Gd-loaded 
AuNPs as compared to commercially available (small molecule based) MRI contrast 
agents.  
 
The EPR data are important as they show the way to enhance the relaxivity by 
reducing the tumbling of nanoparticle-attached ligands. 
  
We explored several strategies to reduce the tumbling of nanoparticle-attached 
ligand which may result in increased relaxivity of gold nanoparticle based MRI 
contrast agents. They are discussed in the following sections. 
Paramagnetic Species τR 
VOSO4 (Free VO
2+) 4.52 × 10-11s 
VO-DTPA 4.84×10-11s 
VO-DTPA@AuNPs 1.03 × 10-10s 
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3.4 Growth of AuNPs 
 
The first strategy which we used to reduce the tumbling rate of nanoparticle-attached 
ligand was increasing the core size of nanoparticles. As the size of AuNPs is 
increased, their curvature is decreased. At the surface of larger particles which have 
relatively small curvature, ligands are packed more tightly as compared to the 
surface of small nanoparticles. For example, Mei et al.14 used similar arguments to 
account for the digestion rate of small and large gold nanoparticles by sodium 
cyanide. They concluded that the larger gold nanoparticles are digested slower due to 
smaller curvature leading to more tight packing of the ligands as compared to the 
smaller nanoparticles (Figure3.14).  
 
 
  
Figure 3.14: Ligand packing density at the surface of AuNPs having various 
diameters.
14
 
 
It was speculated that the tight packing of ligand will result in reduced tumbling of 
nanoparticle-attached ligand, which will enhance the relaxivity. 
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 Various methods have been reported in the literature15-16 for increasing the size of 
gold nanoparticles based on Ostwald ripening phenomenon. According to this 
principle, discovered by Wilhelm Ostwald in 1896, larger particles are 
thermodynamically more stable due to their low surface to volume ratio (that results 
in lower surface energy). The molecules at the surface of smaller nanoparticles have 
high surface energy so they detach from the surface and reattach onto the surface of 
larger particles (Figure 3.15). Thus, the number of smaller particles decreases while 
larger particles continue to grow. 
 
  
Figure 3.15:  Schematic of the Ostwald ripening process. 
 
  The most common reported method for AuNP growth involves heating the AuNPs 
in the solid state. For example, Teranishi et al.15 reported that when the thiol 
protected AuNPs are heated in the solid state at increased temperatures (i.e. 150, 
190, 230 oC etc), their size increases to ~ 3.5, 5.5 and 7.0 nm, respectively. Similar 
results were observed by Shimizu et al.17  
 
The alternative one step strategy to prepare gold nanoparticles with larger core sizes 
is by changing the ratio between Au and Ligand16 during nanoparticle synthesis. 
Usually 1:1 ratio is used. By changing this ratio, the size of AuNPs can be tuned / 
changed. For example, Murray and co-workers18 described in detail the effect of    
Au : ligand molar ratio between on the core size of the AuNPs. They reported the 
size of alkanethiols protected AuNPs was increased by increasing the ratio of gold to 
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alkanethiols. This effect can be explained by slower ligand passivation as compared 
to the growth of incipient AuNPs at lower ligand / gold ratio. 
 
The change in size of AuNPs can be easily monitored by intensity of surface 
plasmon band (SPB) using UV-Vis spectroscopy (as discussed in chapter 2, section 
2.3.1). The bigger particles have more intense SPB as compared to the smaller 
particles (Figure 3.17).15 
 
We tested several methods for increasing the size of AuNPs protected by DTPA 
based ligand 6. In the first instance, freshly prepared AuNPs were heated in the solid 
state at 90-200 oC, but no significant increase in AuNP diameter (shown by UV-Vis 
spectra, Figure 3.16) was observed. Even heating for longer period (i.e. for 12-24 h) 
and at high temperature (i.e. 230-280 oC) failed to increase the size of the small 
AuNPs. 
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Figure 3.16: UV-Vis spectra of small AuNPs heated at various temperatures in solid 
state. 
 
The second strategy was to vary the ratio between gold and ligand during synthesis. 
Various ratios between gold and ligand such as 3/1, 5/1, 7/1 were used. No 
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significant difference in size was observed by UV-Vis spectra, moreover the AuNPs 
were not very stable. So this method was ruled out for growing the DTPA based 
ligand protected AuNPs. 
 
In a third approach, the crude aqueous solution of freshly prepared AuNPs was 
heated at reflux and the increase in nanoparticle size was monitored by UV-Vis 
spectroscopy. The crude AuNP synthesis mixture contained excess ligands which 
were needed for stabilisation of AuNPs. The reflux temperature (i.e. boiling point) of 
aqueous solution of AuNPs was increased by addition of ca. 20% v/v DMF. This 
method was successful and UV-Vis spectra of grown AuNPs are shown in Figure 
3.17. The exact diameter of grown AuNPs was then confirmed by TEM (discussed in 
next section 3.4.1.1).  
 
 
Figure 3.17: UV/Vis spectra of small and large AuNPs. 
 
After the growth of aq AuNPs, DMF was removed by dialysis against deionised 
water using 12-14 kDa dialysis tubing. The excess ligands were removed by gel 
permeation chromatography using 0.1 M NaCl as an eluent and Sephadex gel (G-
100) as a stationary phase. The purified larger AuNPs were again dialysed against 
deionised water to remove NaCl. The water was evaporated to get solid grown 
AuNPs protected by DTPA ligand 6. 
~ 2.0 nm ~ 4.0 nm ~ 6.0 nm
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3.4.1 Characterisation of grown AuNPs 
 
The grown AuNPs were characterised by TEM, TGA, AAS and ICP (after loading 
with Gd). 
 
3.4.1.1 Transmission electron microscopy (TEM) analysis 
 
The TEM analysis of the grown gold nanoparticles was carried out to determine the 
exact diameter and level of aggregation. The TEM analysis was done in the same 
way as for small gold nanoparticles (discussed in chapter 2) i.e. by placing a drop of 
aq solution of grown AuNPs on a copper grid, allowing the solvent to evaporate to 
dryness and then analysing by TEM. The TEM images along with size distribution 
histograms for grown AuNPs obtained by refluxing freshly prepared aq AuNPs with 
addition of DMF are shown in Figures 3.18 and 3.19. The TEM picture also showed 
that gold nanoparticles are well dispersed. 
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Figure 3.18: TEM image and size distribution histogram for grown AuNPs (~4.0 nm). 
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Figure 3.19: TEM image and size distribution histogram for grown AuNPs (~6.0 nm). 
 
3.4.1.2 Thermogravimetric analysis (TGA) of grown AuNPs 
 
TGA of grown AuNPs was carried out in order to determine the organic content of 
AuNPs. The TGA data for grown AuNPs along with small AuNPs (~2.0 nm) is 
shown in the Figure 3.20 which indicates the decreased organic content with 
increased particle size. The 4.0 nm AuNPs showed ~17 % organic content and 6.0 
nm AuNPs showed 8.0 % organic content.  
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Figure 3.20: TGA graphs of small AuNPs (black) and large (red for 4.0 nm and green 
for 6.0 nm) AuNPs. 
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The ratio between gold and protecting ligand (Au / Ligand) was increased with 
increased particle size because a greater proportion of the Au is located in the core 
rather than at the surface. Therefore, fewer ligand molecules are required for 
stabilisation of the larger AuNPs. This is well established in the literature.15 The 
TGA graphs for grown AuNPs are shown in Figure 3.20. 
 
3.4.1.3 ICP and AAS analysis of Gd-loaded large AuNPs 
 
The AuNPs were analysed by ICP, AAS and UV-Vis spectroscopy after loading with 
gadolinium and results are shown in Table 3.4. 
 
Table 3.4:  ICP, UV/Vis and AAS data for large (4.0 nm & 6.0 nm) Gd-loaded 
AuNPs. 
 
Technique Element 
AuNPs 
diameter 
Metal content / % 
ICP Gd 
4.0 nm 4.21 
6.0 nm 2.57 
UV/Vis Gd 
4.0 nm 4.39 
6.0 nm 2.32 
AAS Au 
4.0 nm 70.35 
6.0 nm 82.25 
 
The results of different techniques are quite comparable to each other. The Gd 
content was later used to determine the relaxivity of Gd-loaded AuNPs. The 
increased gold content in grown AuNPs as compared to small AuNPs is also 
confirmed by TGA analysis (as discussed in section 3.4.1.2.).  
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3.4.2 Composition of grown AuNPs 
 
Composition of large AuNPs was calculated by the same method as for the small 
AuNPs (discussed in chapter 2). The average nanoparticle composition was 
calculated for ~4.0 nm and ~6.0 nm Gd-loaded AuNPs: 
Au1543 Ligand160 Gd128  (~ 4.0 nm AuNPs) 
Au8429 Ligand65 Gd65  (~ 6.0 nm AuNPs) 
 
3.4.3 Rotational time (τR) of ligand in large (4.0 and 6.0 nm) AuNPs 
 
The large AuNPs were complexed with vanadyl as described in section 3.3. The ratio 
between VO2+ and DTPA ligand@AuNPs was kept 1 / 3 in order to avoid spin-spin 
interaction. The τR of grown (~4.0 nm and 6.0 nm) gold nanoparticles were 
determined by simulating room temperature EPR spectra. The τR of free vanadyl, 
VO-DTPA, VO-DTPA@AuNPs (~2.0 nm) VO-DTPA@AuNPs (~4.0 nm) and VO-
DTPA@AuNPs (~6.0 nm) are shown in Table 3.5. 
 
Table 3.5: Rotational correlational time of VO
2+
, VO-DTPA and VO-
DTPA@AuNPs. 
 
Paramagnetic Species τR / s 
VOSO4 (Free VO
2+) 4.52 × 10-11 
VO-DTPA@AuNPs (~2.0 nm) 1.03 × 10-10 
VO-DTPA@AuNPs (~4.0 nm) 1.25×10-10 
VO-DTPA@AuNPs (~6.0 nm) 1.90×10-10 
 
The τR of the ligand in large (4.0 & 6.0 nm) AuNPs was not found to be significantly 
different from the ligands in small AuNPs, but the τR in larger AuNPs (~6.0 nm)-
attached ligand was found to be reasonably higher (i.e. 4 fold) than that of free 
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vanadyl. The increased τR with the increase in nanoparticle size suggested the 
decreased tumbling of ligand at the surface of relatively larger AuNPs which might 
give higher relaxivity of nanoparticle based MRI contrast agents. The effect of 
decreased tumbling rate on relaxivity is discussed in the following section.  
 
3.4.4 Relaxivity measurements of large AuNPs 
 
Relaxivity measurements of large (~4.0 nm and ~6.0 nm) Gd-loaded AuNPs were 
carried out using the same method as for the small Gd-loaded AuNPs. The R1 values 
for small and large Gd-loaded AuNPs are shown in Table 3.6.  
 
It was observed that r1 increased steadily with increased size of AuNPs. The increase 
in r1 is directly attributed to the decreased tumbling of nanoparticle-attached ligand 
in larger AuNPs as compared to small AuNPs as discussed in section 3.5. In the 
larger AuNPs, the higher packing density of ligand due to tight packing resulted in 
higher relaxivity (Figure 3.14). 
 
Table 3.6: Relaxivity values of small and large AuNPs. 
 
 
 
 
 
 
 
 
 
 
 
Although larger AuNP based contrast agents have higher (about 3 fold) relaxivity 
than the small AuNPs, there are some disadvantages associated with larger AuNPs 
which might not favour their use for real applications as MRI contrast agents. The 
Gd-loaded gold 
nanoparticles 
Relaxivity / mM
-1
s
-1
 
 
~ 2.0 nm 
 
4.77 
 
~ 4.0 nm 
 
8.34 
 
~ 6.0 nm 
 
11.04 
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larger AuNPs are relatively less stable19 and hence may be more toxic as compared 
to the small AuNPs. Overall, our strategy of increasing nanoparticle size for 
increasing relaxivity was successful but due to disadvantages (associated with large 
nanoparticles) alternative methods / strategies were explored for increasing relaxivity 
of small gold nanoparticle based MRI contrast agents. This is discussed in the next 
section. 
 
3.5 Polyelectrolyte self assembly around nanoparticles 
 
An alternative strategy to decrease the tumbling of nanoparticle-attached ligands (in 
order to enhance the relaxivity of gold nanoparticle based MRI contrast agents) 
could include increasing the rigidity of the nanoparticle-attached ligands. The gold 
nanoparticles protected by DTPA based ligand have overall significant negative 
charge as each Gd-DTPA chelate has a -2 charge. The flexibility of charged 
nanoparticle-attached ligands can thus be reduced by adsorbing oppositely charged 
polyelectrolytes.  
 
 Polyelectrolytes are reported20 to self assemble around charged species i.e. 
positively charged polyelectrolytes can form self assembled layers around 
negatively charged species and vice versa. The main driving force for this 
assembly is electrostatic interactions. Multilayered materials can be prepared by 
layer by layer (LBL) self assembly technique. The LBL technique was developed 
in 1997 by G. Decher.21 The LBL involves the alternating deposition of 
oppositely charged polyelectrolytes on charged templates. For example as shown 
in Figure 3.21, the positively charged solid substrate was selected as a template 
and on this solid substrate the polyelectrolyte layers can be deposited by simply 
dipping it into solutions containing charged polyelectrolyte of interest. After 
formation of each layer, the excess / unbound molecules can be removed by 
washing with a suitable solvent. The multilayer build up based on LBL is 
schematically shown in Figure 3.21. 
 
  Chapter 3  
127 
 
 
Figure 3.21: Schematic diagram of layer by layer (LBL) self assembly (“A” for film 
deposition process and “B” for simplified molecular picture) by consecutive adsorption 
of cationic and anionic polyelectrolytes on positively charged solid substrate.
21
 
 
The LBL principle can also be used to form multilayers of polyelectrolytes using 
charged particles as templates. The charged particles are usually used to prepare 
micro- and nanometre sized capsules, as the particle core after formation of 
polyelectrolytes layers can be destroyed / dissolved by suitable solvents to get 
hollow microcapsules. The micro- and nanometre sized capsules have wide range of 
applications in drug delivery systems, gene therapy and biosensor devices. For 
example, Kotov et al.22 successfully reported polyelectrolyte multilayer formation 
around nanoparticles (Figure 3.22). Polyelectrolytes have also been reported to self-
assemble on the surface of charged gold nanoparticles.23-24 
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Charged particles
Polyelectrolytes multilayered protected particles
(iii) further LBL assembly
 
Figure 3.22: Schematic illustration layer by layer self assembly of oppositely charged 
polyelectrolytes at a charged particle surface.
23 
 
The negatively charged Gd-loaded AuNPs were reacted with various oppositely 
(positively) charged polyelectrolytes (discussed in the following sections) to form 
polyelectrolyte layers around gold nanoparticles. We hoped that adsorption of a 
polymer layer on the Gd-loaded AuNPs will slow down molecular tumbling (and 
enhance relaxivity) without adversely affecting the diffusion of water molecules. 
 
3.5.1 Poly (ethyleneimine) (PEI) coating on Gd-loaded AuNPs  
 
PEI is a cheap commercially available organic polymer (Figure 3.23). It is a weakly 
basic aliphatic water soluble polyelectrolyte. PEI has high density of amino groups 
that can be protonated at pH lower than 10 and in acidic medium PEI showed 
maximum protonation (Figure 3.23).25 As  pH was kept slightly basic (7.5-8.0) 
during PEI coating at AuNPs, so PEI was partially protonated to give polycationic 
PEI. 
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Figure 3.23: Poly (ethyleneimine) (PEI).  
 
The polycationic PEI can adsorb at the surface of negatively charged Gd-loaded 
AuNPs (Figure 3.24). PEIs are available in different molecular masses.26 Three 
different PEIs (PEI-1, 2 and 3) with number average molar masses (Mn) 423, 1800 
and 60000 Da, respectively were selected. The ratio between NH+ and Gd-
DTPA@AuNPs- was kept 2 / 1 to ensure complete adsorption of PEI. The pH of the 
PEI-protected-Gd-loaded AuNPs (Figure 3.19) was controlled using dilute HCl 
around physiological range (~7.5-8.0).  
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Figure 3.24: PEI-protected Gd-loaded AuNPs. 
 
Before measuring relaxivity of polyelectrolyte coated Gd-loaded AuNPs, their 
stability was tested as discussed below. 
 
3.5.2 Stability of polyelectrolyte coated Gd-loaded AuNPs 
 
 The stability of polyelectrolytes coated AuNPs was tested by UV-Vis spectroscopy 
and electron microscopy. UV-Vis spectra showed that the PEI-protected Gd-loaded 
AuNPs exhibited the SPB at the same position as the nanoparticles without any PEI 
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coating (Figure 3.25). Thus, the nanoparticles after polyelectrolyte coating are not 
aggregated.  
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Figure 3.25: UV-Vis spectra of Gd-loaded AuNPs without PEI coating (green) and with 
PEI (red) coating. 
 
Similarly, the TEM images of polyelectrolyte coated AuNPs also showed that the 
AuNPs are well dispersed and no aggregation was observed. A typical TEM image 
with size distribution histogram of PEI-1 protected AuNPs is shown in Figure 3.26. 
 
Both UV-Vis and TEM data confirmed the stability of nanoparticles after 
polyelectrolyte coating. The relaxivity of polyelectrolyte coated-Gd-loaded AuNPs is 
discussed in the next section.  
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Figure 3.26: TEM image and size distribution histogram of PEI-protected-Gd-loaded 
AuNPs. 
 
3.5.3 Relaxivity of PEI-protected-Gd-loaded AuNPs 
 
The relaxivity of polyelectrolyte protected Gd-loaded AuNPs was found higher than 
the nanoparticles without any polyelectrolyte coating (Table 3.7 p.133). The increase 
in relaxivity confirmed the successful adsorption of polycationic PEI at the 
negatively charged surface of Gd-loaded AuNPs. The PEI layer increased the rigidity 
(decreased tumbling) of nanoparticle-attached ligand which resulted in an increase in 
relaxivity. Furthermore, the relaxivity of PEI protected nanoparticles was increased 
as the molar mass of the ligand was increased. The charge ratio between positively 
charged PEI and negatively charged nanoparticles was kept the same, but the length 
of PEI molecules increased as their molar mass increased. The larger PEI molecules 
resulted in more rigid structures as compared to smaller PEI molecules.  
 
3.5.4 PAMAM dendrimer layers around AuNPs and their relaxivity 
 
In order to prove the general applicability of polyelectrolyte coating for reducing 
tumbling of nanoparticle-attached ligand, PAMAM (poly (amido amine)) dendrimers 
were also used. Dendrimers are reported27 to be less toxic than PEI. 
 
Dendrimers are repeatedly branched large molecules usually ranging in the size of 1-
10 nm. They have very well defined three dimensional architecture. Dendrimers 
have three main parts: core, branches, and end groups or termini (Figure 3.27). 
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Generation (G) of a dendrimer is the number of repeated branching cycles as is 
evident from Figure 3.27. For example if a dendrimer is prepared by performing one 
branching reaction onto the core, its generation will be one, and if prepared by 
performing branching reaction twice then it will be a second generation dendrimer 
and so on.  
   
Figure 3.27: Schematic representation of a dendrimer. 
   
Several reports on dendrimer based MRI contrast agents are found in literature. For 
example nano-sized dendrimers based MRI contrast agents are reported27 as non 
toxic materials. 
  
We selected PAMAM (polyamidoamine) dendrimer for coating charged Gd-loaded 
AuNPs in order to reduce tumbling of nanoparticle-attached ligand that will enhance 
the relaxivity. PAMAM is the most common class of dendrimers consisting of  
alkyl-diamine core and tertiary amine branches and is commercially available in 
generations G0-10 (Figure 3.28 shows G0 PAMAM).  
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Figure 3.28: Zero generation PAMAM dendrimer (in aq solution). 
 
PAMAM is water soluble as it has hydrophilic end groups. In the aq solution,  
PAMAM gets partially protonated. Two generations of PAMAM i.e. G0 and G4 were 
selected in our study. The PAMAM protected Gd-loaded AuNPs exhibited higher 
relaxivity as compared to nanoparticles without any dendrimers (Table 3.7). The G0 
PAMAM protected nanoparticles did not show any increase in relaxivity, but G4 
PAMAM showed ~50% increase in relaxivity as compared to nanoparticles without 
any dendrimers protection. This increase is somewhat (~5%) higher than for the PEI-
protected-Gd-loaded AuNPs. The PAMAM dendrimers due to their branched 
structure resulted in more rigid structure when they adsorbed at the charged surface 
of Gd-loaded AuNPs. The more rigid structure decreased the tumbling of 
nanoparticle-attached ligands which enhanced the relaxivity. 
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Table 3.7: R1 of polyelectrolyte and dendrimer coated Gd-loaded AuNPs. 
 
Gd-Compound Molar Mass of 
Polyelectrolyte and 
Dendrimer / Da 
r1 / mM
-1
s
-1
 Increase in r1 
relative to Gd- 
AuNPs / % 
Gd-AuNPs - 4.77 - 
PEI-1-Gd-AuNPs 423 6.50 36 
PEI-2-Gd-AuNPs 1800 6.74 41 
PEI-3-Gd-AuNPs 60000 7.00 46 
PAMAM (G0)-Gd-
AuNPs 
517 4.74 - 
PAMAM (G4)-Gd-
AuNPs 
14000 7.10 50 
 
 
3.5.5 Layer by layer assembly of polyelectrolytes around Gd-loaded 
AuNPs 
 
In the above section, the Gd-loaded AuNPs were protected by monolayers of various 
polyelectrolytes and dendrimers that resulted in reduced tumbling of nanoparticle-
attached ligand and consequently an increase in r1 was observed. In order to further 
increase relaxivity, multilayers of polyelectrolytes were assembled around AuNPs. 
The multilayers were formed by LBL technique (discussed in section 3.5) which 
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involves sequential coating by oppositely charged polyelectrolytes.28-29 PEI  (Figure 
3.23) and poly (acrylic acid) (PAA) (negatively charged) (Figure 3.29) 
polyelectrolytes were selected for multilayers formation. Two different PEIs (PEI-I 
and PEI-II) with molar masses 1300 and 2000 respectively, and two different PAAs 
(PAA-I and PAA-II) with molar masses 1200 and 2100 were selected. On the 
negatively charged surface of Gd-loaded AuNPs, positively charged PEI layer was 
coated first. The excess PEI was removed by dialysis against deionised water using 
12-14 kDa dialysis tubing. The PAA was then coated on positively charged PEI-Gd-
DTPA@AuNPs. The PAA-PEI-Gd-DTPA@AuNPs (Figure 3.30) were again 
dialysed to remove the excess PAA. The removal of excess polyelectrolytes i.e. PEI 
and PAA by dialysis was confirmed by a control test. In the control test, ca. 100 mg 
of each polyelectrolyte dissolved in ca. 10 mL of deionised water was dialysed 
against deionised water. The dialysis showed complete disappearance of 
polyelectrolytes which confirmed that the excess polyelectrolytes could pass through 
the dialysis membrane and thus could be removed. In this way, multilayers of 
oppositely charged polyelectrolytes were formed at Gd-loaded AuNPs (Figure 3.30). 
*
O O
n
 
 
Figure 3.29: Chemical structure of PAA polyelectrolyte. 
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Figure 3.30: Polyelectrolyte multilayers on the surface of Gd-loaded AuNPs 
 
The relaxivity (r1) was measured after formation of each layer at Gd-loaded AuNPs 
and a plot of r1 values against the number of polyelectrolyte layers is shown in 
Figure 3.31. 
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Figure 3.31: R1 values vs no of polyelectrolyte layers@ Gd-loaded AuNPs 
 
Figure 3.31 shows that initially r1 increased with the increased number of 
polyelectrolyte layers. The increase in r1 is due to the progressive reduction in the 
tumbling of nanoparticle-attached ligand. Interestingly, in case of PEI-I and PAA-I, a 
plateau was then reached. Despite the reduced tumbling of nanoparticle-attached 
ligand, presumably the slower water exchange rate between Gd-DTPA chelates at 
AuNP surface and the surrounding medium also affected the r 1. Furthermore, rapid 
loss in r1 was observed after the fourth layer of polyelectrolyte. The rapid loss in R1 
suggested the drop in water exchange rate between Gd at nanoparticle surface and 
surrounding medium. Peyratout et al.30 reported that the water exchange through 
polyelectrolyte layers is strongly affected by thickness of the layer. Thus it can be 
suggested that the rapid loss in r1 occurred due to increased thickness of 
polyelectrolyte layers which hindered the water exchange.  
 
 The effect of polyelectrolyte multilayers on relaxivity of Gd-loaded AuNPs was 
further confirmed using another pair of polyelectrolytes with higher molar masses. 
PEI-II and PAA-II coated AuNPs were prepared and their relaxivity was measured. 
The relaxivity behaviour of PEI-II-PAA-II is depicted in Figure 3.31. The greater 
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increase in r1 was observed by PEI-II and PAA-II as compared to PEI-I and PAA-I. 
The effect of molar mass of polyelectrolyte on relaxivity has already been discussed 
in section 3.5.1 (Table 3.7). The other difference is the rapid loss in r1 after 
formation of only two layers. Presumably the larger polyelectrolytes formed 
relatively thick layers which hindered the water exchange resulting in sudden 
decrease in r1.  
 
3.6 Conclusions 
 
The EPR analysis of vanadyl labelled AuNPs showed that fairly high tumbling rate 
of nanoparticle-attached ligand limited the increase in relaxivity of Gd-loaded 
AuNPs as compared to the small molecule based MRI contrast agents. The relaxivity 
can be increased further by reducing the tumbling of nanoparticle-attached ligand. 
Two strategies were developed to reduce the tumbling of nanoparticle-attached 
ligand. The small (~ 2.0 nm) gold nanoparticles were grown into larger nanoparticles 
(4-6 nm). The larger nanoparticles have more flat surface (smaller curvature). At the 
more flat surface of larger nanoparticles the tumbling of ligand was decreased due to 
higher ligand density / tighter ligand packing. The increased nanoparticle size led to 
higher relaxivity. 
 
 The Gd-DTPA chelates have a significant negative charge at AuNPs surface. This 
negative charge can be neutralised by adsorbing oppositely charged polyelectrolytes. 
The adsorption of oppositely charged polyelectrolytes at the charged nanoparticles 
increased the rigidity of nanoparticle-attached ligand. The increased rigidity resulted 
in an increase in relaxivity.  
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Chapter 4: Gold nanoparticles protected by nitroxide 
based ligand as redox sensitive MRI contrast agents 
 
4.1 Introduction 
 
Chapters 2 and 3 discuss the Gd-loaded-gold nanoparticles (Gd3+-based) as MRI 
contrast agents and various strategies for increasing their relaxivity. Nitroxides are 
organic paramagnetic molecules which can also be used as MRI contrast agents. This 
is the focus of this chapter. Nitroxides can also produce T1 contrast due to the single 
unpaired electron. However, their use as MRI contrast agents is hampered due to 
several reasons e.g. 
 
 They are less stable in vivo because they are rapidly reduced (the redox 
behaviour of nitroxides will be discussed later in this chapter). 
 They have a low magnetic moment ~ 1.00 BM, hence their efficiency of T1 
shortening is very low as compared to Gd3+ (which has quite high magnetic 
moment 7.9 BM ) based chelates.1-2 
 
However, the redox sensitive properties of nitroxides can be exploited to study the 
redox status of living tissues. Another important feature of nitroxides which attracted 
researchers, is the ability of nitroxides to pass through the blood brain barrier (BBB), 
while the other Gd-based contrast agents could not penetrate in this specific area.3 
BBB is a layer of special cells (endothelial cells) which separates the circulating 
blood from the cerebrospinal fluid of the central nervous system. Generally large 
species such as bacteria etc and hydrophilic molecules are restricted while 
endothelial cells permit small hydrophobic molecules to cross the BBB. 
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4.1.1 Nitroxide based contrast agents  
 
In the early 1980s, nitroxides were identified as potential MRI contrast agents due to 
the previously mentioned features i.e. paramagnetism and permeability through 
BBB. In 1983, Brasch and co-workers4 published a preliminary report on the 
utilization of nitroxides as contrast agents for MRI. They used a                  
piperidinyl derivative of stable nitroxide radical to study the brains of living animals 
and found that the nitroxide based free radical crossed the BBB (which was 
confirmed by MRI). After confirming the feasibility of using nitroxides as MRI 
contrast agents in animals, their stability was studied. Couet et al.5 described the 
stability of two different nitroxides (Figure 4.1) (a) a six member ring i.e. N-
succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl (TES) and (b) a five member 
ring i.e. 2,2,5,5-tetramethylpyrrolidine-1-oxyl-3-carboxylic acid (PCA), in vitro as 
well as in vivo. 
 
N
O  
N O
COOH
N
O  
COOH
TES PCA  
Figure 4.1: Chemical structures of TES (piperidinyl based nitroxide) and PCA 
(pyrrolidinyl based nitroxide).
5
 
 
Both the in vivo and in vitro studies confirmed that PCA is more resistant to 
reduction and hence is more stable as compared to TES. The five-membered ring 
based PCA is more stable than six-membered TES because it is planar rather than 
puckered. 
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To increase the efficiency of nitroxide based MRI contrast agents, dendrimers were 
selected as templates. At the termini of dendrimer molecules, several nitroxide 
moieties can be attached (Figure 4.2).6-8 It has been found that for higher generation 
dendrimers, extensive line broadening could be observed due to spin-spin exchange 
interactions. Yordanov et al.7 reported spin labelled dendrimers in EPR imaging 
studies. They selected the PAMAM (G 6) dendrimer and different amounts (e.g. 198 
and 80) of nitroxides were attached on them. Their studies showed that with the 
increased number of nitroxides, the tendency of dendrimers to aggregate could 
increase which hinders the in vivo applications. The aggregation of nitroxide-
attached dendrimers may be due to highly lipophilic nature of their surface.  
 
 
Figure 4.2: G2 DAB dendrimer containing 16 nitroxide moieties.
6
 
 
Winalski et al.152 described the relaxation measurements of different dendrimers 
functionalised with various numbers of nitroxides. Three different types of 
dendrimers were selected (a) tris(2-aminoethyl)amine (TREN) (b) DAB and (c) 
PAMAM. To these dendrimers, nitroxides were attached. The relaxivity of these 
dendrimer based nitroxides was increased with the increased number of nitroxides to 
a certain level of dendrimer generation and then became approximately constant. 
This might be due to sharing of hydration spheres by nitroxides in higher 
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generations. The sharing of hydration spheres may be due to hydrogen bonding 
between amides of the terminal groups. The relaxivity of PAMAM (G 4) containing 
32 nitroxides was found even higher (5.00 mM-1s-1) than the Gd-DTPA               
(4.76 mM-1s-1). In fact the relaxivity per nitroxide was 0.18 mM-1s-1. Many other 
reports can be found in the literature describing the utilization of nitroxides as MRI 
contrast agents.2, 4, 9-11 
 
We used gold nanoparticles as a template for nitroxides based MRI contrast agents. 
Nanoparticles make it possible to attach several nitroxides per particle. The 
nanoparticle-attached nitroxides were expected to have better relaxivity due to 
reduced tumbling of nanoparticle-attached nitroxides. Furthermore, gold 
nanoparticles might be able to pass through BBB after coating with suitable 
biomolecules such as carbohydrates etc. 
 
Gold nanoparticles protected by nitroxide radical based ligands could not be 
synthesized by Brust et al.12 protocol, because nitroxide radicals are decomposed 
during the reduction of Au(III) to Au(0). Therefore the nitroxide protected gold 
nanoparticles found in literature13-15 were prepared by a ligand exchange approach 
using triphenylphosphine (PPh3@AuNPs) protected AuNPs. The nitroxide protected 
AuNPs prepared by this strategy could not be utilised for the purpose of MRI 
contrast agents due to several reasons. Firstly, they were insoluble in aqueous 
medium (the MRI contrast agents must be water soluble). Secondly the ligand 
exchange approach may lead to the incomplete exchange reaction particularly at 
room temperature (Figure 4.3). The elevated temperature could result in complete 
ligand exchange but may be accompanied by some decomposition of the nitroxide 
radicals.  
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Figure 4.3:  Nitroxides spin labelled AuNPs (insoluble in aqueous medium).
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Therefore, we developed a different approach to prepare nitroxide protected, water 
soluble gold nanoparticles. This approach is also based on the ligand exchange 
reaction; however, it involves two steps and will be discussed in detail in section 4.3. 
 
4.2 Synthesis of triphenylphosphine (PPh3) protected gold 
nanoparticles (AuNPs) 
 
Due to relatively weak affinity of phosphorus for gold, PPh3 can be displaced from 
the gold nanoparticle surface with sulphur containing ligands and hence it is good 
starting material for ligand exchange reactions. The PPh3 protected AuNPs (Figure 
4.4) were synthesized and purified by following a literature procedure.17 
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Figure 4.4: Triphenylphosphine protected gold nanoparticles. 
 
PPh3 protected AuNPs were characterised by conventional techniques e.g. UV-Vis, 
TEM and TGA. The UV-Vis spectrum showed SPB at 520-525 nm. TGA showed 
ca. 25 % organic content in the AuNPs. This low amount of ligand corresponds to 
the large steric bulk of ligand (PPh3) as compared to straight chain ligands. This 
amount of organic content (i.e. PPh3) determined from TGA will be used to calculate 
the stoichiometry for further ligand exchange reactions. The diameter determined 
from the TEM image of the PPh3@AuNPs was found 1.91 ± 0.24 nm.  
 
4.3 Synthesis of gold nanoparticles protected by nitroxide based 
ligand 
 
We prepared nitroxide protected water soluble AuNPs using a modified ligand 
exchange approach18 which involved two steps. In the modified ligand exchange 
approach, the triphenylphosphine molecules were exchanged with a relatively more 
stable ligand DSP (dithiobis [succinimdylpropionate]) ligand at relatively elevated 
temperature (i.e. 50 oC) in chloroform. The ligand exchange reaction at elevated 
temperature (i.e. 50 oC) was done to ensure the complete ligand exchange reaction.  
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Figure 4.5: Scheme showing synthesis of AuNPs protected by nitroxides based ligand. 
 
The AuNPs protected by DSP (i.e. after first step of ligand exchange approach) 
could not be purified, because the DSP ligand can be easily hydrolysed during 
purification. As free DSP ligand was not removed, excess amount of amino-TEMPO 
was required in the second step. 1.0 min after the addition of DSP to the 
PPh3AuNPs, the amino-TEMPO solution in chloroform was added. The amino        
(-NH2) group of amino-TEMPO reacted rapidly with the activated ester group of the 
DSP ligand at the AuNP surface to form stable amide linkage (Figure 4.5). NHS 
esters are easy to hydrolyze by adventitious water; this small amount of carboxylate 
(Figure 4.5) will make the gold nanoparticles soluble in aqueous media. After 
stirring the reaction mixture for ca. 2h, the solvent was evaporated at room 
temperature, and AuNPs were purified using Sephadex LH-20 as a stationary phase 
and MeOH as an eluent. The purified AuNPs protected by nitroxide based ligand 
were quite soluble in MeOH, and furthermore the concentrated solution of these 
nanoparticles in MeOH was miscible with deionised water. The miscibility with 
water confirmed our assumption that some of the NHS groups of DSP ligand were 
hydrolysed into carboxylic acid (-COOH) groups (Figure 4.5). The purified AuNPs 
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protected by nitroxide based ligand were characterised by UV-Vis, TEM 
spectroscopies, TGA, elemental analysis and EPR (characterisation is discussed in 
the next section). 
 
4.3.1 Characterisation of AuNPs protected by nitroxide based 
ligand 
 
The purified AuNPs were characterised by UV-Vis., TEM, TGA, elemental analysis 
and EPR spectroscopy which are discussed below. 
 
4.3.1.1 UV-Vis spectrum of AuNPs protected by nitroxide based ligand 
 
The UV-Vis spectrum of gold nanoparticles protected by nitroxide based ligand 
showed SPB at 520-525 nm (Figure 4.6), which confirmed the formation of gold 
nanoparticles and its intensity is consistent with the size  (~2.0 nm) of the 
nanoparticles. 
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Figure 4.6: UV-Vis spectrum of AuNPs protected by nitroxide based ligand 
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4.3.1.2 TEM 
 
A TEM image of nitroxide based ligand protected AuNPs was recorded by the same 
method as for the DTPA ligand protected AuNPs (discussed in ch. 2 and 3). The 
TEM image shows well dispersed gold nanoparticles with an average diameter 2.12 
± 0.39 nm (Figure 4.7).  
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Figure 4.7: TEM image and size distribution histogram of AuNPs protected by 
nitroxides based ligand 
 
4.3.1.3 TGA of AuNPs protected by nitroxide based ligand 
 
The thermogravimetric analysis (Figure 4.8) showed ca. 32% of total organic matter 
present on the gold nanoparticle surface. As mentioned in section 4.3, it is possible 
that two different types of ligands are present at the nanoparticles surface. Hence for 
the exact determination of nanoparticle composition, elemental analysis of the 
nanoparticles was carried out and is discussed in the next section. 
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Figure 4.8: TGA graph of AuNPs protected by nitroxide based ligand. 
 
4.3.1.4 Elemental analysis of AuNPs protected by nitroxide based ligand 
 
The elemental analysis was carried out to estimate the nanoparticle composition. The 
best fit composition (Au : LigandA: LigandB = 34 : 13 : 1) (Table 4.1) (Figure 4.5) 
determined from elemental analysis was found to be in agreement with the TGA 
results. 
 
Table 4.1: Percentage composition of various elements present in nitroxide protected 
AuNPs. 
 
 
 
 
 
 
 
 
Element C H N Au 
 
% Theory 
 
17.69 
 
2.85 
 
3.15 
 
68 
 
% Found 
 
19.05 
 
2.42 
 
3.08 
 
65 
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From TEM and elemental analysis data, formula of one nanoparticle is suggested as: 
Au295Ligand(A)116 Ligand(B)9.  
 
4.3.2 EPR analysis of AuNPs protected by nitroxide based ligand 
 
The nitroxide radical gives three lines in an EPR spectrum due to hyperfine 
interaction with 14N (I = 1) (as discussed in chapter 3, section 3.1.1.3). Nitroxide-
functionalised gold nanoparticles have several nitroxides close to each other. These 
nitroxides can interact with each other via spin-spin exchange interactions. The spin-
spin interaction results in a broad line instead of three lines in the EPR spectrum 
(Figure 4.9). 
  
Figure 4.9: EPR spectra of free nitroxide radical (green) and nitroxide based ligand at 
AuNP surface (red). 
 
The single broad line by nitroxide protected AuNPs has also been reported 
previously by Chechik et al13. In their report they described that the single broad line 
is observed only when the nanoparticle surface is highly covered with nitroxides i.e. 
more than 20 nitroxides per particle.  
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The line width of the single broad line is an important parameter to estimate the 
concentration of nitroxides on the surface of the nanoparticle. As shown in Figure 
4.10, nitroxide radicals exhibit three lines at low concentration (e.g. 10-4 M); these 
lines become broader (i.e. due to exchange broadening) and then merge to give a 
single broad line with the increased concentration of nitroxides. The line width of the 
single broad line decreases with the further increase in nitroxide concentration 
(Figure 4.7)19, this phenomenon is called exchange narrowing. 
 
 
Figure 4.10: EPR spectra of di-t-butyl nitroxide radical in ethanol at room temperature 
having various concentrations: (a) 10
-4 
M,  (b) 10
-2 
M, (c) 10
-1
 M and (d) pure liquid 
nitroxide.
19 
 
The line width of EPR spectrum of AuNPs protected by nitroxide based ligand was 
found to be 16.8 G. Based on the literature, the nitroxide protected gold 
nanoparticles with similar line width were expected to have ~ 40 nitroxides per 
particle.13  Thus EPR confirmed that several nitroxides are closely present at the 
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nanoparticles surface; therefore they can be studied for the purpose of MRI contrast 
agents. Their relaxation measurements and redox behaviour will be discussed in 
section 4.3.5 and 4.3.6 respectively. 
 
4.3.3 Quantitative estimation of nitroxide at AuNPs surface by EPR 
spectroscopy 
 
Unfortunately EPR signal intensity of nitroxide protected AuNPs was not in 
agreement with the TGA and elemental analysis data. For example, 6.4 mg of 
nitroxide protected AuNPs dissolved in 2.9 mL of deionised water exhibited EPR 
spectra with double integral intensity corresponding to ca. 13 wt% of nitroxide based 
ligand while elemental analysis (and TGA) predicted ca. 32 wt % of the nitroxide 
based ligand. This discrepancy is attributed to the decomposition of some of the 
nitroxides at the nanoparticles surface. However the total organic content determined 
by TGA is compatible with the elemental analysis data. This suggests that amino-
TEMPO successfully reacted with DSP ligand but nitroxide functionality degraded 
during the reaction. To check if nitroxide degradation resulted in hydroxylamine, 
attempts to oxidised hydroxylamine back to nitroxide with PbO2 failed. In another 
control experiment, the nitroxide protected AuNPs were decomposed by KI and I2 
solution in MeOH in order to release the nitroxide based ligand which will form a 
disulphide linkage to give a diradical (Figure 4.11).  
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Figure 4.11: Scheme showing control test. 
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The nitroxide based diradical was expected to exhibit spectra with some additional 
peaks (*) due to be spin-spin interactions (Figure 4.12). The intensity of the 
additional peaks (*) was found lower than expected in DCM which confirmed the 
decomposition of nitroxides. Furthermore, no difference in the EPR signal (double 
integral) intensity was found before and after decomposing nitroxide protected 
AuNPs.  
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Figure 4.12: EPR spectrum of nitroxide diradicals. 
 
4.3.4 Determination of nitroxide radical concentration 
 
The accurate nitroxide radicals’ concentration must be known for determination of 
relaxivity. The calibration curve was set up using double integral values of EPR 
spectra of known concentrations of nitroxide radical solutions (TEMPO was used 
radical for the calibration curve) (Figure 4.13). This calibration curve was then used 
for determination of nitroxide concentration in nitroxide protected gold nanoparticle 
solutions. 
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Figure 4.13: Calibration curve for determination of [NO]. 
 
4.3.5 Relaxation measurements 
 
 The relaxivity of nitroxide protected gold nanoparticles in water was measured 
using the same method as for Gd-loaded AuNPs. The relaxivity of nitroxide 
protected AuNPs (0.32 mM-1s-1) was slightly higher than that for free nitroxides 
(0.30 mM-1s-1) (Table 4.2). This slight increase may be due to reduced tumbling of 
nanoparticle-attached nitroxide based ligand. This value of relaxivity for nitroxide 
based compound is much smaller as compared to Gd3+-based chelates, and is easily 
justified by the presence of seven unpaired electrons in Gd3+, while the nitroxide 
contain only one unpaired electron. The similar values of relaxivity for nitroxide 
based contrast agents have also been reported previously3. However, unlike the Gd3+ 
based contrast agents, relatively hydrophobic nitroxides can pass through the BBB 
and they can report on redox status of the brain tissues. Furthermore, nitroxides are 
non-toxic, while Gd3+ ions are extremely toxic and they must be chelated before 
utilisation for MRI applications. Gd3+ may also leach from the chelates which can 
cause serious problems.  
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Table 4.2: Comparison of R1 values of Nitroxides@AuNPs with Gd-DTPA@AuNPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.6 Redox behaviour of nitroxide at the surface of AuNPs 
 
It was hoped that attaching several nitroxides to the gold nanoparticles surface would 
increase their stability towards reducing agents. Nitroxides can undergo redox 
transformation i.e. either to oxoammonium cation by gaining one electron or 
hydroxylamine by losing one electron2, but in biological media they are reduced       
(e.g. by ascorbic acid). This limits their applications as T1-contrast agents in MRI 
imaging. However their redox behaviour can be exploited to study the redox status of 
the living tissues. 
 
Nitroxides are cell permeable and depending upon the presence of abnormal amounts 
of oxidising or reducing species in the cells, the cell status can be studied by 
measuring the rate of nitroxide transformation reactions and then comparing with the 
rate of reduction of nitroxides in the normal cells. For example in the tumour cells, 
the nitroxides are reduced more rapidly as compared to normal tissues. 
 
The rate of reduction of free nitroxides and nitroxides at the surface of gold 
nanoparticles was studied in vitro. Sodium ascorbate, a commonly used reducing 
agent, was used as a reducing agent. Sodium ascorbate was selected rather than 
Compound Relaxivity / mM
-1
s
-1
 
Free Nitroxides 0.29 
Nitroxides@AuNPs 0.32 
Gd-DTPA 3.83 
Gd-loaded AuNPs 4.77 
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ascorbic acid in order to avoid the decomposition of gold nanoparticles in acidic 
medium. Ascorbate ions can reduce nitroxide radicals as they possess a labile H-
atom (Figure 4.14). The ascorbate radical formed is relatively persistent. 
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Figure 4.14: Mechanism of reduction of nitroxide radicals by sodium ascorbate. 
 
The rate of reduction of free as well as nanoparticle-attached nitroxides was 
monitored by recording EPR spectra at regular intervals. EPR spectra of 
nanoparticle-attached nitroxides and free nitroxides in the presence of sodium 
ascorbate (4-fold excess) are shown in Figures 4.15 and 4.16 respectively. In Figure 
4.15, the two sharp lines are assigned to ascorbate radical. The intensity of the single 
broad line exhibited by gold nanoparticle-attached nitroxides (Figure 4.15) and of 
three lines exhibited by free nitroxides (Figure 4.16) was reduced over time. The 
decrease in intensity was due to reduction of nitroxides by sodium ascorbate (Figure 
4.14). During the reduction of surface-bound nitroxides, very weak evolution of 14N 
hyperfine interactions (**) (i.e. three lines) was observed due to decrease in the 
number of nitroxides attached to the same nanoparticle (Figure 4.15). The decreased 
number of nitroxides per particle decreased the spin-spin interactions which resulted 
in appearance of three lines (**). 
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Figure 4.15: EPR spectra of Nitroxides@AuNPs in the presence of reducing agent at 
various intervals of time. 
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Figure 4.16: EPR spectra of free nitroxides (i.e. amino-TEMPO) in the presence of 
reducing agent at various intervals of time. 
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The rate of reduction of free as well as nanoparticle-attached nitroxides was 
determined by plotting the double integral intensity of their EPR spectra vs time 
(Figure 4.17). Figure 4.17 shows that free nitroxides are reduced more rapidly as 
compared to the nitroxides adsorbed at the surface of gold nanoparticles. The 
nitroxides at gold nanoparticle surface have compact packing and hence access of 
ascorbate to the nitroxides is restricted as compared to the access to the free 
nitroxides. The nanoparticle-attached nitroxides follow the first order decay while 
the first order decay was not well fitted for the free nitroxides (Figure 4.17). This 
difference in the reduction behaviour might be attributed to the different 
compositional changes as the reaction proceeds. 
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Figure 4.17: Rate of reduction of free nitroxides and nanoparticles-attached nitroxides. 
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4.4 Conclusions 
 
Water soluble gold nanoparticles protected by nitroxide based ligand were prepared 
and characterised. After characterisation, the relaxivity measurements and oxidising 
behaviour of nitroxide protected gold nanoparticles was studied and compared with 
free nitroxides in vitro. The nitroxide protected gold nanoparticles showed a slightly 
higher relaxivity than the free nitroxides. This increase in relaxivity is attributed to 
the slower tumbling of nitroxide ligand at the nanoparticle surface as compared to 
the free nitroxides. The nitroxides at nanoparticles surface also showed slow 
reduction as compared to the free nitroxides due to compact packing, which may 
encourage their in vivo applications as MRI contrast agents. 
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Chapter 5: Other applications of lanthanide-loaded        
gold nanoparticles 
 
5.1 Introduction 
 
Previous chapters (2-3) describe the preparation of gold nanoparticles protected by 
DTPA based ligand and their applications as MRI contrast agents. The DTPA ligand 
protected AuNPs have also some other useful and interesting applications apart from 
MRI contrast agents. For example, the DTPA based ligand is a strong chelate which 
can also bind other lanthanides such as terbium (Tb3+), europium (Eu3+), dysprosium 
Dy3+ etc. As Tb3+ and Eu3+ both exhibit luminescence (discussed in the next section), 
therefore Tb3+ or Eu3+-loaded AuNPs in principle can be used as optical imaging 
contrast agents. By loading Gd3+ (as MRI contrast agent) and Tb3+ (as optical imaging 
contrast agent) on the same nanoparticle, dual imaging contrast agents can be 
obtained.1 MRI usually provides high spatial resolution to give physiological and 
anatomical information while optical imaging allows the rapid screening i.e. accurate 
delineation between the targeted (diseased) and the surrounding (normal) tissues.2 
Currently a lot of effort is being devoted to the development of dual modal imaging 
probes.3-5 For example, Lee and co-workers5 described iron oxide particles conjugated 
to fluorescent dye doped silica nanoparticles for dual optical and magnetic resonance 
imaging (Figure 5.1). 
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Figure 5.1: Schematic representation of  dual imaging contrast agents i.e. core-satellite 
DySiO2-(Fe3O4)n nanoparticles.
5
 
  
Dye (Rhodamine) doped silica nanoparticles acted as optical imaging contrast agents 
while iron oxide particles were used as MRI contrast agents. 
  
Furthermore, gold nanoparticles protected by DTPA ligand can also be used to test an 
important EPR methodology. The relaxation of unpaired electrons of paramagnetic 
species can be enhanced by other paramagnetic lanthanide metal ions which are close 
to each other. So, if we attach a nitroxide radical to the gold nanoparticles which 
already have lanthanides, the relaxation enhancement of nitroxide radical by 
paramagnetic lanthanide ion can be monitored by EPR spectroscopy. The EPR 
methodology which was tested using nitroxide-labelled-lanthanide-loaded gold 
nanoparticles will be discussed in the second part of this chapter. 
 
5.1.1 Luminescence 
 
Luminescence is the emission of light by a substance and it occurs when excited 
electron returns to the ground state from the excited state. Luminescence phenomena 
are divided into two classes depending upon the nature of the excited state: 
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• Fluorescence  
• Phosphorescence 
 
In fluorescence the electrons in the excited orbital have opposite spin as compared to 
the electrons in the ground state. Therefore they return to the ground state rapidly by 
emission of photons as this transition is spin allowed (paring of opposite spins). The 
emission rates of fluorescence are usually in the range of 108 s-1 (typical florescence 
life times are near 10 ns). Phosphorescence is the emission of light from triplet excited 
states. In phosphorescence the excited electron has the same spin orientation as the 
ground state electron. The transition to the ground state is thus forbidden and hence 
emission becomes slow. The phosphorescence life times are typically in milliseconds 
to seconds.6 
 
In lanthanides, 4f orbitals are shielded by outer lying 5s25p6 filled sub shells, and 
hence the spectral properties of LnIII are minimally affected by the external field, 
caused by counter ions or ligands. As a result, very narrow f→f absorption bands are 
observed as compared to d→d absorption bands of transition metals. The f→f 
absorption bands are observed mostly in visible or near infrared regions. The f→f 
transitions have very low molar absorptivities i.e. typically <3 M-1 cm-1. Therefore 
both absorption and emission bands are weak for lanthanides. The radiative life times 
for f-f transitions are in the range of 0.1-1.0 ms. 7-8 
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Figure 5.2: Partial energy diagram for lanthanide aqua ions (the main luminescent 
levels are drawn as red and fundamental levels are indicated as blue).
9 
 
Most lanthanides are luminescent, but some exhibits stronger emission than the others 
(Figure 5.2). Lanthanides can be either fluorescent (PrIII, NdIII, HoIII, ErIII, YbIII) or 
phosphorescent (SmIII, EuIII, GdIII, TbIII, DyIII, TmIII, PrIII). Some lanthanide ions (e.g. 
PrIII) exhibits both fluorescence and phosphorescence transitions. The emission of the 
lanthanides covers the entire spectrum i.e. from UV (GdIII) to visible (e.g. TbIII, SmIII 
etc) and near-infrared (PrIII, YbIII etc).8 
 
5.1.2 Sensitization (antenna effect) 
 
Electronic transitions of lanthanides take place by redistribution of electrons within the 
4f-subshell. These transitions are forbidden by electric dipole selection rules (i.e. there 
is no change of parity from the ground state to the excited state).7 However these rules 
are relaxed by several factors / mechanisms. For example, mixing / coupling of 
vibrational states (i.e. J-mixing) and mixing with opposite parity wave functions, such 
as 5d orbitals, ligand orbitals or charge transfer states, results in breaking of the 
selection rules. For example for Eu3+, 7F0 ↔ 
5D0 transition is not allowed according to 
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the selection rule, but in actual practice this transition is observed weakly due to J-
mixing. The coupling between these electronic and vibrational states and the 4f wave 
functions depends on the interaction between 4f-orbitals and surrounding ligands.8 As 
mentioned above, f-orbitals are shielded, and hence very weak absorption and 
emission bands are obtained by direct excitation of lanthanides.  
 
 The weak f→f oscillator strength can be overcome by indirect excitation. The indirect 
excitation phenomenon is also termed “sensitisation or antenna effect”. The indirect 
excitation process involves three steps as depicted in Figure 5.3: 
 
• The light is absorbed by surroundings of the lanthanide ions which may be 
either inorganic matrix or organic ligands (chromophores). 
• Energy is then transferred onto the lanthanide ions. 
• The lanthanide ions show luminescence by emitting absorbed energy in the 
form of photons.  
 
 
Figure 5.3: Block diagram showing energy flow paths during sensitisation of 
lanthanide luminescence. 
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Usually organic ligands (chromophores) are used as sensitisation agents. Many organic 
chromophores have very strong absorption and emission characteristics i.e. they have 
very high value of molar absorptivities (>104 M-1cm-1). 
 
As lanthanide ions or / and lanthanide chelates need a sensitizer in close proximity 
which can enhance lanthanide luminescence, gold nanoparticles can be used as a 
template to achieve this target because: 
 
• More than one functional group / ligand can be attached on the surface of 
AuNPs easily.  
• The sensitizer species / ligand can be attached on the nanoparticle surface in 
the same ligand shell as the lanthanide-DTPA chelate. 
• There is no need to make a separate linker molecule to bring lanthanide 
chelate close to the sensitizer species. 
• The ratio between sensitizer and lanthanide chelates at the nanoparticle surface 
can be tuned depending upon the requirement.  
 
On the other hand, as gold absorbs light in the visible region strongly, this might affect 
the luminescence of lanthanide chelates at its surface. In order to test the feasibility of 
gold nanoparticles as dual imaging contrast agents, a ligand containing sensitizer 
group was designed which can be attached on gold nanoparticles protected by DTPA 
ligand and is discussed in the next section. 
 
5.2 Design and synthesis of tryptophan based ligand 7 
 
Tryptophan contains an indole group which absorbs light in UV-Vis region. The 
absorbed energy can be transferred to lanthanide ions if the tryptophan and lanthanide 
ion are in close proximity. Recently, Duhme-Klair and co-workers10 reported the long 
lived luminescence of Tb-containing amphiphile which was sensitised by a tryptophan 
based compound. The Tb-chelate and the sensitizer were brought close to each other in 
a micelle via non-covalent interactions (Figure 5.4). 
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Figure 5.4: Schematic illustration of the intermolecular sensitisation process.
10
 
 
  
Thus it was confirmed that covalent linkage between lanthanide ion and the sensitizer 
is not necessary for efficient transfer of energy. This report10 strongly supports the idea 
of attaching tryptophan based ligand and lanthanide ion on the gold nanoparticle 
surface in the same ligand shell.  
 
The tryptophan based ligand 7 (Figure 5.5) was synthesised by DCC coupling of L-
amino tryptophan ester hydrochloride with dithiobutyric acid.  
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Figure 5.5: Chemical structure of tryptophan based ligand 7 
 
The dithiobutyric acid was selected as it contains disulphide group which will make 
the ligand attach at the gold nanoparticle surface. The other important advantage of 
dithiobutyric acid selection was to maintain the chain length of ligand 7 in the same 
range as DTPA ligand 6. The Tryptophan ligand 7 was characterised by MS and NMR 
spectroscopies (data shown in experimental chapter 7).   
 
5.3 UV-Vis absorption and emission spectra of tryptophan ligand 7 
 
After characterisation, the absorption and emission spectra of tryptophan based ligand 
7 were recorded and compared with L-tryptophan ester hydrochloride. The UV-Vis 
absorption spectra (Figure 5.6) show λmax = 282 nm for L-tryptophan and tryptophan 
ligand. The absorbance of tryptophan ligand 7 in the normalised UV-Vis spectra was 
twice as high as for L-tryptophan. This is due to the presence of two tryptophan units 
in the tryptophan ligand molecule. The UV-Vis spectra were used to determine the 
wavelength for excitation of tryptophan ligand. 
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Figure 5.6: UV-Vis spectra of L-tryptophan and tryptophan based ligand 7. 
 
The fluorescence emission spectra of tryptophan ligand were recorded by exciting at 
282 nm. The emission spectrum of tryptophan ligand shows very strong emission in 
the range of 330-430 nm (Figure 5.7).11 
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Figure 5.7: Fluorescence emission spectrum of tryptophan ligand 7. 
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The UV-Vis absorption and emission spectra of tryptophan ligand 7 thus confirmed 
that the tryptophan ligand can be used for sensitisation of lanthanide ion.  
 
5.4 Synthesis of gold nanoparticles stabilised by DTPA based 
ligand 5 
 
Gold nanoparticles stabilised by ester-protected DTPA ligand 5 were selected, because 
of their solubility in organic media. The solubility of gold nanoparticles in organic 
medium rather than aqueous medium was preferred for ease of the ligand exchange 
reaction. In aqueous medium, the rate of ligand exchange reaction at gold 
nanoparticles surface was negligible. After ligand exchange reaction in organic 
medium, the t-butyl ester groups of DTPA ligand at nanoparticles surface can be 
removed easily by TFA / DCM deprotection (and will be discussed in section 5.5.1) so 
that DTPA ligand can chelate lanthanides. 
 
Gold nanoparticles protected by DTPA ligand 5 (Figure 5.8) were synthesized by 
Brust’s biphasic method12 and then purified by size exclusion chromatography. The 
biphasic approach was used because DTPA ligand 5 is soluble in organic medium 
while the gold salt (used for AuNPs preparation) is soluble in aqueous medium. 
Brust’s protocol has been discussed in detail previously (chapter 2 section 2.3). 
Tertiary (t)-butyl ester protected DTPA ligand 5 was selected to get the gold 
nanoparticles which should be soluble in organic medium. In organic medium ligand 
exchange reaction at gold nanoparticles surface with other thiol based ligands can be 
done easily as compared to the aqueous medium.13-14  
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Figure 5.8: Gold nanoparticles protected by DTPA ligand 5. 
 
The purified gold nanoparticles protected by DTPA ligand 5 were characterised by 1H 
NMR, UV-Vis (SPB at 520-525 nm), TGA and TEM. 
 
5.4.1 1H NMR characterisation of AuNPs protected by DTPA 
ligand 5 
 
The AuNPs protected by DTPA ligand 5 were characterised by 1H NMR spectroscopy 
to confirm the successful adsorption of the ligand at the nanoparticles surface and the 
complete removal of tetraoctylammonium bromide (which was used as a phase 
transfer agent) and any free ligand during purification. The proton peaks of ligand at 
the surface of nanoparticles become broader due to incomplete averaging of 
anisotropic interactions (discussed in chapter 2, section 2.3.2). The 1H NMR spectra of 
free DTPA ligand 5 and the ligand adsorbed on the gold nanoparticle surface are 
shown in Figure 5.9.  
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Figure 5.9: 
1
H NMR spectra of free DTPA ligand 5 (a) and ligand 5 adsorbed at AuNPs 
surface (b). 
 
  
Figure 5.9 shows significant broadening of the 1H peaks consistent with the successful 
adsorption of ligand at the nanoparticle surface. Furthermore, no evidence of any free 
ligand is observed in 1H NMR spectrum. After NMR characterisation of gold 
nanoparticles, the DTPA ligand coverage at nanoparticle surface was estimated by 
TGA and is discussed in the next section. 
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5.4.2 TGA of AuNPs protected by DTPA ligand 5 
 
Thermogravimetric analysis (TGA) was carried out by the same method as for the 
AuNPs protected by DTPA ligand 6 (discussed in chapter 2 section 2.3.4) to determine 
the amount of organic content (DTPA ligand 5) present at gold nanoparticle surface. 
Organic content was needed to estimate the composition of AuNPs. The TGA graph of 
AuNPs protected by DTPA ligand 5 (Figure 5.10) shows about 47 % of the organic 
content. This amount is compatible with similar type of AuNPs protected by thiol 
based ligands.15 
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Figure 5.10: TGA plot of AuNPs protected by DTPA ligand 5. 
 
5.4.3 TEM of AuNPs protected by DTPA ligand 5 
 
TEM was carried out by the same method as for the gold nanoparticles discussed in 
previous chapters. TEM image (Figure 5.11) of AuNPs showed well dispersed 
nanoparticles with average diameter 2.42 ± 0.34 nm.  
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Figure 5.11: TEM image and size distribution histogram of AuNPs protected by DTPA 
ligand 5. 
 
From TGA and TEM data, the composition of the gold nanoparticles protected by 
DTPA ligand was estimated (Au439 Ligand88) which was used for tryptophan labelling 
and then lanthanide loading onto the nanoparticles. 
 
5.5 Ligand exchange of tryptophan ligand 7 with DTPA ligand 5 at 
AuNP surface  
 
By ligand exchange approach, the ligands with higher affinity than the ligands already 
present at gold nanoparticle surface, can be replaced. Some DTPA ligands from the 
AuNP surface were replaced with tryptophan ligand 7 (Figure 5.12) using a ligand 
exchange approach. As both tryptophan and DTPA ligands have similar affinity for 
gold, the reaction mixture was stirred overnight for successful ligand exchange 
reaction. The ratio between tryptophan and DTPA ligand was kept 1 / 6. It is difficult 
to determine the exact extent of ligand exchange, however the feasibility of ligand 
exchange of one thiol based ligand with another thiol based ligand at gold nanoparticle 
surface was confirmed by EPR spectroscopy with a spin labelled ligand and will be 
discussed in section 5.8.2 in this chapter. 
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Figure 5.12: Tryptophan labelled AuNPs 
 
5.5.1 Deprotection of t-butyl ester groups of DTPA and tryptophan 
ligand at AuNPs 
 
The deprotection of t-butyl ester groups of DTPA ligand 5 at AuNP surface was 
carried out to generate the chelating unit. The deprotection was carried out using 1:1 
mixture of TFA and DCM by a modified literature procedure16 as described in detail in 
chapter 2 (section 2.2.4). To avoid the decomposition of gold nanoparticles in acidic 
medium, the deprotection reaction was carried under the inert (N2) atmosphere. After 
deprotection, the AuNPs were water soluble which is a sign of successful deprotection. 
 
5.5.2 Lanthanide (Tb3+ and Eu3+) loading on tryptophan labelled 
AuNPs and their fluorescence emission spectra 
 
From several luminescent lanthanides, Tb3+ and Eu3+ were selected as they exhibit the 
most intense emission band in the visible region. Lanthanide loading onto the AuNPs 
protected by DTPA ligand was monitored by UV-Vis titration using xylenol orange as 
an indicator as described in detail in chapter 2 (section 2.4.2).  
  Chapter 5  
181 
 
 
The fluorescence emission spectra of Tryptophan labelled Tb-loaded gold 
nanoparticles were recorded by exciting the tryptophan at 282 nm and then at 375 nm 
(i.e. direct excitation of Tb3+). It was expected that the energy absorbed by tryptophan 
molecule will be transferred to the Tb3+ ion which will exhibit strong emission band, 
but unfortunately Tb3+ did not show any emission band (Figure 5.13). This absence of 
emission band of Tb3+-chelate at gold nanoparticle surface may be due to several 
reasons. Gold absorbs light in the UV-Vis region; hence it is possible that much of the 
incoming light is absorbed by gold nanoparticles rather than sensitizer molecule or 
lanthanide ions. Second possibility might be the chemical decomposition of tryptophan 
ligand during deprotection step, because if the tryptophan was decomposed, there will 
be no alternative way by which energy was absorbed and then transferred to Tb3+. The 
third possibility is the quenching of the fluorescence by gold nanoparticles.  
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Figure 5.13: Fluorescence emission spectra of Tb-DTPA chelates at the surface of 
AuNPs (red) and free Tb-DTPA chelates in aq solution (black). 
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5.6 Control experiments to confirm the quenching of lanthanide 
ion fluorescence by AuNPs 
 
Two independent control experiments were carried to explore the reason for the 
absence of Tb3+ emission band at gold nanoparticle surface. 
 
5.6.1 Ligand exchange approach (first control experiment) 
 
In the first control experiment, most lanthanide-DTPA chelates were displaced from 
the gold surface using a large (100 fold) excess of an alkane thiol (Figure 5.14).  
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Figure 5.14: Schematic representation of the first control experiment. 
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The purpose of removing all lanthanide -DTPA chelates from the gold surface was to 
remove the possibility of quenching the fluorescence of lanthanide-chelates by gold 
nanoparticles. Mercaptopropionic acid was used for ligand exchange as it is water 
soluble and has strong affinity (due to thiol group) for gold. The fluorescence 
emission spectra of Eu3+-loaded AuNPs were recorded before and after ligand 
exchange. When the lanthanide-DTPA chelates were replaced from the nanoparticle 
surface, they exhibited intense fluorescence emission spectra (Figure 5.15) upon 
excitation at 400 nm. This confirmed that Eu-DTPA chelate fluorescence was 
quenched by gold nanoparticles. 
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Figure 5.15: Fluorescence emission spectra of Eu
3+
-DTPA@AuNPs, first control 
experiment (black) and second control experiment (blue). 
 
5.6.2 Second control experiment (decomposition of AuNPs) 
 
The second control experiment confirmed the observations of the first control 
experiment independently. In this experiment, gold nanoparticles were decomposed in 
order to release the lanthanide-DTPA chelates from nanoparticle surface. It is well 
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established in literature17 that gold nanoparticles can be destroyed / aggregated by 
treatment with a mixture of KI (a good ligand in the form of iodide) and I2 (strong 
oxidizing agent) in MeOH. When the lanthanide-loaded AuNPs were treated with a 
mixture of KI and I2 in MeOH, gold nanoparticles were decomposed immediately; the 
lanthanide-DTPA chelates desorbed from the nanoparticles surface. The desorbed 
lanthanide-DTPA chelates exhibited fluorescence (Figure 5.15). This confirmed the 
observations of first control experiment i.e. the fluorescence of lanthanide-DTPA 
chelates at gold nanoparticles surface was quenched by gold nanoparticles. 
  
In the literature, many researchers described the gold nanoparticles as fluorescence 
quencher,18-20 while some21-22 reported opposite observations. The fluorescence 
quenching by metal nanoparticles is generally ascribed to the enhanced nonradiative 
relaxation of the excited state. For example, Agulia et al.19 described the quenching of 
fluorescence of dansyl cadaverine attached to the gold nanoparticle surface. 
Sometimes the fluorescence emission range of a fluorescent substance overlaps with 
the absorption band (i.e. SPB) of metal (gold) nanoparticles. This may also result in 
diminishing or quenching fluorescence.23 On the other hand, if the chromophores or 
lanthanide chelates are separated (by bulky groups / spacers) about 10-15 nm from the 
nanoparticles surface, the nanoparticles do not quench the fluorescence. For example it 
has been reported that CdSe(ZnS) particles do not show any luminescence at the 
surface of gold nanoparticles, but when polyelectrolyte layers of ~11 nm thickness 
were formed between gold nanoparticles and CdSe(ZnS) nanocrystals, a strong 
luminescence was observed.24  
 
In tryptophan labelled lanthanide-loaded AuNPs, fluorescence of tryptophan or 
lanthanide chelate or of both may be quenched. But as the lanthanide-DTPA chelates 
showed fluorescence even without tryptophan, the lanthanide fluorescence is likely to 
be quenched by gold nanoparticles.   
  Chapter 5  
186 
 
5.7 Conclusions 
 
Multifunctional gold nanoparticles bearing a fluorophore were prepared. Various 
fluorescent lanthanides were chelated with DTPA based ligand at AuNPs surface. A 
tryptophan based ligand (sensitizer for lanthanides) was prepared and adsorbed at the 
nanoparticle surface via ligand exchange approach. Unfortunately tryptophan-labelled 
lanthanide-loaded AuNPs did not show any fluorescence. The fluorescence was found 
to be quenched by gold nanoparticles as confirmed by two independent control 
experiments.  
 
The next section of this chapter describes the other applications of lanthanide-
functionalised gold nanoparticles. 
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5.8 Distance measurements by EPR spectroscopy 
 
The second part of this chapter describes another important area of applications of 
lanthanide-loaded gold nanoparticles which deals with the use of gold nanoparticles as 
a model system for distance measurements. Interradical distance measurements have 
wide spread applications in dynamics and structural studies of biomacromolecules and 
their complexes.25 For example site-directed spin labelling (SDSL), discovered in 
1994, is a technique used for probing protein local environment using EPR 
spectroscopy. To study with EPR, a spin label is attached to the proteins, which exhibit 
EPR spectra depending upon the dynamical and local chemical behaviour of proteins. 
In most SDSL, nitroxide based spin labels are used (Figure 5.16). Furthermore, two 
spin labels can also be attached at two different sites of the protein, the distance 
between these two spins can be determined on the basis of dipolar interactions using 
EPR spectroscopy. Most important applications of SDSL is to study the membrane 
proteins as these proteins represent more than 50% of all proteins and future drug 
targets, and are difficult to crystallize.26 
 
Figure 5.16: Reaction of the methanethiosulfonate spin label with cysteine to generate 
the disulfide-linked side chain to a protein.
26
 
 
The following four techniques were developed for distance measurements in various 
ranges. 
 
1. Exchange interaction ESR 
2. Dipolar cw-EPR  
3. DEER (double electron-electron resonance) 
4. Double quantum coherence 
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The first two methods (based on continuous wave (cw) EPR) are limited to only 
short distance measurements (0.4-2.5 nm) as they rely on the line shape analysis for 
which strong interactions are required. The remaining two methods (3 and 4) are 
based on pulsed EPR, and are much more sensitive than the cw-EPR spectroscopy. 
These methods can extract dipolar interactions of weaker intensity and are thus 
sensitive to long range distances between 1.7-8.0 nm.27  A new method for distance 
measurements is being developed based on relaxation enhancement by paramagnetic 
metal ions.28 For example, recently Jeschke  and co-workers described the distance 
measurement between nitroxide spin label and lanthanide chelate which are attached 
at two ends of a model compound (Figure 5.17).25 The lanthanide chelate was used 
for relaxation enhancement of nitroxide spin label. 
 
2.72 nm
 
Figure 5.17: Structure of a model compound having lanthanide chelate and nitroxide 
spin label.
25
 
 
Gold nanoparticles protected by DTPA ligand were selected as a model system for 
distance measurements by DEER due to several reasons. For example nanoparticles 
having good size range (i.e. 1.5 nm to 15 nm) can be prepared easily with predictable 
size distribution. Their size can be determined independently by TEM. Furthermore 
more than one ligand can be attached at gold nanoparticle surface easily. For 
distance measurements based on relaxation enhancement method, a spin label and a 
lanthanide ion are needed. The DTPA ligand which is used for stabilisation of gold 
nanoparticles can chelate lanthanides easily, while the spin label was synthesized 
separately and then attached at gold nanoparticles surface by ligand exchange 
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approach. Thus these nanoparticles; a model system can be used to test the 
application of pulsed EPR method for distance measurements to the heterogeneous 
systems. The synthesis and characterisation of TEMPO based ligand 8 (i.e. nitroxide 
based spin label) by EPR is discussed in next section.  
 
5.8.1 Synthesis of TEMPO based ligand 8  
 
TEMPO based ligand 8 was synthesized by peptide coupling of dithiodipropionic acid 
with amino-TEMPO. Dithiodipropionic acid contain disulphide group which will 
make the ligand adsorb at the gold nanoparticle surface, while amino-TEMPO has a 
stable nitroxide radical (Figure 5.18). The TEMPO based ligand was characterised by 
MS (data shown in experimental chapter) and EPR spectrum. The EPR spectrum 
showed characteristic features due to spin-spin interactions between the two nitroxide 
radicals. A free nitroxide exhibit three lines, but if two nitroxides are placed close to 
each other (as in TEMPO based ligand 8), some extra lines of low intensity (marked as 
* in Figure 5.18) are observed, which confirmed the successful synthesis of TEMPO 
based ligand 8. 
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Figure 5.18: EPR spectrum of TEMPO based ligand 8 in DCM. 
 
5.8.2 Spin-labelling of AuNPs by TEMPO based ligand 8  
 
Spin labelling of gold nanoparticles with TEMPO based ligand i.e. nitroxide spin label 
was carried out at 60-65 oC. The number of spin labels per nanoparticle can be 
controlled by controlling stoichiometric ratio between gold nanoparticles and spin 
label (i.e. TEMPO based ligand 8). To avoid multiple distances, on average 2-3 spin 
labels were adsorbed per nanoparticle. The spin labelling was monitored using EPR 
spectroscopy. After spin labelling, the free ligand could be removed by size exclusion 
chromatography. When the nitroxide spin labels were adsorbed at gold nanoparticles 
surface, the characteristic features (*) in their EPR spectrum disappeared (Figure 
5.20). Another important change in an EPR spectrum of nitroxide adsorbed at the 
nanoparticle surface was the line broadening. The line broadening occurs due to slower 
motion of the nitroxide at the nanoparticle surface than the free nitroxide (Figure 5.20). 
These two changes in EPR spectrum of TEMPO based ligand at gold nanoparticle 
surface confirmed the successful spin labelling of gold nanoparticles.  
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Figure 5.19: Spin labelled AuNPs protected by DTPA ligand 5. 
 
*
*
 
Figure 5.20: EPR spectra of free nitroxide spin label (black) and adsorbed at AuNP 
surface (red). 
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5.8.3 Deprotection of t-butyl ester groups of DTPA ligand at AuNP 
surface 
 
The t-butyl esters groups of DTPA ligand were removed in order to chelate with 
lanthanides. As deprotection involves the use of acid (TFA) and DCM (discussed 
previously in chapter 2, section 2.2.4), the reaction was carried out under inert 
atmosphere in order to avoid the decomposition of nitroxide radical. Furthermore, use 
of excess (about 2 fold) DCM as compared to TFA, also helped to avoid nitroxide 
radical decomposition. The nitroxide radical can disproportionate in the presence of 
acid. During deprotection reaction, about half of nitroxide radicals at the nanoparticle 
surface were found to decompose as evident from the EPR spectra shown in Figure 
5.22. The deprotected spin-labelled gold nanoparticles (Figure 5.21) were water 
soluble, and were purified by size exclusion chromatography. 
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Figure 5.21: Water soluble spin-labelled AuNPs protected by DTPA ligand 6. 
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Figure 5.22: EPR spectra of nitroxide spin labelled AuNPs before (red) and after 
(black) t-butyl ester deprotection. 
 
5.8.4 Lanthanide loading on nitroxide spin labelled AuNPs and 
their cw and pulsed-EPR measurements 
 
Various lanthanides (Gd3+ and Dy3+) were loaded at the gold nanoparticle surface 
(Figure 5.23). The loading was monitored using xylenol orange titration using UV-
Vis spectroscopy (as discussed in chapter 2, section 2.4.2).  
 
The lanthanides loaded spin-labelled gold nanoparticles were characterised by cw-
EPR and pulsed-EPR spectroscopy. In cw-EPR spectra, line broadening of the 
nitroxides was observed, which was increased with the increased concentration of 
lanthanides as shown in Figure 5.24. The line broadening occurs due to relaxation 
enhancement of nitroxide radical by the paramagnetic lanthanide ion. Some sharp 
lines are also observed in the Figure 5.24 (marked as **), these signals are due to 
nitroxides leaching from the nanoparticle surface (i.e. free nitroxides). As the amount 
of lanthanides was increased, the intensity of sharp lines was not affected, which 
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confirmed that lanthanides only enhance the relaxation rate of nitroxides which are 
close to lanthanides. 
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Figure 5.23: Lanthanide loaded spin-labelled AuNPs 
 
  Chapter 5  
195 
 
**
[Gd3+]@ nitroxide labelled AuNPs
increasing
**
 
Figure 5.24: CW-EPR spectra of nitroxide spin labelled AuNPs in the presence of 
various [Gd
3+
] concentrations. 
 
5.8.5 Pulsed-EPR experiments 
 
All the pulsed-EPR experiments were carried out in the laboratory of Prof. Gunnar 
Jeschke at ETH Zürich (Switzerland). The pulsed EPR experiments consist of two 
main parts: (a) distance measurements by Double Electron-Electron Resonance 
(DEER), and (b) relaxation enhancement of nitroxide electron by lanthanides (pulse 
EPR measurements). 
 
5.8.5.1 Distance measurements (by DEER experiments) 
The four pulse DEER experiment has become the most frequently used approach to 
measure the nitroxide-nitroxide distances in the range between 1.6 and 8 nm. Recently 
the same experiment has been performed on the Gd3+ ion as a detection spin and with a 
nitroxide radical as a pumped species25, 29. The nitroxide-nitroxide distance and Gd3+-
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nitroxide distance at the surface of gold nanoparticle measured by DEER experiments 
are shown in Table 5.1.  
 
Table 5.1: Mean distance and the width of distance distribution obtained from the fit 
of DEER data. 
Gd and La at spin 
labelled AuNPs  
NO-NO distance Gd3+-NO distance 
r / nm Distribution 
width (r) / nm 
r /nm Distribution 
width (r) / nm 
0.0 % Gd3+ 2.40 0.53 - - 
2 % Gd3+ 2.46 0.53 2.85 0.57 
4 % Gd3+ - - 2.85 0.67 
32 % La3+ 2.45 0.57 - - 
 
The mean distance data are completely consistent and provide the averaged nitroxide-
nitroxide distance of approx. 2.44 nm and the Gd3+-nitroxide distance of 2.85 nm 
(Table 5.1). Gd3+-nitroxide distance was found slightly larger than the nitroxide-
nitroxide distance because the DTPA ligand which chelated Gd3+ is bigger than the 
nitroxide spin label (i.e. ligand 8).  
 
5.8.5.2 Relaxation enhancement measurements  
 
Relaxation enhancement (T1) of nitroxides by paramagnetic lanthanide ions at gold 
nanoparticle surface was determined by fitting of inversion recovery traces. For Dy3+-
loaded spin labelled AuNPs, the relaxation enhancement depends on the amount of 
Dy3+. The optimal enhancement contrast is achieved at 50-60 K (Figure 5.25). The 
enhancement is one order of magnitude less than that observed previously for the 
nitroxide and lanthanide labelled membrane inserting polypeptide. This unexpectedly 
small relaxation enhancement of nitroxide by Dy3+ might be due to some underlying 
relaxation mechanism at the surface of gold nanoparticles.  
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Figure 5.25: Relaxation time vs temperature curves for Dy
3+
-loaded spin labelled 
AuNPs. 
 
The relaxation enhancement for Gd3+-loaded spin labelled AuNPs was also found 
similar in behaviour as for Dy3+ (Figure 5.26).  
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Figure 5.26: Relaxation time vs temperature curves for Gd
3+
-loaded spin labelled 
AuNPs. 
  
5.9 Conclusions 
 
Water soluble nitroxide spin labelled AuNPs were prepared and then loaded with Dy3+ 
and Gd3+. For this model system, the distance measurement data by DEER 
experiments were found in full agreement with the previous reported results29 for 
model systems. But unfortunately, the relaxation enhancement studies of nitroxide by 
lanthanides (Dy3+ and Gd3+) at the surface of gold nanoparticles were unexpected i.e. 
no significant relaxation enhancement was observed. It might be due to the interaction 
of nitroxide free electrons with the gold surface electrons.  
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Chapter 6: Conclusions and proposed future work 
 
6.1 General conclusions 
 
Gold nanoparticle based MRI contrast agents (CAs) were synthesized and 
characterised. The relaxation measurements showed that gold nanoparticle based 
CAs have slightly higher efficiency than the commercially available MRI contrast 
agent i.e. Gd-DTPA.1 Due to promising multifunctionality features of gold 
nanoparticles, applicability of these nanoparticle based contrast agents for MRI as 
target specific agents was evaluated by attaching a recognition vector. The target-
specific studies of multifunctional gold nanoparticle based CAs were successful. 
 
In order to explore the moderate increase in relaxivity, EPR spectroscopy was used 
which confirmed that moderate increase in relaxivity was due to relatively fast 
tumbling of nanoparticle-attached Gd-DTPA chelates. The EPR results diverted the 
project to develop strategies for reducing mobility of the Gd-DTPA chelates at the 
nanoparticle surface. The immobilisation of Gd-DTPA chelates was increased by 
depositing layers of oppositely charged polyelectrolytes at the negatively charged 
surface of Gd-DTPA@AuNPs. The polyelectrolyte layers reduced mobility, which 
resulted in significant increase in relaxivity. The increase in ligand packing density 
at nanoparticle surface by increasing the size of nanoparticles was an alternative 
strategy which also influenced / increased the relaxivity significantly. Thus EPR 
measurements confirmed the previously reported1-4 moderate increase in relaxivity 
by gold nanoparticle based contrast agents. Apart from Gd-based contrast agents, 
paramagnetic nitroxide radical based contrast agents were also prepared using gold 
nanoparticles as templates.  
  
Several nitroxide radicals were attached at the gold nanoparticles surface to get 
nitroxide based ligand protected gold nanoparticles as MRI contrast agents. The 
redox behaviour of these nitroxide based contrast agents was studied in vitro using 
EPR spectroscopy. The EPR data showed that nitroxides at gold nanoparticle surface 
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underwent chemical reduction slower as compared to free nitroxides which showed 
better efficiency of gold nanoparticle based redox sensitive contrast agents than free 
nitroxides. The relaxivity of nitroxide protected AuNPs was also found slightly 
higher than for free nitroxides.  
 
Gold nanoparticles protected by DTPA based ligands were also studied for some 
other useful applications besides MRI contrast agents. They were studied as optical 
imaging contrast agents after replacing Gd3+ with other lanthanides such as Tb3+ and 
Eu3+. However, fluorescence measurements of Tb and Eu-loaded AuNPs did not 
show any fluorescence, their fluorescence was quenched by gold nanoparticles. The 
nitroxide labelling of DTPA ligand protected AuNPs and then loading with various 
lanthanides (La3+, Dy3+ and Gd3+) provided the opportunity to test a useful (i.e. 
double electron electron resonance) EPR methodology.  
 
The real clinical applications of gold nanoparticle based MRI contrast agents may be 
hampered due to several issues: e.g. their efficiency is not much higher than the 
small molecules based CAs, AuNPs based CAs will have a much higher cost. But 
the results regarding gold nanoparticle based contrast agents presented in this thesis 
will definitely pave the way for multifunctionality studies using other nanomaterials, 
supramolecular assemblies and other similar systems. For example, these results will 
definitely help further studies of mesoporous silica based contrast agents5, which is 
much cheaper than gold, easy to synthesize and might have much higher efficiency 
than gold nanoparticle based CAs. However this work can be further extended to 
explore many other aspects, e.g. quenching of fluorescence of Tb-loaded AuNPs, 
very small increase in relaxivity of nitroxide protected AuNPs etc.   
 
6.2 Proposed future work  
 
As mentioned in the above section, the fluorescence of lanthanide-loaded AuNPs 
was found to be quenched by AuNPs. This quenching can be avoided by 
synthesising some new DTPA ligands with a long carbon tail as compared to DTPA 
ligand 5 or 6. The long tail DTPA ligand will help to avoid the fluorescence 
quenching of lanthanide chelates at gold nanoparticle surface and thus        
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lanthanide-loaded gold nanoparticles can be studied as optical imaging contrast 
agents (Figure 6.1).6 
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Figure 6.1:Tb-DTPA chelates at AuNPs surface with small and long carbon chain. 
 
Secondly various methods for increasing efficiency (relaxivity as well as reducing 
behaviour) of nitroxide protected gold nanoparticles can be explored. For example 
after replacing the triphenylphosphine (PPh3) molecules with dithiobis 
[succinimidylpropionate] (DSP) from triphenylphosphine protected gold 
nanoparticle (PPh3@AuNPs), the DSP can be reacted with PAMAM dendrimers 
(G0) along with amino-TEMPO to get nitroxide and PAMAM dendrimers protected 
gold nanoparticles. PAMAM dendrimers molecules will restrict the tumbling of 
nanoparticles attached nitroxides which will enhance the relaxivity. The insertion of 
dendrimer molecules in between nitroxides at nanoparticles will also help to increase 
the reduction period of nitroxides. Furthermore after attaching suitable biomolecules 
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they can be in vitro and then in vivo studied for brain imaging as they might pass 
through blood brain barrier. 
 
In chapter five, the paramagnetic radicals (i.e. nitroxides) and lanthanide ions (Dy3+, 
Gd3+, La3+) were attached at the surface of gold nanoparticles and these nanoparticles 
were quite soluble in aqueous medium (i.e. water). DNP (dynamic nuclear 
polarisation), which is based on Nuclear Overhauser Effect7 (discovered in 1953), is 
the phenomenon of NMR signals enhancement by electronic spin polarisation. The 
signal intensity of the nuclei under question can be enhanced significantly; for 
example, theoretically 1H NMR signal intensity can be enhanced by a factor of 660. 
The gold nanoparticles with stable radicals and lanthanides at their surface can be 
utilised as model compounds for studying DNP phenomenon. The gold nanoparticles 
having more than one radical at their surface may prove better signal enhancer by 
electron spin polarisation phenomenon than monoradical. The relatively restricted 
tumbling of radicals as compared to free radicals at nanoparticle surface could play a 
significant role in DNP phenomenon. 
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Chapter 7: Experimental 
 
7.1 Materials and chemicals  
 
All chemicals were purchased from Sigma-Aldrich if not stated otherwise. All 
solvents were purchased from Fisher Scientific International. All chemicals were 
used as received without further purification unless stated otherwise. Bio-beads S-XI 
(200-400 mesh) for gel permeation chromatography was purchased from Bio-Rad. 
The Sephadex gel LH-20 was supplied by GE Healthcare. 
Dithiobis(succinimidylpropionate) (DSP) was purchased from Apollo Scientific Ltd. 
TLC analysis was performed on Merck Silica Gel 60 F245 aluminium backed silica 
plates. Column chromatography was performed using silica gel 60 which was 
purchased from BDH. The dialysis membranes with MWCO 500 and 12-14 kDa 
were supplied by Spectrum Laboratories and Fischer Scientific, respectively. 
 
7.2 Instrumentation / techniques 
 
• NMR:  1H and 13C NMR spectra were recorded on JEOL ECX 270 MHz, 
ECX 400 MHz and ECS 400 MHz machines. Values of chemical shifts for 
1H NMR spectra are reported relative to internal standards i.e. CHCl3 in 
CDCl3 (7.26 ppm), CH3OD in CD3OD (3.49 ppm) and HOD in D2O (4.79 
ppm). Similarly, 13C NMR peaks are referenced to the solvent peaks i.e. 
CDCl3 (77.36 ppm) and CD3OD (50.41 ppm). Spectral splitting parameters 
are represented as: s, singlet; t, triplet; q, quartet; m, multiple; br, broad.  
• MS: Mass spectra were recorded on a Bruker micro-TOF with LCQ ion trap 
and ESI ion source. 
• UV/Vis.: UV/Vis. spectra were acquired on a double beam Hitachi U-3000 
spectrophotometer. 
• IR:  IR spectra were recorded on JASCO FT/IR-400 spectrometer. 
• Fluorescence Emission Spectra:  The fluorescence emission spectra were 
acquired on Hitachi F-4500 Flourimeter. 
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• EPR:  The EPR spectra were recorded on Bruker EMX, ESP300E and JEOL 
JES-RE 1X spectrometers. 
• TGA:  The TGA analysis of all samples was performed on STA625 Thermal 
Analyzer. 
• TEM: TEM analysis was carried out using FEI TECNI I2 electron 
microscope. 
• Elemental Analysis:  Elemental analyses were carried out by Microanalysis 
Service at Medac Ltd., (London). 
• NMR Imaging: T1 weighted images were acquired on a spin echo based 
RARE sequence on Bruker Avance II 600 MHz (14 T) NMR spectrometer 
with the GREAT 40 gradient system. Imaging parameters were: time of 
repetition (TR) 400.0 ms, time of echo (TE) 15.0 ms, the thickness of the 
slice 2.0 mm, MTX (matrix size) = 128 × 128, FOV (field of view) = 2.5cm 
× 2.5cm  
• Relaxation Measurements: Relaxation measurements were carried out on 
Bruker AMX 300 MHz spectrometer at room temperature (298 K) 
• Pulsed EPR (DEER) Measurements: Double electron-electron resonance 
measurements were carried on a Bruker EleXsys E680 X/W-band 
spectrometer in collaboration with Prof. Gunnar Jeschke at ETH Zurich, 
Switzerland. 
Gold Nanoparticles Yield Calculations:  The yield of AuNPs protected by 
various (thiol based) ligands was calculated by assuming the 3 / 1 : Au to ligand 
ratio.1 
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7.3 Experimental part for chapter 2 
 
7.3.1 Synthesis of DTPA based ligand 6 
 
7.3.1.1 Alkylation of ethanolamine by t-butyl protected bromoacetate (1) 
 
HO
NH2
HO
6
5
N
O
O
4
3
O
O+
1
NaHCO3
DMF
2
1
Br
O
O
2
 
Compound 1 was synthesized by following the literature procedure.2 To t-butyl 
bromoacetate (13.5 g, 69.2 mmol) dissolved in DMF (50 mL), KHCO3 (7.68 g, 76.8 
mmol) was added. The suspension was cooled to 0 oC and ethanolamine (0.92 mL, 
15.16 mmol) was added over a period of 5 min. The reaction mixture was stirred for 
30 min at 0 oC and for 22 h at room temperature. At the end of this period, diethyl 
ether (75 mL) and saturated aq. NaHCO3 (50 mL) were added. The organic phase 
was separated from aqueous phase and organic phase was washed with saturated aq. 
NaHCO3 (50 mL). The aqueous phases were combined and extracted with diethyl 
ether (75 mL) and organic phases were combined and washed with brine (75 mL). 
The organic phase was dried with anhydrous Na2SO4, and evaporated to get 
compound 1 as white solid. Yield 12.60 g (63 %).  
1
H NMR (CDCl3): δ (ppm) 1.38 (s, 18H, H
1), 2.84 (t, J 5.01 Hz, 2H, H5), 3.41 (s, 
4H, H4), 3.48 (t, J 5.01 Hz, 2H, H6). 
13
C NMR (CDCl3): 28.01 (C
1), 56.53 (C5), 56.80 (C6), 59.20 (C4), 81.38 (C2), 
171.31 (C3). 
HR ESI-MS:  m/z,[M + H] 1+, Calcd. for C14H28NO5:  290.1962, Found:  290.1958 
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7.3.1.2 Bromination of compound 1 
 
2
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Compound 2 was synthesized from compound 1 by following the literature 
procedure.2 Compound 1 (3.63 g, 12.56 mmol) was dissolved in DCM (50 mL). 
Ph3P (3.29 g, 12.56 mmol) was added and solution was cooled to 0 
oC. Solid N-
bromosuccinimide (2.23 g, 12.56 mmol) was added portion wise over a period of 5 
min. After the solution was stirred at 0 oC for 1.5 h, the evaporation of the solvent 
gave semisolid residue. The semisolid residue was triturated with diethyl ether 
(Et2O) (100 mL) and resulting solid was removed by filtration. The ether phase was 
concentrated and then passed through a short silica column, eluting with ether 
(Et2O). Evaporation of ether gave colourless oil as crude product. The crude product 
was purified by flash chromatography using silica gel as a stationary phase and n-
hexane / Et2O (3 / 1) as a mobile phase (Rf 0.35). Yield 3.25 g (73 %). 
1
H NMR (CDCl3): δ (ppm) 1.40 (s, 18H, H
1), 3.08 (t, J 7.42, 2H, H5), 3.38 (t, J 7.42, 
2H, H6), 3.41 (s, 4H, H4).  
13
C NMR (CDCl3): δ 28.21 (C
1), 30.33 (C6), 56.54 (C5), 56.70 (C4), 81.34 (C2), 
170.58 (C3). 
HR ESI-MS:  m/z [M + H] 1+, Calcd. for C14H27BrNO4: 352.1118, Found: 352.1120 
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7.3.1.3 Alkylation of N-ε-CBZ-L-Lysine t-butyl ester hydrochloride by bromo 
derivative 2 
 
NH2O NH
O
OO
. HCl Br
N
O
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O
pH ~ 8.048 h
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Compound 3 was synthesized according to literature procedure.3 N-ε-CBZ-L-Lysine 
t-butyl ester hydrochloride (1.87 g, 5.01 mmol) was taken in a round bottom flask 
containing acetonitrile (10 mL). Compound 2 (4.50 g, 12.09 mmol) was added 
followed by phosphate buffer (2 M, 12 mL, pH 8.0) and the mixture was stirred for 2 
h. After stirring, aqueous layer was replaced with fresh buffer solution and then 
stirred again for 48 h. The organic layer was separated from the aqueous layer. The 
aqueous layer was discarded and organic layer was concentrated to dryness by rotary 
evaporation. The crude material was purified by flash chromatography using silica 
gel as a stationary phase and EtOAc / n-hexane (1 / 2) as a mobile phase (Rf 0.51). 
Yield 3.15 g (72 %). 
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1
H NMR (CDCl3): δ (ppm) 1.28-1.36 (m, 2H, H
12), 1.40 (s, 45H, H1), 1.44-1.65 (m, 
4H, H11, H13), 2.56-2.82(m, 8H, H5,  H
6), 3.15 (t, J 6.40 Hz,  2H, H14), 3.22 (t, J 7.32 
Hz, 1H, H10), 3.40 (s, 8H, H4), 5.04 (s, 2H, H17), 5.12 (br, 1H, H15), 7.20-7.29 (m, 
5H, Ar18-H ). 
13
C NMR (CDCl3): δ (ppm) 23.31 (C
12), 28.11 (C7), 28.25 (C1), 29.45 (C11), 40.81 
(C14), 50.16 (C13), 53.53 (C5), 55.90 (C4), 60.34 (C6), 63.86 (C10), 66.36 (C17), 80.71 
(C8), 80.75 (C2), 127.91, 128.05, 128.39, 136.72 (Ar), 156.73 (C16), 170.61 (C3), 
172.69 (C9).  
HR ESI-MS:  m/z [M + H] 1+, Calcd. for C46H79N4O12: 879.5689, Found: 879.5684 
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7.3.1.4 Deprotection of DTPA-analogue 3 
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Compound 4 was synthesized according to literature procedure.3 Compound 3 (1.0 g, 
1.14 mmol) was taken in a 50.0 mL round bottom flask containing MeOH (25 mL).  
The 5% Pd on C (100.0 mg) was added and reaction mixture was flushed with 
nitrogen gas (3-4 times). The suspension was vigorously stirred for 4 h under 
hydrogen atmosphere at room temperature. The residue was filtered using sintered 
filter and evaporation of solvent gave a yellow coloured crude product. The crude 
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product was purified by flash chromatography using MeOH with a few drops of 
Et3N (Rf 0.28). Yield 0.525 g (62 %). 
1
H NMR (CDCl3): δ (ppm) 1.28-1.36 (m, 2H, H
12), 1.40 (s, 45H, H1), 1.46-1.68 (m, 
4H, H11, H13), 2.64-2.82 (m, 8H, H5,  H
6), 3.04 (t, J 7.13 Hz, 1H, H10), 3.22 (t, 6.58 
Hz,  2H, H14), 3.40 (s, 8H, H4). 
13
C NMR (CDCl3): δ (ppm) 23.20 (C
12), 28.25 (C7), 28.35 (C1), 29.61 (C11), 32.00 
(C13), 40.81 (C14), 50.60 (C5), 53.60 (C6), 56.10 (C4), 64.05 (C10), 80.90 (C8), 81.00 
(C2), 170.78 (C3), 172.80 (C9).  
HR ESI-MS:  m/z [M + H] 1+, Calcd. for: C38H73N4O10 745.5321, Found: 745.5332 
 
7.3.1.5 Coupling of DTPA-analogue 4 with dithiobutyric acid 
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Compound 5 was synthesized using a standard peptide (DCC / DMAP) coupling 
method4. Compound 4 (0.453 g, 0.61 mmol) was taken in a 50 mL round bottom 
flask containing EtOAc (10 mL). Dithiobutyric acid (0.066 g, 0.277 mmol) was 
added and solution was cooled to 0 oC. Dicyclohexylcarbodiimide (DCC) (0.057 g, 
0.277 mmol) and dimethylaminopyridine (DMAP) (0.034 g, 0.277 mmol) were 
added as a mixture of solids and solution was stirred for 48 h at room temperature. 
After stirring, the solid residues were removed by filtration and filtrate was 
evaporated to get a highly viscous yellow coloured crude product. The crude 
compound was purified by flash chromatography using silica gel as a stationary 
phase and ethyl acetate/n-hexane (2/1) as a mobile phase (Rf 0.65). Yield 0.545 g 
(53%). NMR spectrum assignment was done by comparison with similar compounds 
reported in the literature.5 
 
1
H NMR (CDCl3): δ (ppm) 1.40 (s, 90H, H
1), 1.17-1.64 (m, 12H, H8, H9, H10), 1.90-
2.02 (m, 4H, H15), 2.26 (t, J 7.32 Hz, 2H, H14), 2.56-2.70 (m, 16H, H5, H6), 2.76 (t, J 
7.47 Hz, 4H, H16), 3.23-3.16 (m, 6H, H7 ,  H11), 3.40 (s, 16H, H4). 
13
C NMR (CDCl3): δ (ppm) 19.81 (C
9), 21.07 (C15), 24.40 (C1), 24.52 (C17), 25.26 
(C8), 25.68 (C10), 30.89 (C14), 34.28 (C16), 35.50 (C11), 46.39 (C5), 49.81 (C4), 52.16 
(C6), 60.14 (C7), 76.93(C18), 77.06 (C2), 166.89 (C3), 168.24 (C19), 168.95 (C13).  
HR ESI-MS: m/z [M + H]2+, Calcd. for C84H156N8O22S2: 846.5382, Found: 
846.5379 
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7.3.1.6 Deprotection of t-butyl ester groups of DTPA based ligand 5 
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Compound 6 was obtained by deprotection of t-butyl ester groups of compound 5 
using a modified literature procedure.5  Compound 5 (117 mg, 0.069 mmol) was 
taken in a 25 mL round bottom flask. Trifluoroacetic acid (TFA) (1.0 mL) was added 
to the solution of compound 5 in dichloromethane (DCM) (1.5 mL). The reaction 
mixture was stirred overnight at rt. After overnight stirring, DCM and TFA were 
evaporated using rotary evaporator at rt. The crude product (compound 6) was 
dissolved in water (10.0 mL), filtered and dialyzed using 500 MWCO dialysis tubing 
against deionised H2O for 48 h. After dialysis, water was evaporated below 40 
oC to 
get a white product.  Yield 60.0 mg (77 %). 
1
H NMR (D2O): δ (ppm) 1.17-1.66 (m, 12H, H
6, H7, H8), 1.77-1.82 (m, 4H, H13), 
2.28 (t, J 7.01 Hz, 4H, H14), 2.66 (t, J 7.01 Hz, 4H, H12), 2.84-3.08 (m, 10H, H4, H5), 
3.22-3.40 (m, 12H, H3, H9), 3.82 (s, 16H, H2).  
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13
C NMR (D2O): δ (ppm) 23.42 (C
7), 24.81 (C13), 27.82 (C6), 28.19 (C8), 34.35 
(C12), 37.14 (C14), 38.92 (C9), 46.29 (C4), 52.89 (C3), 55.92 (C2), 63.26 (C5), 169.65 
(C1), 175.09 (C15), 175.70 (C11).  
 HR ESI-MS:  m/z [M-H] 2- Calcd. for C44H72N8O22S2: 546.2107, Found: 546.2103 
 
7.3.1.7 Synthesis of AuNPs stabilised by DTPA based ligand 6 
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Gold nanoparticles stabilized by DTPA based ligand 6  were prepared by 
modification of a literature procedure.6 A 1.0 % w/w solution of hydrogen 
tetrachloroauric acid trihydrate (HAuCl4. 3H2O) (4.12 mL, 0.1 mmol) was taken in a 
25 mL round bottom flask. To this flask, DTPA based ligand 6 (60 mg, 0.1 mmol) 
dissolved in deionised water (10.0 mL) was added. A freshly prepared aqueous 
solution of NaBH4 (40 mg, 1.0 mmol) in deionised water (10.0 mL) was added 
immediately after the addition of ligand 6 to the flask. The colour of the stirring 
solution turned dark brown after the addition of sodium borohydride solution, which 
confirmed the formation of gold nanoparticles. After stirring for 10 min, water was 
evaporated below 40 oC using rotary evaporator.  The excess ligand was removed by 
GPC (Sephadex gel G-100) column using aq 0.1M NaCl as eluent. The AuNPs were 
then dialysed against DI H2O using 12-14 kDa MWCO tubing for o / n, and then 
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water was evaporated below 40 oC to get solid AuNPs. Yield 35.0 mg. 
Characterisation of AuNPs protected by DTPA ligand 6 is shown in chapter 2 
(section 2.3).  
7.3.1.8 Complexation of gadolinium (Gd
3+
)
 
with DTPA@AuNPs  
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Complexation of gadolinium (Gd3+) with DTPA units of the ligand attached to gold 
nanoparticles was done by slightly modifying the literature procedure.7 A 10.0 mL 
aqueous AuNPs (5.83mg, 3.92×10-3 mmol of DTPA units) was taken in a 50.0 mL 
round bottom flask. A 1.0 mM aqueous gadolinium chloride hexahydrate was added 
drop wise over a period of 10 min. The amount of Gd3+ was monitored by 
colorimetric titration using xylenol orange as an indicator (discussed in chapter 2, 
section 2.4.1). The reaction mixture was then stirred for further 30 min. Using aq  
(~1 mM) NaOH, the pH of the medium was kept slightly basic (7.5-8.0) during 
addition of Gd3+ to the colloidal solution of AuNPs. After addition of Gd3+, water 
was evaporated below 40 oC to get a dark brown powder, the Gd-loaded AuNPs. The 
free Gd3+ ions were removed by dialyzing the aqueous solution of Gd-loaded AuNPs 
against deionised water for o/n using 12-14 kD MWCO dialyzing tubing. The water 
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was evaporated below 40 oC using rotary evaporator to get solid Gd-loaded AuNPs. 
Yield 6.12 mg. Characterisation of Gd-loaded AuNPs is given in chapter 2 (section 
2.4.3). 
 
7.3.1.9 Synthesis of Gd-DTPA complex 
 Gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) complex was prepared 
in an analogous procedure as described in section 7.3.1.8, from GdCl3 (45 mL, 5.0 
mM) and DTPA (50 mL, 5.0 mM).Yield 0.100 g (81%).  
HR ESI-MS: m/z [M - H]1-, Calcd. for C14H19GdN3O10: 547.0320, Found: 547.0336 
 
7.3.2 Synthesis of biotin-terminated thiol (BTT) 
 
Biotin-terminated thiol (BTT) was synthesized by a modified literature procedure.8 
NHS-(PEO)4-biotin (1.17mg, 1.98×10
-3 mmol) was taken in a 5.0 ml round bottom 
flask. To this flask, 19.44 mM solution of cysteamine in DMSO (0.1 mL, 1.98×10-3 
mmol) was added. The flask was put under vacuum on a Schlenk line, to avoid any 
contact with air or moisture. Anhydrous DMSO (0.9 mL) and anhydrous DMF (1.0 
mL) were then added carefully with pre-dried syringes. The reaction mixture was 
stirred overnight under the blanket of nitrogen at room temperature. The unreacted 
NHS-(PEO)4-biotin was removed by dialysing against deionised water using 500 
MWCO dialysing membrane. Water was evaporated using rotary evaporator to get 
purified BTT. Yield 1.03 mg (93 %). 
HR ESI-MS:  m/z  [M+H] 1+ Calcd. for C24H47N4O7S2: 567.2557, Found: 567.2517 
 
7.3.3 Attachment of biotin-terminated thiol to the AuNP surface 
 
Biotin-terminated thiol (BTT) was attached to the AuNPs  surface using a modified 
literature procedure.9 Gd-loaded AuNPs (3.0 mg, 5.06×10-5 mmol) were taken in a 
5.0 mL round bottom flask. To this flask, 1.58 mM solution of BTT (60.0 µL, 
9.45×10-5 mmol) in DMSO/DMF (1/1) mixture was added. The reaction mixture was 
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stirred for overnight at room temperature. The unreacted BTT was removed by 
dialysis against deionised water for overnight using 12-14 kDa MWCO membrane, 
followed by water evaporation using rotary evaporator to get solid BTT-labelled 
AuNPs. Yield 2.05 mg (68 %).   
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7.4 Experimental part for chapter 3 
 
7.4.1 Vanadyl complexation with DTPA@AuNPs 
Vanadyl (VO2+) was complexed with DTPA@AuNPs using a modified literature 
procedure.10 The AuNPs stabilised by DTPA based ligand 6 (15.0 mg, 0.011 mmol 
of DTPA units) were taken in a 25 mL round bottom flask containing deionised H2O 
(5.0 mL). A 5.0 mM VOSO4 solution (0.75 mL, 3.71 × 10
-3 mmol of VO2+) was 
added drop wise to the stirred solution of AuNPs. After adding VOSO4 solution to 
the AuNPs solution, the reaction mixture was stirred for further 10-15 min. Water 
was evaporated using rotary evaporator at ca. 40 oC to get solid VO-DTPA@AuNPs. 
Yield 11.35 mg. 
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7.4.2 Synthesis of VO-DTPA 
 
Vanadyl (VO2+) chelate with DTPA was synthesised by an analogous procedure as 
described in section 7.4.1 from 5.0 mM DTPA solution (5.0 mL, 0.025 mmol) and 
freshly prepared 5.0 mM aq VOSO4 (4.0 mL, 0.02 mmol). Yield 7.25 mg (78 %). 
 
7.4.3 Growth of AuNPs (~4.0 nm) 
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Small (2.0 nm) AuNPs protected by DTPA ligand 6 were grown into large (~ 4.0 
nm) AuNPs using a modified literature procedure.11-12 Freshly prepared crude small 
AuNPs (50 mg, ~2.0 nm) dissolved in deionised H2O (25 mL) were taken in a 100.0 
mL round bottom flask. To the aqueous solution of AuNPs, DMF (5.0 mL) was 
added. The aqueous solution of crude AuNPs (containing excess of DTPA ligand 6) 
was refluxed for ca. 12 h. After refluxing, the solution was concentrated to ~100 mL 
by rotary evaporation. DMF was removed by dialysis against deionised H2O using 
12-14 kDa MWCO dialysis tubing. Water was evaporated using rotary evaporator at 
ca. 40 oC to get crude grown (4.0 nm) AuNPs. The crude grown (4.0 nm) AuNPs 
were purified by gel permeation chromatography using Sephadex gel (G 100) as a 
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stationary phase and 0.1 M NaCl as a mobile phase. The purified grown AuNPs  
were dialysed for overnight against deionised H2O to remove NaCl followed by 
water evaporation using rotary evaporator to get solid AuNPs (~ 4.0 nm). Yield 26 
mg. Characterisation for grown (~4.0 nm) AuNPs is given in chapter 3 (section 
3.4.1). 
 
7.4.4 Growth of AuNPs (~6.0 nm) 
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Small (~2.0 nm) AuNPs were grown into large (~ 6.0 nm) AuNPs in an analogous 
procedure as described in section 7.4.3 by refluxing of small AuNPs (50.0 mg) in an 
aqueous solution containing DMF (5.0 mL) for ca. 24 h. Yield 19 mg.  
 
7.4.5 Formation of PEI layer around Gd-DTPA@AuNPs 
 
Polyethyleneimine (PEI) layer around Gd-DTPA@AuNPs was formed using a  
modified literature procedure.13 PEI with Mn ~ 423 was used. Gd-loaded AuNPs (5.5 
mg, 4.00×10-3 mmol of Gd-DTPA units) were dissolved in deionised H2O (~5.0 mL) 
in a 25 mL round bottom flask. To the stirred solution of AuNPs, a 27 mM aq PEI 
(60 µL, 0.016 mmol of NH+) was added. The reaction mixture was stirred for further 
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10-15 min at rt. The excess of PEI molecules was removed by dialysis against 
deionised H2O using 12-14 kDa dialysis tubing. Water was evaporated using rotary 
evaporator below 40 oC to get solid PEI-protected AuNPs. 
 
7.4.6 Formation of PAMAM-dendrimer layer around Gd-
DTPA@AuNPs 
 
Poly (amidoamine) (PAMAM) layer around Gd-loaded AuNPs was formed by an 
analogous procedure as described in section 7.4.5, from Gd-loaded AuNPs (5.5 mg, 
4.00×10-3 mmol of Gd-DTPA units) and 55.0 mM aq PAMAM G0 (130.00 µL, 
0.016 mmol of NH+) and 2.0 mM aq PAMAM G4 (108 µL, 0.016 mmol of NH+). 
 
7.4.7 Layer by layer assembly of PEI (Mn~1300) and PAA 
(Mn~1200) 
 
Layer by layer (LBL) assembly of oppositely charged polyelectrolytes around 
negatively charged Gd-loaded AuNPs was carried out using an analogous procedure 
as described in section 7.4.5, from Gd-loaded AuNPs (10.0 mg, 6.69×10-3 mmol of 
Gd-DTPA units), 5.0 mM aq PEI 1 with Mn ~ 1300 (180 µL, 0.026 mmol of NH
+) 
and 5.0 mM aq PAA 1 with Mn~1200 (235 µL, 0.026 mmol of COO
- units). The 
same procedure was followed to form polyelectrolyte self assembly using larger 
polyelectrolytes i.e. PEI 2  (Mn~2000) and PAA 2 Mn~2100). 
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7.5 Experimental part for chapter 4 
 
7.5.1 Synthesis of triphenyl phosphine protected AuNPs 
(PPh3@AuNPs) 
 
P P P
P
HAuCl4. 3H2O(aq) +
PhCH3
RTNaBH4
TOABr Au
PPh3 protected AuNPs
 
Triphenyl phosphine (PPh3) protected AuNPs were prepared using the literature 
procedure.14 A 1.0 % (w/w) aq solution of tetrachloroaurate trihydrate (5.0 mL, 
0.127 mmol) was taken in a 50 mL round bottom flask. Tetraoctylammonium 
bromide (100 mg, 0.183 mmol) solution in toluene (5.0 mL) was added to the stirred 
gold solution. The reaction mixture was stirred for 5.0 min. The colour of the organic 
phase turned orange due to the transfer of gold from the aqueous phase to organic 
phase and the aqueous phase became colourless. Triphenyl phosphine (PPh3) (130 
mg, 0.496 mmol) was added as a solid to the above solution and the reaction mixture 
was stirred for further 2.0 min. A freshly prepared solution of NaBH4 (130 mg, 3.42 
mmol) in deionised H2O (5.0 mL) was added to the stirred reaction mixture. The 
colour of organic phase turned from orange to dark brown within seconds. The 
reaction mixture was stirred for further 10-15 min. The organic phase was separated 
from the aqueous phase. The solvent (toluene) was removed using rotary evaporator 
at ~30-35oC to get solid crude PPh3 protected AuNPs. The crude AuNPs were 
purified by gel permeation chromatography using Bio-Beads SX-I gel (Bio-Rad) as a 
stationary phase and DCM as an eluent. Yield 54 mg.  
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7.5.2 Synthesis of AuNPs protected by nitroxide based ligand  
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The gold nanoparticles protected by TEMPO based ligand were prepared using a 
modified literature procedure.15 The PPh3 protected AuNPs (30.0 mg, 0.03 mmol of 
PPh3) dissolved in chloroform (5.0 mL) were taken in a 25 mL round bottom flask. 
The temperature of the gold solution was raised to ~50 oC. To the stirred solution, 
dithiobis(succinimidylpropionate) (DSP) (124 mg, 0.31 mmol) solution in 
chloroform (5.0 mL) was added and the reaction mixture was stirred for 1.0 min at 
50 oC. After 1 min, 4-amino-TEMPO (210 mg, 1.22 mmol) solution in chloroform 
(5.0 mL) was added. The reaction mixture was stirred at 50 oC for further 2 h. After 
stirring, the chloroform was evaporated using rotary evaporator to get crude AuNPs 
protected by TEMPO based ligand. The excess of free ligand molecules was 
removed by gel permeation chromatography using Sephadex LH-20 as a stationary 
phase and MeOH as an eluent. Yield 17.0 mg. Characterization of AuNPs protected 
by TEMPO based ligand is given in chapter 4 (section 4.3.1). 
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7.6 Experimental part of chapter 5 
 
7.6.1 Synthesis of tryptophan based ligand 7 
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Tryptophan based ligand 7 was synthesised by a standard peptide coupling method.4 
L-tryptophan ethyl ester hydrochloride (0.51 g, 1.898 mmol) was taken in a 50 mL 
round bottom flask containing EtOAc (15.0 mL). To the stirred solution of 
tryptophan, dithiobutyric acid (0.200 g, 0.8403 mmol) was added. DCC (0.3964 g, 
1.92 mmol) and DMAP (0.2355 g, 1.93 mmol) were added as a solid mixture to the 
above solution. The reaction mixture was then stirred for 48 h. After stirring, the 
solid residue was removed by filtration, and EtOAc was removed by rotary 
evaporation to get crude tryptophan based ligand 7. The crude product was purified 
by flash chromatography using silica gel as a stationary phase and EtOAc/n-hexane 
(4/1) as an eluent (Rf 0.62). Yield 0.38 g (67%). 
1
H NMR (CDCl3): δ (ppm) 1.18 (t, J 7.05 Hz, 6H, H
9), 1.78-1.95 (m, 4H, H2), 2.17 
(t, J 7.05 Hz, 4H, H1), 2.47 (t, J 7.90 Hz, 4H, H3), 3.18-3.36 (m, 4H, H10), 4.11 (q, 
4H, J 7.05 Hz, H8 ), 4.86-4.96 (m, 2H, H6), 6.32 (d, J 7.80 Hz, 2H H12), 6.88-7.18 
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(m, 4H, Ar-H15+16), 7.29 (d, J 7.42 Hz , 2H, Ar-H17), 7.50 (d, J 7.80 Hz , 2H, Ar-
H14), 8.95 (s+br, 2H, H5).  
13
C NMR (CDCl3): δ (ppm) 14.10 (C
9), 24.50 (C2), 25.20 (C3), 34.20 (C1), 52.80 
(C10), 61.40 (C8), 109.60 (Ar-C), 111.60 (Ar-C), 118.30 (Ar-C), 119.20 (Ar-C), 
121.90 (Ar-C), 123.10 (Ar-C), 127.60 (Ar-C), 136.10 (Ar-C), 171.90 (C4), 172.10 
(C7).  
HR ESI-MS:  m/z [M + H] 1+, Calcd. for C34H43N4O6S2: 667.2619, Found: 667.2640 
 
7.6.2 Synthesis of AuNPs stabilised by DTPA ligand 5 
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AuNPs stabilised by DTPA ligand 5 were synthesised by a modified Brust’s biphasic 
method.6 A 1.0 % (w/w) solution of hydrogen tetrachloroaurate trihydrate (5.0 mL, 
0.127 mmol of Au) was taken in a 50 mL round bottom flask. Tetraoctylammonium 
bromide (347 mg, 0.635 mmol) solution in toluene (12.0 mL) was added to the 
stirred gold solution. The mixture was stirred for ca. 5.0 min until all Au (III) 
precursor had transferred to the organic phase. Visually, the colour of the aqueous 
phase turned from yellow to colourless, while the colour of the toluene phase became 
red brown. A 10 % (w/w) solution of DTPA ligand 5 (107 mg, 0.0635 mmol) in 
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toluene was then added to the reaction mixture. A freshly prepared solution of 
NaBH4 (48 mg, 1.27 mmol) in deionised H2O (3.0 mL) was added 10 s after adding 
the ligand. Au (III) was reduced to Au (0) within seconds; the reaction mixture was 
stirred for further 10-15 min. The organic phase was separated from aqueous phase. 
The organic phase (toluene) was evaporated below 40 oC using rotary evaporator to 
give a dark brown residue, which was dissolved in a minimum amount of toluene 
and purified by gel permeation chromatography using Bio-Beads SX-I gel (Bio-Rad) 
as a stationary phase and toluene as an eluent. Yield 75 mg.  
 
7.6.3 Ligand exchange of tryptophan based ligand 7 with AuNPs 
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The ligand exchange reaction with AuNPs protected by ligand 5 was carried out 
using a modified literature procedure.16 AuNPs (10.0 mg, 4.73×10-3 mmol of DTPA 
units) were taken in a 25 mL round bottom flask containing MeOH (10.0 mL). To 
the stirred solution of AuNPs, a 1.0 mM solution of tryptophan ligand 7 in MeOH 
(0.8 mL, 7.85 ×10-4 mmol) was added. The reaction mixture was stirred for 
overnight at 30 oC. The solvent was evaporated using rotary evaporator, and the 
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AuNPs labelled with tryptophan based ligand were purified by gel permeation 
chromatography using Bio-Beads SX-I gel (Bio-Rad) as a stationary phase and DCM 
as an eluent, followed by DCM evaporation using rotary evaporator to get solid 
tryptophan ligand labelled AuNPs. Yield 7.50 mg. 
 
7.6.4 Deprotection of t-butyl ester groups of DTPA based ligand 5 
and tryptophan ligand 7 at AuNP surface 
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Deprotection of t-butyl ester groups of DTPA ligand 5 and tryptophan ligand 7 at 
AuNP surface was carried out using procedure described in section 7.3.1.6 from 
AuNPs (10.0 mg) and DCM / TFA (2 mL / 1 mL, respectively) under the blanket of 
N2 atmosphere. The dialysis was carried out against deionised H2O using 12-14 kDa 
MWCO dialysis membrane. Yield 6.0 mg. 
 
7.6.5 Lanthanide (Tb3+ and Eu3+) loading on AuNPs 
 
The loading of lanthanides (Tb3+ and Eu3+) was done by an analogous procedure as 
described in section 7.3.1.8 using tryptophan based ligand labelled AuNPs (10.0 mg, 
5.30×10-3 mmol of DTPA units), a 5.0 mM TbCl3 (1.0 mL, 5.0×10
-3 mmol) and  a 
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5.0 mM EuCl3 (1.0 mL, 5.0×10
-3 mmol). Yield:  Tryptophan labelled Tb-loaded 
AuNPs 6.5 mg, Tryptophan labelled Eu-loaded AuNPs 7.01 mg.  
 
7.6.6 Synthesis of Ln3+-DTPA Chelates 
 
Lanthanide (Tb and Eu-DTPA) complexes were prepared by an analogous procedure 
as described in section 7.3.1.8, from 5.0 mM aq DTPA (20.0 mL, 0.10 mmol) and 
5.0 mM aq TbCl3 (18.0 mL, 0.09 mmol of Tb
3+) and 5.0 mM aq EuCl3 (18.0 mL, 
0.09 mmol of Eu3+) . Yield: Tb-DTPA 36.85 mg (78 %), Eu-DTPA 33.69 mg     
(69.0 %). 
Tb-DTPA:  HR ESI-MS  m/z [M - H] 1-, Calcd. for C14H19TbN3O10: 526.0329, 
Found: 526.0326 
Eu-DTPA:  HR ESI-MS  m/z [M - H] 1-, Calcd. for C14H19EuN3O10: 542.0278, 
Found: 542.0302 
N
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N
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Ln3+ Tb3+ Eu3+= &
Ln3+
 
 
 
7.6.7 Ligand exchange of Tb-DTPA chelates@AuNPs with 3-
mercaptopropionic acid 
 
Ligand exchange reaction was done by an analogous procedure as described in 
section 7.6.3, from tryptophan labelled Tb-loaded-AuNPs (8.0 mg, 4.24×10-3 mmol 
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of DTPA units) and a 100.00 mM aq 3-mercaptopropionic acid (4.0 mL, 0.4 mmol). 
Yield 5.0 mg.  
 
7.6.8 Treatment of tryptophan labelled Tb-loaded AuNPs with KI 
and I2 
 
The tryptophan labelled Tb-loaded AuNPs (5.0 mg) were taken in a 25 mL round 
bottom flask. To this flask, a solution of iodine (40 mg) and potassium iodide (900 
mg) in MeOH (20 mL) was added. The AuNPs were destroyed immediately after the 
addition of iodine solution. The decomposition of the AuNPs was evident by their 
colour change from dark brown to yellow. 
  
7.6.9 Synthesis of TEMPO based ligand 8 (TEMPO based spin 
label) 
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TEMPO based ligand 8 was synthesised using a standard coupling method.17 3,3-
Dithiodipropionic acid (0.105 g, 0.5 mmol) was taken in a 100 mL round bottom 
flask containing 5.0 mL of THF. DCC (0.227 g, 1.0 mmol) dissolved in DCM (5.0 
mL) was added to the stirred solution. Then solution of 4-amino-TEMPO (0.172 g, 
1.0 mmol) in DCM (5.0 mL) was added followed by DMAP (10.0 mg, 0.08 mmol). 
The reaction mixture was stirred for 72 h at room temperature. The mixture was then 
filtered and washed with acidified water (2×50 mL, 40.0 mL water + 10.0 mL conc. 
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HCl) and then immediately with 50 mL deionised H2O. The organic phase was dried 
over anhydrous Na2SO4 and combined aqueous phases were extracted with DCM 
(3×10 mL). Solvent was removed and the product was purified by flash 
chromatography using silica gel as a stationary phase and DCM / MeOH (12 / 1) as 
eluent (Rf 0.42). Yield 130 mg (50 %).  
HR ESI-MS:  m/z [M + H] 1+, Calcd. for C24H45N4O4S2: 517.2877, Found: 517.2861 
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7.6.10 Labelling of AuNPs by TEMPO based spin label 8 
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The labelling of AuNPs protected by ligand 5 was done by ligand exchange method 
as described in section 7.6.3 from AuNPs (50.0 mg, 0.027 mmol of DTPA ligand 
molecules) and a 1.0 mM solution of spin label ligand 8 in DMF (4.5 mL, 4.43×10-3 
mmol).Yield 34 mg.  
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7.6.11 Deprotection of t-butyl ester groups of DTPA ligand 5 at 
AuNP surface   
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The AuNPs labelled with TEMPO based ligand 8 (10.0 mg) dissolved in DCM (2.0 
mL) were taken in a 25 mL round bottom flask. The flask was closed with a septum 
(suba seal) and put under inert atmosphere. Under an inert atmosphere, TFA (1.0 
mL) was syringed in. The reaction mixture was stirred for 4 h under the blanket of 
N2 atmosphere. After stirring, DCM/TFA was evaporated at room temperature using 
rotary evaporator and the residual TFA was immediately quenched with 0.1 M 
NaOH. Deprotected spin labelled AuNPs were dialysed against deionised H2O for 
overnight and then purified by gel permeation chromatography using Sephadex gel 
(G 100) as a stationary phase and deionised H2O as an eluent. Yield 6.5 mg. 
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7.6.12 Lanthanide-loading on (ligand 8) spin labelled AuNPs 
protected by DTPA ligand 
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Lanthanides (Gd3+, Dy3+ and La3+) were loaded using a procedure as described in 
section 7.6.5 from spin labelled (by ligand 8) AuNPs (15.0 mg) and a 1.0 mM 
solution of GdCl3.6H2O, DyCl3.6H2O and LaCl3.7H2O). Yield (Gd-loaded-spin-
labelled-AuNPs) 11.23 mg, (Dy-loaded-spin-labelled-AuNPs) 9.56 mg, (La-loaded-
spin-labelled-AuNPs) 12.36 mg.  
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